No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4i5bB1, 1.0000, 0.00, 1.000, 91, 91, STRUCTURE OF HUMAN MHC CLASS II PROTEIN HLA-DR1 CARRYING AN INFLUENZA HEMAGGLUTININ PEPTIDE PARTIALLY FILLING THE BINDING GROOVE
2, d1t5wB2, 0.9957, 0.23, 0.989, 92, 91, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
3, d4i5bE1, 0.9955, 0.23, 1.000, 91, 91, STRUCTURE OF HUMAN MHC CLASS II PROTEIN HLA-DR1 CARRYING AN INFLUENZA HEMAGGLUTININ PEPTIDE PARTIALLY FILLING THE BINDING GROOVE
4, d1t5wE2, 0.9949, 0.25, 0.989, 92, 91, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
5, d2icwB2, 0.9939, 0.27, 0.989, 92, 91, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
6, p3qxaE1, 0.9938, 0.27, 0.989, 92, 91, HLA-DR1 BOUND WITH CLIP PEPTIDE
7, d2icwE2, 0.9938, 0.27, 0.989, 92, 91, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
8, p5jlzD1, 0.9924, 0.30, 0.890, 91, 91, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 IN COMPLEX WITH MODIFIED ALPHA- ENOLASE PEPTIDE 26-40 WITH CITRULLINE AT THE POSITION 32
9, d1jwuB2, 0.9924, 0.30, 0.989, 92, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B2
10, p3qxdE1, 0.9922, 0.31, 0.989, 91, 91, F54C HLA-DR1 BOUND WITH CLIP PEPTIDE
11, d1r5iF2, 0.9922, 0.31, 0.989, 92, 91, CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX
12, d1r5iB2, 0.9922, 0.31, 0.989, 92, 91, CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX
13, d2ojeF2, 0.9916, 0.32, 0.989, 92, 91, MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA
14, d2ojeB2, 0.9915, 0.32, 0.989, 92, 91, MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA
15, p3s5lE1, 0.9913, 0.33, 0.989, 93, 91, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
16, p2xn9E1, 0.9911, 0.33, 0.989, 91, 91, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL RECEPTOR STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
17, d1sebF2, 0.9907, 0.34, 0.989, 92, 91, COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
18, d1sebB2, 0.9907, 0.34, 0.989, 92, 91, COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
19, d2ipkB2, 0.9906, 0.34, 0.989, 92, 91, CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DR1 IN COMPLEX WITH THE FLUOROGENIC PEPTIDE ACPKXVKQNTLKLAT (X=3- [5-(DIMETHYLAMINO)-13-DIOXO-13-DIHYDRO-2H-ISOINDOL-2-YL]- L-ALANINE) AND THE SUPERANTIGEN SEC3 VARIANT 3B2
20, p3s5lB1, 0.9904, 0.34, 0.989, 93, 91, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
21, d1jwsB2, 0.9902, 0.34, 0.989, 92, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B1
22, d1jwmB2, 0.9901, 0.35, 0.989, 92, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1(HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3
23, d1d5mB2, 0.9900, 0.35, 0.890, 91, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB
24, p3s4sE1, 0.9895, 0.36, 0.989, 93, 91, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
25, d1t5xB2, 0.9895, 0.36, 0.989, 92, 91, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR) AND THE SUPERANTIGEN SEC3-3B2
26, d2g9hB2, 0.9891, 0.37, 0.989, 92, 91, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN I (SEI) IN COMPLEX WITH A HUMAN MHC CLASS II MOLECULE
27, p4ov5Q1, 0.9890, 0.37, 0.989, 91, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
28, p3s4sB1, 0.9887, 0.37, 0.989, 93, 91, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
29, p6cqjB1, 0.9886, 0.37, 0.989, 91, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
30, d1d5zB2, 0.9881, 0.38, 0.890, 92, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB
31, p4ov5B1, 0.9879, 0.39, 0.989, 91, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
32, p6cqjH1, 0.9878, 0.39, 0.989, 91, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
33, d1klgB2, 0.9878, 0.39, 0.989, 92, 91, CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37 THR28-->ILE MUTANT) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
34, p5nigB1, 0.9869, 0.41, 0.890, 92, 91, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 WITH MODIFIED ALPHA-ENOLASE PEPTIDE 326-340 (ARGININE 327 TO CITRULLINE) 
35, p4ov5H1, 0.9869, 0.40, 0.989, 91, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
36, d1kluB2, 0.9869, 0.40, 0.989, 92, 91, CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
37, p5ni9B1, 0.9867, 0.41, 0.890, 91, 91, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 WITH THE ALPHA-ENOLASE PEPTIDE 326-340 
38, p4ov5E1, 0.9867, 0.41, 0.989, 91, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
39, p4ov5N1, 0.9866, 0.41, 0.989, 91, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
40, d1sjeB2, 0.9865, 0.41, 0.989, 92, 91, HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDE BOUND IN A HAIRPIN CONFORMATION
41, p4md5B1, 0.9864, 0.41, 0.890, 91, 91, IMMUNE RECEPTOR
42, p3l6fB1, 0.9864, 0.41, 0.989, 93, 91, STRUCTURE OF MHC CLASS II MOLECULE HLA-DR1 COMPLEXED WITH PHOSPHOPEPTIDE MART-1
43, d5laxB1, 0.9863, 0.41, 0.890, 92, 91, CRYSTAL STRUCTURE OF HLA_DRB1*04:01 IN COMPLEX WITH ALPHA-ENOLASE PEPTIDE 26-40
44, p5jlzB1, 0.9860, 0.42, 0.890, 92, 91, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 IN COMPLEX WITH MODIFIED ALPHA- ENOLASE PEPTIDE 26-40 WITH CITRULLINE AT THE POSITION 32
45, d1pywB2, 0.9860, 0.41, 0.989, 92, 91, HUMAN CLASS II MHC PROTEIN HLA-DR1 BOUND TO A DESIGNED PEPTIDE RELATED TO INFLUENZA VIRUS HEMAGGLUTININ FVKQNA(MAA)AL IN COMPLEX WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
46, d1sjhB2, 0.9857, 0.42, 0.989, 92, 91, HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE
47, d1fv1B2, 0.9857, 0.42, 0.890, 92, 91, STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES
48, p4c56E1, 0.9856, 0.42, 0.989, 91, 91, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
49, p6cqrG1, 0.9855, 0.42, 0.989, 92, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
50, p6bilB1, 0.9853, 0.42, 0.890, 91, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
51, p4c56K1, 0.9853, 0.42, 0.989, 91, 91, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
52, p6bijB1, 0.9851, 0.43, 0.890, 91, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
53, d1fv1E2, 0.9851, 0.43, 0.890, 92, 91, STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES
54, p6bivA1, 0.9850, 0.43, 0.890, 91, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED LL37 PEPTIDE
55, p4x5wB1, 0.9850, 0.43, 0.989, 91, 91, HLA-DR1 WITH CLIP102-120(M107W)
56, p4mcyB1, 0.9849, 0.43, 0.890, 91, 91, IMMUNE RECEPTOR
57, p6cqrB1, 0.9848, 0.43, 0.989, 92, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
58, p3pgdB1, 0.9839, 0.45, 0.989, 93, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 CANONICAL PEPTIDE ORIENTATION
59, p3pgcB1, 0.9839, 0.45, 0.989, 92, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 FLIPPED PEPTIDE ORIENTATION
60, p3pgdE1, 0.9838, 0.45, 0.989, 93, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 CANONICAL PEPTIDE ORIENTATION
61, p6atiE1, 0.9837, 0.45, 0.890, 91, 91, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN-64CIT59-71
62, p4mdjB1, 0.9837, 0.45, 0.857, 91, 91, IMMUNE RECEPTOR
63, p6bixB1, 0.9835, 0.45, 0.890, 91, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED LL37 PEPTIDE
64, p6cpoB1, 0.9833, 0.46, 0.901, 91, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
65, p6atiB1, 0.9832, 0.45, 0.890, 91, 91, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN-64CIT59-71
66, p4ov5K1, 0.9831, 0.46, 0.989, 92, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
67, p6atfB1, 0.9830, 0.46, 0.890, 91, 91, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN59-71
68, p6atfE1, 0.9829, 0.46, 0.890, 91, 91, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN59-71
69, d2ianG2, 0.9828, 0.47, 0.989, 91, 91, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
70, p4y19B1, 0.9826, 0.48, 0.890, 93, 91, IMMUNE COMPLEX
71, p4x5xB1, 0.9826, 0.47, 0.978, 110, 91, HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W)
72, p6cpoE1, 0.9825, 0.47, 0.901, 92, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
73, p6binB1, 0.9823, 0.47, 0.890, 91, 91, HLA-DRB1 IN COMPLEX WITH TYPE II COLLAGEN PEPTIDE
74, p3pdoB1, 0.9823, 0.47, 0.989, 93, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP102-120
75, p4ah2B1, 0.9822, 0.47, 0.989, 107, 91, HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN CANONICAL ORIENTATION
76, p6cqqG1, 0.9818, 0.47, 0.901, 91, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
77, p6birB1, 0.9816, 0.48, 0.890, 91, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED VIMENTIN PEPTIDE
78, p4mczB1, 0.9816, 0.48, 0.890, 91, 91, IMMUNE RECEPTOR
79, p4md0B1, 0.9815, 0.48, 0.890, 91, 91, IMMUNE RECEPTOR
80, p4is6B1, 0.9812, 0.48, 0.890, 91, 91, CRYSTAL STRUCTURE OF HLA-DR4 BOUND TO GP100 PEPTIDE
81, p4mdiB1, 0.9810, 0.49, 0.857, 91, 91, IMMUNE RECEPTOR
82, p3pgcE1, 0.9810, 0.49, 0.989, 91, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 FLIPPED PEPTIDE ORIENTATION
83, p6cqqB1, 0.9807, 0.49, 0.901, 91, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
84, d2iamB2, 0.9802, 0.53, 0.989, 92, 91, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
85, p4md4B1, 0.9801, 0.50, 0.890, 91, 91, IMMUNE RECEPTOR
86, p4x5xD1, 0.9797, 0.50, 0.978, 110, 91, HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W)
87, d1d5xB2, 0.9797, 0.50, 0.890, 92, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB
88, d4aenB1, 0.9796, 0.34, 0.989, 90, 90, HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION
89, d1kg0B2, 0.9796, 0.35, 0.989, 90, 90, STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TO THE MHC CLASS II RECEPTOR HLA-DR1
90, d1hxyB2, 0.9792, 0.35, 0.989, 90, 90, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II
91, p3qxdB1, 0.9786, 0.53, 0.989, 91, 91, F54C HLA-DR1 BOUND WITH CLIP PEPTIDE
92, d1hqrB2, 0.9779, 0.52, 0.890, 91, 91, CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH- AFFINITY ZINC-DEPENDENT SITE ON MHC CLASS II
93, d2sebB2, 0.9777, 0.54, 0.890, 91, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II
94, d2wbjF1, 0.9775, 0.38, 0.889, 90, 90, TCR COMPLEX
95, p4y1aB1, 0.9774, 0.54, 0.890, 93, 91, IMMUNE COMPLEX
96, d2wbjB1, 0.9773, 0.38, 0.889, 90, 90, TCR COMPLEX
97, p3o6fB1, 0.9769, 0.54, 0.890, 107, 91, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
98, d2ianQ2, 0.9758, 0.41, 0.978, 90, 90, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
99, d1dlhE2, 0.9758, 0.42, 0.978, 90, 90, CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
100, d1fytB2, 0.9755, 0.41, 0.989, 90, 90, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR1
101, d1h15E2, 0.9754, 0.56, 0.890, 91, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE
102, p6biyB1, 0.9750, 0.56, 0.890, 91, 91, HLA-DRB1 IN COMPLEX WITH HISTONE 2B PEPTIDE
103, p6cqnB1, 0.9749, 0.57, 0.846, 92, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
104, p6bizB1, 0.9749, 0.56, 0.890, 91, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED HISTONE 2B PEPTIDE
105, d1d6eB2, 0.9749, 0.42, 0.889, 90, 90, CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB
106, d2ianL2, 0.9745, 0.43, 0.978, 90, 90, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
107, d1dlhB2, 0.9744, 0.44, 0.978, 90, 90, CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
108, p3qxaB1, 0.9741, 0.58, 0.989, 92, 91, HLA-DR1 BOUND WITH CLIP PEPTIDE
109, d2ianB2, 0.9739, 0.44, 0.978, 90, 90, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
110, p6atzB1, 0.9736, 0.44, 0.889, 90, 90, HLA-DRB1*1402 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
111, p6cqlB1, 0.9730, 0.59, 0.846, 92, 91, CRYSTAL STRUCTURE OF A TCR 
112, p5v4mF1, 0.9730, 0.58, 0.890, 102, 91, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
113, p6atzD1, 0.9727, 0.45, 0.889, 90, 90, HLA-DRB1*1402 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
114, d1bx2E2, 0.9726, 0.45, 0.889, 90, 90, CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN
115, p5v4mL1, 0.9725, 0.59, 0.890, 102, 91, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
116, d4fqxB1, 0.9717, 0.49, 0.956, 92, 90, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
117, p5v4mI1, 0.9715, 0.60, 0.890, 102, 91, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
118, d1bx2B2, 0.9712, 0.47, 0.889, 90, 90, CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN
119, p6cplB1, 0.9710, 0.61, 0.846, 91, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
120, p5v4nC1, 0.9708, 0.48, 0.989, 102, 90, STRUCTURE OF HLA-DR1 WITH BOUND ALPHA3(135-145) PEPTIDE
121, p5v4mC1, 0.9704, 0.61, 0.890, 102, 91, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
122, d1lo5B2, 0.9698, 0.49, 0.989, 90, 90, CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN A IN COMPLEX WITH HUMAN MHC CLASS II
123, d5laxD1, 0.9696, 0.32, 0.888, 89, 89, CRYSTAL STRUCTURE OF HLA_DRB1*04:01 IN COMPLEX WITH ALPHA-ENOLASE PEPTIDE 26-40
124, d1zglH2, 0.9689, 0.66, 0.890, 92, 91, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
125, d1aqdE2, 0.9689, 0.34, 0.989, 89, 89, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
126, d1j8hB2, 0.9687, 0.51, 0.889, 90, 90, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
127, d1zglK2, 0.9684, 0.67, 0.890, 92, 91, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
128, p6cqjE1, 0.9682, 0.35, 0.989, 89, 89, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
129, d1aqdK2, 0.9671, 0.37, 0.989, 89, 89, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
130, d4e41B1, 0.9667, 0.38, 0.989, 89, 89, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
131, p6cpnB1, 0.9659, 0.67, 0.846, 91, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
132, p2q6wE1, 0.9656, 0.55, 0.811, 90, 90, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
133, d1aqdH2, 0.9653, 0.40, 0.989, 89, 89, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
134, d1aqdB2, 0.9651, 0.40, 0.989, 89, 89, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
135, p3t0eB1, 0.9650, 0.67, 0.890, 107, 91, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
136, p2q6wB1, 0.9649, 0.55, 0.811, 90, 90, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
137, d4e41G1, 0.9641, 0.42, 0.989, 89, 89, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
138, p5v4nF1, 0.9636, 0.57, 0.989, 102, 90, STRUCTURE OF HLA-DR1 WITH BOUND ALPHA3(135-145) PEPTIDE
139, d1h15B2, 0.9617, 0.74, 0.890, 91, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE
140, d1zglE2, 0.9594, 0.84, 0.890, 91, 91, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
141, d1zglB2, 0.9588, 0.84, 0.879, 92, 91, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
142, d2fseD2, 0.9584, 0.50, 0.989, 89, 89, CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE HLA-DR1 (DRB1*0101) COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
143, d3c5jB1, 0.9572, 0.51, 0.831, 89, 89, CRYSTAL STRUCTURE OF HLA DR52C
144, d1ymmB2, 0.9561, 0.65, 0.889, 90, 90, TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
145, p4i0pH1, 0.9533, 0.59, 0.573, 89, 89, HLA-DO IN COMPLEX WITH HLA-DM
146, d2fseB2, 0.9532, 0.42, 0.989, 88, 88, CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE HLA-DR1 (DRB1*0101) COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
147, p4i0pD1, 0.9520, 0.59, 0.573, 89, 89, HLA-DO IN COMPLEX WITH HLA-DM
148, d5ksvB1, 0.9514, 0.74, 0.656, 90, 90, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP2
149, p4h1lE1, 0.9503, 0.60, 0.831, 89, 89, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
150, p4h1lB1, 0.9502, 0.60, 0.831, 89, 89, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
151, p4d8pD1, 0.9476, 0.76, 0.656, 103, 90, STRUCTURAL AND FUNCTIONAL STUDIES OF THE TRANS-ENCODED HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) MOLECULE
152, d1s9vE2, 0.9476, 0.77, 0.656, 92, 90, CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
153, p4gbxB2, 0.9453, 0.38, 1.000, 87, 87, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5
154, d5ksuE1, 0.9449, 0.80, 0.656, 90, 90, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP1 AT 2.73 RESOLUTION
155, d1a6aB2, 0.9442, 0.54, 0.807, 88, 88, THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3
156, d5ujtE1, 0.9441, 0.80, 0.611, 92, 90, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
157, d1jk8B2, 0.9441, 0.79, 0.611, 92, 90, CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX
158, d5ksuB1, 0.9437, 0.81, 0.656, 90, 90, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP1 AT 2.73 RESOLUTION
159, d4ozhD1, 0.9436, 0.80, 0.656, 90, 90, S16 PROTEIN COMPLEX
160, p4d8pB1, 0.9432, 0.82, 0.656, 103, 90, STRUCTURAL AND FUNCTIONAL STUDIES OF THE TRANS-ENCODED HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) MOLECULE
161, p4p2rB1, 0.9426, 0.89, 0.678, 90, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
162, d5ujtH1, 0.9424, 0.82, 0.611, 92, 90, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
163, d4ozgD1, 0.9420, 0.81, 0.656, 90, 90, D2 PROTEIN COMPLEX
164, p4p2qL1, 0.9419, 0.92, 0.678, 90, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
165, p4p2rL1, 0.9414, 0.92, 0.678, 90, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
166, p4p2qB1, 0.9413, 0.90, 0.678, 90, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
167, p4p2rG1, 0.9411, 0.93, 0.678, 90, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
168, d1s9vB2, 0.9411, 0.85, 0.656, 92, 90, CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
169, d5ujtB1, 0.9403, 0.83, 0.611, 92, 90, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
170, p4p2qQ1, 0.9400, 0.94, 0.678, 90, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
171, p4p2qG1, 0.9386, 0.96, 0.678, 90, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
172, p6bgaB1, 0.9375, 0.90, 0.678, 116, 90, 2B4 I-EK TCR-MHC COMPLEX WITH AFFINITY-ENHANCING VELCRO PEPTIDE 
173, d4h25E1, 0.9374, 0.49, 0.839, 87, 87, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
174, d4h26E1, 0.9368, 0.50, 0.839, 87, 87, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
175, d4grlB1, 0.9365, 0.76, 0.618, 92, 89, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
176, d1i3rF2, 0.9356, 1.33, 0.670, 120, 91, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
177, d5ks9D1, 0.9355, 1.09, 0.615, 91, 91, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
178, p4oziB1, 0.9354, 0.88, 0.656, 90, 90, S2 PROTEIN COMPLEX
179, d3pl6B1, 0.9354, 0.77, 0.618, 92, 89, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
180, d1i3rB2, 0.9347, 0.96, 0.678, 120, 90, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
181, d5ks9B1, 0.9342, 0.96, 0.678, 120, 90, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
182, d4h26B1, 0.9342, 1.13, 0.615, 91, 91, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
183, d4h25B1, 0.9342, 0.53, 0.839, 87, 87, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
184, d1i3rD2, 0.9342, 0.53, 0.839, 87, 87, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
185, p3qiwB1, 0.9341, 0.96, 0.678, 120, 90, CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC-P5E/I-EK
186, d1i3rH2, 0.9340, 0.99, 0.678, 90, 90, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
187, d1ktdB2, 0.9339, 0.96, 0.678, 120, 90, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
188, d4ozfB1, 0.9334, 0.96, 0.678, 120, 90, JR5.1 PROTEIN COMPLEX
189, d4ozhB1, 0.9332, 0.90, 0.656, 90, 90, S16 PROTEIN COMPLEX
190, d1uvqB2, 0.9331, 0.89, 0.656, 90, 90, CRYSTAL STRUCTURE OF HLA-DQ0602 IN COMPLEX WITH A HYPOCRETIN PEPTIDE
191, d3qiuB1, 0.9326, 0.79, 0.629, 92, 89, CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK
192, d5ksaB1, 0.9324, 1.00, 0.678, 90, 90, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
193, d1ktdD2, 0.9324, 1.11, 0.615, 91, 91, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
194, d2nnaB2, 0.9320, 0.96, 0.678, 120, 90, STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DQ8 BOUND WITH A DEAMIDATED GLUTEN PEPTIDE
195, p4p2rQ1, 0.9318, 1.14, 0.615, 92, 91, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
196, p4oziD1, 0.9318, 0.92, 0.685, 89, 89, S2 PROTEIN COMPLEX
197, d4z7uD1, 0.9313, 0.92, 0.656, 90, 90, S13 COMPLEX
198, d4z7uB1, 0.9310, 1.14, 0.615, 91, 91, S13 COMPLEX
199, d4z7wB1, 0.9307, 1.13, 0.615, 91, 91, T316 COMPLEX
200, d4mayB1, 0.9306, 0.90, 0.611, 90, 90, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
201, p3lqzB1, 0.9306, 0.82, 0.618, 92, 89, CRYSTAL STRUCTURE OF HLA-DP2
202, d4z7wD1, 0.9300, 0.71, 0.625, 103, 88, T316 COMPLEX
203, p4p2oB1, 0.9297, 0.91, 0.611, 90, 90, CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH 2A/I-EK
204, d4ozgB1, 0.9296, 0.82, 0.685, 89, 89, D2 PROTEIN COMPLEX
205, d3qibB1, 0.9295, 0.92, 0.656, 90, 90, CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
206, p4gg6D1, 0.9291, 1.03, 0.678, 91, 90, PROTEIN COMPLEX
207, d5ksbD1, 0.9290, 1.18, 0.615, 91, 91, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
208, d1kt2D2, 0.9289, 1.14, 0.615, 91, 91, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
209, d5ksbB1, 0.9286, 1.01, 0.678, 118, 90, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
210, d1kt2B2, 0.9278, 1.11, 0.615, 91, 91, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
211, d4z7vD1, 0.9267, 1.01, 0.678, 118, 90, L3-12 COMPLEX
212, d1fneD2, 0.9260, 1.10, 0.615, 91, 91, HISTOCOMPATIBILITY ANTIGEN
213, d1fngD2, 0.9255, 0.86, 0.685, 89, 89, HISTOCOMPATIBILITY ANTIGEN
214, d1ieaD2, 0.9253, 0.87, 0.685, 89, 89, HISTOCOMPATIBILITY ANTIGEN
215, d1r5vB2, 0.9250, 0.86, 0.685, 89, 89, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
216, d1r5vD2, 0.9248, 0.76, 0.682, 89, 88, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
217, d1fneB2, 0.9246, 0.76, 0.682, 89, 88, HISTOCOMPATIBILITY ANTIGEN
218, d1fngB2, 0.9237, 0.87, 0.685, 89, 89, HISTOCOMPATIBILITY ANTIGEN
219, d1iebB2, 0.9236, 0.88, 0.685, 89, 89, HISTOCOMPATIBILITY ANTIGEN
220, d4z7vB1, 0.9234, 0.90, 0.685, 89, 89, L3-12 COMPLEX
221, d1ieaB2, 0.9232, 0.97, 0.611, 90, 90, HISTOCOMPATIBILITY ANTIGEN
222, d1r5wD2, 0.9219, 0.88, 0.685, 89, 89, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
223, d1r5wB2, 0.9219, 0.78, 0.682, 89, 88, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
224, d3c60D2, 0.9195, 0.78, 0.682, 89, 88, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
225, d3c5zD2, 0.9192, 0.91, 0.584, 104, 89, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
226, d3c5zH2, 0.9191, 0.92, 0.584, 105, 89, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
227, d3c60H2, 0.9187, 0.92, 0.584, 105, 89, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
228, d1iebD2, 0.9180, 0.92, 0.584, 104, 89, HISTOCOMPATIBILITY ANTIGEN
229, p3o6fF1, 0.9174, 0.94, 0.685, 89, 89, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
230, d1lnuB2, 0.9131, 0.47, 0.882, 102, 85, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
231, d1lnuF2, 0.9128, 1.46, 0.571, 120, 91, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
232, d1lnuH2, 0.9126, 1.46, 0.571, 120, 91, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
233, d1lnuD2, 0.9126, 1.46, 0.571, 120, 91, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
234, p4p5mF1, 0.9107, 1.14, 0.578, 120, 90, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
235, p4p57D1, 0.9107, 0.80, 0.632, 100, 87, MHC TCR PEPTIDE COMPLEX
236, p6blxB1, 0.9105, 0.80, 0.632, 103, 87, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8G9E
237, p4p23D1, 0.9100, 1.01, 0.573, 106, 89, J809.B5 TCR BOUND TO IAB/3K
238, p6blqB1, 0.9092, 0.91, 0.580, 102, 88, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8E9E
239, p4p5kB1, 0.9086, 1.02, 0.573, 109, 89, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGY AND AUTOIMMUNITY
240, d1mujB2, 0.9079, 0.93, 0.625, 103, 88, CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE
241, d1d9kD2, 0.9074, 1.17, 0.596, 92, 89, CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
242, d3c6lD2, 0.9071, 1.02, 0.596, 90, 89, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20
243, d2iadB2, 0.9067, 0.92, 0.591, 102, 88, CLASS II MHC I-AD IN COMPLEX WITH AN INFLUENZA HEMAGGLUTININ PEPTIDE 126-138
244, d3c6lH2, 0.9036, 0.95, 0.636, 89, 88, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20
245, p4p5tH1, 0.9029, 0.95, 0.591, 102, 88, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
246, p4p5tD1, 0.9006, 0.88, 0.598, 101, 87, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
247, p3wexH1, 0.8998, 0.90, 0.598, 101, 87, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
248, p3rdtD1, 0.8995, 0.94, 0.632, 96, 87, CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
249, p3wexB1, 0.8994, 0.91, 0.598, 101, 87, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
250, d4p46D1, 0.8993, 0.94, 0.632, 96, 87, J809.B5 Y31A TCR BOUND TO IAB3K
251, p3wexD1, 0.8982, 0.91, 0.598, 102, 87, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
252, d1d9kH2, 0.8981, 0.95, 0.632, 96, 87, CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
253, d1iaoB2, 0.8969, 1.08, 0.596, 90, 89, CLASS II MHC I-AD IN COMPLEX WITH OVALBUMIN PEPTIDE 323-339
254, d2pxyD2, 0.8963, 0.93, 0.644, 88, 87, CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
255, p4p4kB1, 0.8962, 0.93, 0.563, 89, 87, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
256, p4p4kF1, 0.8956, 1.09, 0.625, 100, 88, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
257, d2z31D2, 0.8938, 1.10, 0.625, 100, 88, CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
258, p3wexF1, 0.8934, 0.95, 0.563, 89, 87, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
259, p6blrB1, 0.8931, 0.99, 0.632, 96, 87, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8E9E6SS
260, p4p5kE1, 0.8926, 0.98, 0.586, 109, 87, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGY AND AUTOIMMUNITY
261, d1u3hH2, 0.8914, 1.08, 0.625, 103, 88, CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
262, p5dmkF1, 0.8889, 1.16, 0.557, 91, 88, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
263, p5dmkB1, 0.8884, 1.02, 0.586, 100, 87, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
264, p5dmkH1, 0.8873, 1.01, 0.586, 100, 87, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
265, d1u3hD2, 0.8863, 1.04, 0.598, 100, 87, CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
266, p5dmkD1, 0.8860, 1.19, 0.557, 91, 88, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
267, d1iakB2, 0.8844, 1.04, 0.586, 100, 87, HISTOCOMPATIBILITY ANTIGEN I-AK
268, p4p5mB1, 0.8832, 0.94, 0.616, 87, 86, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
269, p2p24B1, 0.8825, 1.01, 0.628, 99, 86, I-AU/MBP125-135
270, d1f3jE2, 0.8815, 0.97, 0.570, 101, 86, HISTOCOMPATIBILITY ANTIGEN I-AG7
271, p4p5mD1, 0.8812, 1.06, 0.586, 89, 87, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
272, d1f3jB2, 0.8797, 1.03, 0.628, 99, 86, HISTOCOMPATIBILITY ANTIGEN I-AG7
273, d1es0B2, 0.8773, 1.08, 0.586, 89, 87, CRYSTAL STRUCTURE OF THE MURINE CLASS II ALLELE I-A(G7) COMPLEXED WITH THE GLUTAMIC ACID DECARBOXYLASE (GAD65) PEPTIDE 207-220
274, d3mbeF1, 0.8766, 1.01, 0.593, 87, 86, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
275, p3mbeB1, 0.8765, 1.02, 0.593, 87, 86, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
276, d1k2dB2, 0.8736, 1.03, 0.593, 87, 86, CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A
277, p3cupB1, 0.8733, 1.04, 0.570, 87, 86, CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE I-AG7 IN COMPLEX WITH THE PEPTIDE GAD221-235
278, d1jl4B2, 0.8635, 1.25, 0.586, 103, 87, CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
279, p4p4rD1, 0.8492, 0.95, 0.631, 85, 84, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
280, p4gg6B1, 0.8479, 0.80, 0.642, 93, 81, PROTEIN COMPLEX
281, p4p4rB1, 0.8472, 0.80, 0.654, 81, 81, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
282, p4p5mH1, 0.8447, 0.83, 0.642, 93, 81, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
283, p4p57B1, 0.8435, 0.84, 0.642, 94, 81, MHC TCR PEPTIDE COMPLEX
284, d5u1rA1, 0.7884, 0.74, 0.650, 97, 80, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
285, d5u72C1, 0.7871, 2.21, 0.125, 176, 88, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
286, d5d7jC1, 0.7845, 2.20, 0.125, 176, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
287, d5u1rC1, 0.7827, 2.21, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
288, p5opiA1, 0.7824, 2.22, 0.125, 178, 88, CRYSTAL STRUCTURE OF THE TAPBPR-MHC I PEPTIDE EDITING COMPLEX
289, d4pjcC1, 0.7820, 2.15, 0.124, 180, 89, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
290, d5d7iA1, 0.7807, 2.22, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
291, d4pjaC1, 0.7798, 2.23, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
292, d4pj5A1, 0.7784, 2.24, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
293, d4pjcA1, 0.7783, 2.26, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
294, d5u72A1, 0.7777, 2.04, 0.126, 178, 87, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
295, d4pjfA1, 0.7759, 2.26, 0.125, 176, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR
296, d5u6qA1, 0.7756, 2.28, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
297, d5d7jE1, 0.7754, 2.07, 0.126, 176, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
298, d4pjaA1, 0.7754, 2.26, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
299, d5u16C1, 0.7753, 2.06, 0.126, 178, 87, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
300, d4l4vA1, 0.7752, 2.29, 0.125, 178, 88, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
301, d5d5mA1, 0.7745, 2.05, 0.126, 177, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
302, d5u17A1, 0.7743, 2.29, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
303, p5gjyA1, 0.7743, 2.07, 0.126, 178, 87, CRYSTAL STRUCTURE OF DUCK MHC CLASS I FOR 1.71 ANGSTROM
304, d4lcwA1, 0.7743, 2.04, 0.174, 177, 86, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
305, d5u2vA1, 0.7742, 2.08, 0.126, 178, 87, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
306, p3bevA1, 0.7739, 2.07, 0.126, 178, 87, 11MER STRUCTURE OF AN MHC CLASS I MOLECULE FROM B21 CHICKENS ILLUSTRATE PROMISCUOUS PEPTIDE BINDING
307, d4pjeA1, 0.7738, 2.26, 0.151, 176, 86, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR
308, d5u16A1, 0.7737, 2.06, 0.126, 176, 87, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
309, d4pj7A1, 0.7731, 2.27, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
310, d4l4tA1, 0.7730, 2.08, 0.126, 178, 87, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
311, d4pj5C1, 0.7729, 2.07, 0.126, 178, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
312, d4nqdA1, 0.7729, 2.07, 0.126, 178, 87, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
313, d4pjiA1, 0.7724, 2.27, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
314, d4pjiC1, 0.7722, 2.08, 0.126, 178, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
315, p5nq1A1, 0.7721, 2.08, 0.126, 177, 87, PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; WITH HUMAN BETA2 MICRO GLOBULIN; PRESENTING DFEREGYSL 
316, d4pj7C1, 0.7720, 2.28, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
317, d5d7iC1, 0.7719, 2.25, 0.146, 181, 89, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
318, d4pjbC1, 0.7719, 2.30, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
319, p4cvzA1, 0.7715, 2.28, 0.125, 178, 88, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
320, d4d0cA2, 0.7714, 2.28, 0.136, 178, 88, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
321, d4pjxA1, 0.7712, 2.21, 0.151, 175, 86, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
322, d4iiqC2, 0.7710, 2.31, 0.138, 177, 87, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
323, d4pjeC1, 0.7709, 2.08, 0.126, 176, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR
324, d4pjgA1, 0.7707, 2.15, 0.115, 176, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
325, d4lcwC1, 0.7704, 2.28, 0.125, 178, 88, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
326, p4l9lC2, 0.7703, 2.31, 0.125, 178, 88, CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.2 MAIT TCR IN COMPLEX WITH BOVINE MR1
327, d5u2vC1, 0.7701, 2.09, 0.126, 178, 87, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
328, d2yf1A1, 0.7700, 2.19, 0.115, 174, 87,  
329, d4pjbA1, 0.7699, 2.32, 0.124, 178, 89, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
330, d5u6qC1, 0.7695, 2.12, 0.140, 177, 86, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
331, d4pjfC1, 0.7694, 2.30, 0.136, 178, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR
332, d4l4vC1, 0.7694, 2.28, 0.125, 178, 88, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
333, d5d5mC1, 0.7688, 2.30, 0.125, 178, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
334, d4nqeA1, 0.7688, 2.29, 0.125, 178, 88, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
335, p4lccC2, 0.7685, 2.10, 0.126, 178, 87, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1
336, p4pj8A1, 0.7684, 2.10, 0.126, 178, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
337, d4nqdC1, 0.7682, 2.12, 0.105, 172, 86, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
338, d4pjxC1, 0.7679, 2.13, 0.116, 175, 86, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
339, d4pj9A1, 0.7677, 2.09, 0.126, 176, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRAJ20 TCR
340, d4pjdA1, 0.7676, 2.31, 0.136, 178, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
341, d4pjhC1, 0.7675, 2.12, 0.126, 178, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR
342, d5u17C1, 0.7674, 2.10, 0.126, 178, 87, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
343, p3bewD1, 0.7674, 2.31, 0.125, 178, 88, 10MER CRYSTAL STRUCTURE OF CHICKEN MHC CLASS I HAPLOTYPE B21
344, d4pjhA1, 0.7671, 2.09, 0.126, 176, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR
345, d4pjgC1, 0.7671, 2.26, 0.138, 176, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
346, p5d7lA1, 0.7670, 2.11, 0.126, 177, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
347, p5gjxA1, 0.7664, 2.33, 0.125, 178, 88, CRYSTAL STRUCTURE OF DUCK MHC I FOR 2.06 ANGSTROM
348, d4nqcC1, 0.7664, 2.29, 0.136, 177, 88, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
349, d4nqcA1, 0.7663, 2.14, 0.172, 177, 87, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
350, d2bsuD3, 0.7658, 2.13, 0.126, 176, 87,  
351, d4l4tC1, 0.7655, 2.33, 0.125, 178, 88, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
352, d4nqeC1, 0.7651, 2.05, 0.138, 181, 87, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
353, p5hgbD1, 0.7650, 2.10, 0.126, 176, 87, HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE
354, p5aczA1, 0.7649, 2.11, 0.126, 176, 87, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 11MER CHICKEN PEPTIDE
355, p5hgbG1, 0.7647, 2.14, 0.170, 180, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE
356, p4l8sC3, 0.7647, 2.30, 0.140, 175, 86, CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
357, d4d0bA2, 0.7646, 2.13, 0.170, 180, 88, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
358, p3bewA1, 0.7646, 2.40, 0.103, 171, 87, 10MER CRYSTAL STRUCTURE OF CHICKEN MHC CLASS I HAPLOTYPE B21
359, p3h9hD1, 0.7640, 2.37, 0.136, 177, 88, HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE
360, p4cvxD1, 0.7639, 2.28, 0.138, 176, 87, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE
361, d3p77A1, 0.7639, 2.12, 0.159, 180, 88, CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE
362, d2bsuA3, 0.7639, 2.46, 0.125, 176, 88,  
363, p3h9hA1, 0.7638, 2.05, 0.149, 176, 87, HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE
364, d4pjdC1, 0.7637, 2.09, 0.138, 181, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
365, p4cvxA1, 0.7637, 2.03, 0.138, 180, 87, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE
366, d2clrD2, 0.7637, 2.29, 0.126, 177, 87, THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE
367, d1vgkA2, 0.7637, 2.46, 0.125, 176, 88, THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KD AT 2.0 A RESOLUTION
368, p5werD1, 0.7629, 2.09, 0.159, 181, 88, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
369, d2dypA2, 0.7629, 2.19, 0.136, 181, 88, CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G
370, d2clrA2, 0.7629, 2.21, 0.125, 179, 88, THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE
371, d4wdiD1, 0.7623, 2.12, 0.159, 180, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
372, p4no3A1, 0.7623, 2.11, 0.159, 181, 88, CRYSTAL STRUCTURE OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2
373, d2bsvA3, 0.7622, 2.18, 0.136, 182, 88,  
374, p5nq1D1, 0.7621, 2.14, 0.159, 180, 88, PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; WITH HUMAN BETA2 MICRO GLOBULIN; PRESENTING DFEREGYSL 
375, p5werA1, 0.7618, 2.08, 0.138, 181, 87, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
376, p5hgaD1, 0.7617, 2.34, 0.146, 181, 89, HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE
377, p5gsvA1, 0.7617, 2.47, 0.124, 177, 89, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 142-5
378, p4wu5A1, 0.7617, 2.15, 0.170, 180, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT)
379, p3kynA1, 0.7617, 2.20, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE
380, p5hgbJ1, 0.7615, 2.14, 0.170, 180, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE
381, p5hgbA1, 0.7615, 2.16, 0.170, 180, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE
382, d5xs3A1, 0.7614, 2.14, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA CLASS I ANTIGEN
383, p4wu5D1, 0.7614, 2.14, 0.170, 180, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT)
384, p5tezA1, 0.7613, 2.14, 0.170, 178, 88, TCR F50 RECGONIZING M1-HLA-A2
385, p3kyoA1, 0.7609, 2.15, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE
386, d1ydpA2, 0.7606, 2.31, 0.157, 180, 89, 1.9A CRYSTAL STRUCTURE OF HLA-G
387, d1zvsA2, 0.7605, 2.17, 0.170, 179, 88, CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX
388, d2yezA1, 0.7604, 2.16, 0.170, 180, 88, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
389, p5hgdD1, 0.7603, 2.19, 0.159, 181, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE
390, p4wu7D1, 0.7603, 2.22, 0.140, 177, 86, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(2F)
391, d2v2xD2, 0.7596, 2.18, 0.170, 180, 88, T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.
392, p5hgdA1, 0.7594, 2.16, 0.170, 180, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE
393, p4d0dJ1, 0.7594, 2.14, 0.159, 181, 88, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE
394, d1ogaA2, 0.7593, 2.19, 0.170, 180, 88, A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
395, p5gsxD1, 0.7592, 2.48, 0.136, 176, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 142-2
396, p3vxoD1, 0.7592, 2.05, 0.163, 181, 86, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(2F)
397, p3vxoA1, 0.7592, 2.20, 0.136, 180, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(2F)
398, p5jhdF1, 0.7591, 2.17, 0.170, 180, 88, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
399, p5hhmA_, 0.7590, 2.17, 0.170, 180, 88, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
400, p3ixaA1, 0.7590, 2.10, 0.172, 180, 87, HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE
401, p5iszA1, 0.7588, 2.27, 0.159, 180, 88, CRYSTAL STRUCTURE OF LS01-TCR/M1-HLA-A*02 COMPLEX
402, p5hhmF_, 0.7588, 1.99, 0.151, 180, 86, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
403, d1a6zA2, 0.7587, 2.09, 0.172, 180, 87, HFE (HUMAN) HEMOCHROMATOSIS PROTEIN
404, d3p73A1, 0.7586, 2.27, 0.159, 180, 88, CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE
405, d1a6zC2, 0.7586, 2.38, 0.159, 178, 88, HFE (HUMAN) HEMOCHROMATOSIS PROTEIN
406, p5d7lC1, 0.7585, 2.38, 0.159, 178, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
407, d4wdiA1, 0.7582, 2.26, 0.148, 179, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
408, d2d31A2, 0.7582, 2.26, 0.148, 179, 88, CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER
409, p5nq3A1, 0.7579, 2.37, 0.159, 178, 88,  PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; WITH HUMAN BETA2 MICRO GLOBULIN; PRESENTING EFEDLTFLA 
410, d4z76D1, 0.7579, 2.20, 0.128, 173, 86, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
411, d2vllD2, 0.7578, 2.19, 0.136, 182, 88, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
412, p5hghA1, 0.7576, 2.19, 0.159, 181, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 10MER EPITOPE
413, p3nfnA1, 0.7576, 2.33, 0.146, 181, 89, RECOGNITION OF PEPTIDE-MHC BY A V-DELTA/V-BETA TCR
414, d2v2wD2, 0.7576, 2.22, 0.136, 182, 88, T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
415, p4wu7A1, 0.7575, 2.14, 0.159, 181, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(2F)
416, p3h9sA1, 0.7574, 2.19, 0.170, 180, 88, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE
417, p5hgaA1, 0.7573, 2.19, 0.170, 180, 88, HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE
418, p5f1nA1, 0.7573, 2.15, 0.159, 181, 88, MHC COMPLEXED TO 11MER PEPTIDE
419, d5iueE1, 0.7571, 2.18, 0.170, 180, 88, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
420, d3bzeA2, 0.7571, 2.05, 0.138, 180, 87, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- 2 E
421, d2vllA2, 0.7570, 2.19, 0.170, 180, 88, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
422, p4d0dA1, 0.7569, 2.15, 0.136, 181, 88, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE
423, d2d31D2, 0.7569, 2.15, 0.125, 180, 88, CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER
424, p5werG1, 0.7568, 2.23, 0.148, 180, 88, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
425, d4z77D1, 0.7568, 2.16, 0.159, 181, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
426, p3kyoC1, 0.7567, 2.32, 0.138, 176, 87, CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE
427, p4d0dG1, 0.7566, 2.21, 0.159, 181, 88, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE
428, p3ixaD1, 0.7566, 2.35, 0.136, 179, 88, HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE
429, p5jhdA1, 0.7565, 2.21, 0.148, 182, 88, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
430, p3vxnA1, 0.7565, 2.18, 0.170, 179, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(WT)
431, d2gtzA2, 0.7565, 2.32, 0.138, 176, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION
432, p3w0wA1, 0.7564, 2.03, 0.140, 180, 86, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121
433, d5w1wA1, 0.7563, 2.12, 0.172, 180, 87, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
434, d2v2xA2, 0.7563, 2.20, 0.170, 180, 88, T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.
435, p3vxuA1, 0.7562, 2.08, 0.161, 181, 87, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
436, p5hhpA1, 0.7561, 2.13, 0.172, 180, 87, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-G4E
437, p5degA1, 0.7561, 2.24, 0.148, 180, 88, CRYSTAL STRUCTURE OF B*27:06 BOUND TO THE PVIPR PEPTIDE
438, p4mnqA1, 0.7561, 2.15, 0.159, 181, 88, TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS
439, d1b0gA2, 0.7561, 2.18, 0.170, 180, 88, CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX
440, d3qfdA1, 0.7560, 2.12, 0.161, 180, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE
441, d2a83A2, 0.7560, 2.19, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)
442, p5gsxA1, 0.7559, 2.11, 0.161, 180, 87, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 142-2
443, p5gsbA1, 0.7559, 2.18, 0.159, 181, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 37-3
444, d4z76A1, 0.7558, 2.08, 0.161, 181, 87, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
445, p3vxuF1, 0.7558, 2.19, 0.159, 181, 88, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
446, d2esvA2, 0.7554, 2.24, 0.136, 180, 88, STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX
447, p5ad0A1, 0.7553, 2.20, 0.148, 180, 88, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 11MER CHICKEN PEPTIDE
448, d3o4lA1, 0.7553, 2.24, 0.136, 182, 88, GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
449, d1b0gD2, 0.7553, 2.18, 0.170, 180, 88, CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX
450, d4z78A1, 0.7552, 2.23, 0.159, 180, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
451, p3mgtD1, 0.7552, 2.23, 0.153, 175, 85, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
452, p3pwvA1, 0.7551, 2.13, 0.151, 181, 86, AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801 (BOLA-A11)
453, p5gsrA1, 0.7550, 2.18, 0.159, 181, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE I5A
454, d1eezA2, 0.7549, 2.23, 0.136, 182, 88, CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)
455, p3mrhA1, 0.7548, 2.12, 0.161, 180, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT
456, p2x4oA1, 0.7548, 2.21, 0.102, 179, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128
457, d1eezD2, 0.7548, 2.21, 0.136, 180, 88, CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)
458, p4no5A1, 0.7547, 2.17, 0.159, 181, 88, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2
459, d2av7D2, 0.7547, 2.17, 0.159, 180, 88, CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.
460, d2vlkA2, 0.7546, 2.18, 0.159, 180, 88, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
461, p4g43D1, 0.7545, 2.17, 0.159, 181, 88, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO P5E
462, p3vxpD1, 0.7545, 2.21, 0.148, 180, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L)
463, p3czfA1, 0.7545, 2.13, 0.161, 181, 87, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)
464, p3bp7A1, 0.7545, 2.17, 0.159, 181, 88, THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2709 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA
465, d1kj2H2, 0.7544, 2.54, 0.148, 176, 88, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
466, d4z78D1, 0.7543, 2.13, 0.172, 180, 87, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
467, p3d18A1, 0.7543, 2.20, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH A VARIANT OF THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2(L)) OF EPSTEIN-BARR VIRUS
468, d3bh9A2, 0.7543, 2.19, 0.159, 180, 88, CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
469, d2j8uH2, 0.7543, 2.30, 0.125, 181, 88, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
470, p5gsrC1, 0.7542, 2.18, 0.138, 182, 87, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE I5A
471, d1zvsD2, 0.7542, 2.20, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX
472, p3mgtJ1, 0.7541, 2.17, 0.159, 181, 88, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
473, d2gitD2, 0.7541, 2.10, 0.161, 181, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
474, d1im9E2, 0.7541, 2.22, 0.136, 180, 88, CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4
475, d4z77A1, 0.7540, 2.24, 0.159, 181, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
476, d1inqA2, 0.7540, 2.13, 0.161, 180, 87, STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE H13A COMPLEXED TO H2-DB
477, d5iueI1, 0.7539, 2.13, 0.161, 181, 87, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
478, d1jgdA2, 0.7539, 2.18, 0.170, 181, 88, HLA-B*2709 BOUND TO DECA-PEPTIDE S10R
479, d1hhiA2, 0.7539, 2.19, 0.136, 182, 88, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
480, p5nq3D1, 0.7538, 2.30, 0.114, 181, 88,  PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; WITH HUMAN BETA2 MICRO GLOBULIN; PRESENTING EFEDLTFLA 
481, p3v5kD1, 0.7538, 2.11, 0.126, 181, 87, HLA2.1 KVAELVWFL
482, d3kpmA1, 0.7538, 2.19, 0.148, 181, 88, CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF A MIMOTOPE
483, d1im3I2, 0.7537, 2.14, 0.161, 181, 87, CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
484, p5werJ1, 0.7536, 2.20, 0.136, 181, 88, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
485, d5w1wK1, 0.7536, 2.19, 0.159, 180, 88, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
486, p4u6yA1, 0.7536, 2.21, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH FLNDK A 15 MER SELF- PEPTIDE
487, p3wl9A1, 0.7536, 2.21, 0.159, 181, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8I10F)
488, p3v5hD1, 0.7536, 2.50, 0.135, 178, 89, HLA-A2.1 KVAEIVHFL
489, d3pwnA1, 0.7536, 2.27, 0.148, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT
490, p3klaA1, 0.7536, 2.22, 0.148, 180, 88, CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR
491, d1im3E2, 0.7536, 2.14, 0.172, 180, 87, CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
492, d1hhiD2, 0.7536, 2.17, 0.159, 180, 88, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
493, p4g42D1, 0.7535, 2.15, 0.159, 181, 88, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO PEPITDE P8D
494, d1t1zA2, 0.7535, 2.18, 0.159, 180, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-6A
495, p4k7fD1, 0.7534, 2.21, 0.159, 181, 88, NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201
496, p4gupA1, 0.7534, 2.14, 0.161, 181, 87, STRUCTURE OF MHC-CLASS I RELATED MOLECULE MR1
497, p4cw1A1, 0.7534, 2.39, 0.149, 176, 87, COMPLEX OF A B14 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE
498, d3o3bA1, 0.7533, 2.22, 0.159, 181, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1
499, d1im3M2, 0.7533, 2.17, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
500, d1im3A2, 0.7533, 2.08, 0.128, 176, 86, CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
501, p3hpjD1, 0.7532, 2.40, 0.138, 176, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE
502, d1i7uD2, 0.7532, 2.16, 0.159, 181, 88, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V
503, p3v5dD1, 0.7531, 2.22, 0.159, 181, 88, HLA-A2.1 KVAELVHFL
504, d2clzA2, 0.7531, 2.22, 0.159, 181, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE
505, d1hhgD2, 0.7531, 2.14, 0.161, 180, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
506, p5nmkA1, 0.7530, 2.13, 0.161, 181, 87, HLA A02 PRESENTING SLFNTIAVL
507, d5iueG1, 0.7530, 2.19, 0.159, 180, 88, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
508, p3v5dA1, 0.7530, 2.26, 0.125, 178, 88, HLA-A2.1 KVAELVHFL
509, p3qzwD1, 0.7530, 2.15, 0.161, 181, 87, PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402
510, d2v2wA2, 0.7530, 2.20, 0.159, 180, 88, T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
511, p5wliJ1, 0.7529, 2.12, 0.126, 180, 87, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
512, p3haeP1, 0.7529, 2.19, 0.159, 180, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
513, p3am8B1, 0.7529, 2.24, 0.170, 180, 88, CRYSTAL STRUCTURE OF A HUMAN MAJOR HISTOCOMPATIBILTY COMPLEX
514, d1s7vA2, 0.7529, 2.18, 0.159, 181, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
515, d1i7tD2, 0.7529, 2.15, 0.114, 180, 88, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V
516, d1i7tA2, 0.7529, 2.21, 0.159, 180, 88, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V
517, d3pwlA1, 0.7528, 2.24, 0.148, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE
518, d1s7vD2, 0.7528, 2.13, 0.125, 181, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
519, p4d0dD1, 0.7527, 2.15, 0.161, 181, 87, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE
520, p3klaD1, 0.7527, 2.15, 0.161, 181, 87, CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR
521, d2ve6D2, 0.7527, 2.14, 0.159, 181, 88, CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
522, d5mepD1, 0.7526, 2.13, 0.125, 181, 88, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILGKFLHWL
523, p3wlbA1, 0.7526, 2.34, 0.138, 176, 87, HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8T10F)
524, p5wxdA1, 0.7525, 2.19, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 1)
525, p3bp4A1, 0.7525, 2.18, 0.114, 178, 88, THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA
526, d1i7uA2, 0.7525, 2.12, 0.161, 181, 87, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V
527, p5menA1, 0.7524, 2.18, 0.170, 180, 88, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHWL IN COMPLEX WITH COGNATE T-CELL RECEPTOR
528, p3haeD1, 0.7524, 2.15, 0.172, 180, 87, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
529, d2av1A2, 0.7524, 2.21, 0.159, 180, 88, CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.
530, p5im7C1, 0.7523, 2.14, 0.161, 181, 87, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
531, p4f7tA1, 0.7523, 2.12, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505)
532, p3haeJ1, 0.7523, 2.21, 0.159, 180, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
533, d3bhbA2, 0.7523, 2.19, 0.159, 181, 88, CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
534, d5w1wP1, 0.7522, 2.19, 0.170, 180, 88, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
535, p3mgoD1, 0.7522, 2.21, 0.170, 180, 88, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
536, d3ciiA2, 0.7522, 2.21, 0.159, 180, 88, STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E
537, d1rjyD2, 0.7522, 2.22, 0.159, 181, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
538, d5meoA1, 0.7521, 2.25, 0.148, 180, 88, HUMAN LEUKOCYTE ANTIGEN PRESENTING ILGKFLHRL
539, d1zagD2, 0.7520, 2.20, 0.159, 180, 88, HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
540, d1bqhA2, 0.7520, 2.22, 0.149, 180, 87, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
541, p4g8gA1, 0.7519, 2.25, 0.125, 181, 88, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
542, p4cw1D1, 0.7519, 2.13, 0.161, 181, 87, COMPLEX OF A B14 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE
543, d1duyD2, 0.7519, 2.38, 0.091, 178, 88, CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX
544, p5wliG1, 0.7518, 2.30, 0.124, 181, 89, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
545, p5hhoA1, 0.7518, 2.23, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E
546, d3ciiD2, 0.7518, 2.38, 0.138, 175, 87, STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E
547, d1t1yA2, 0.7518, 2.18, 0.159, 181, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-5V
548, p3mgoG1, 0.7517, 2.16, 0.114, 180, 88, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
549, d2av1D2, 0.7517, 2.18, 0.159, 180, 88, CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.
550, p5w1vF1, 0.7516, 2.22, 0.149, 180, 87, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
551, p3qzwA1, 0.7516, 2.22, 0.148, 181, 88, PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402
552, p3haeA1, 0.7515, 2.20, 0.159, 180, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
553, d3bzeG2, 0.7515, 2.20, 0.159, 181, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- 2 E
554, d2f54A2, 0.7515, 2.26, 0.159, 179, 88, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
555, d2av7A2, 0.7515, 2.25, 0.170, 180, 88, CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.
556, d1t1xA2, 0.7515, 2.21, 0.159, 180, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-4L
557, d1jhtA2, 0.7515, 2.25, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART- 1/MELAN-A.
558, p5wxcA1, 0.7514, 2.14, 0.161, 181, 87, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 2)
559, p3i6gD1, 0.7514, 2.20, 0.159, 181, 88, NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201
560, d2gt9A2, 0.7514, 2.23, 0.148, 181, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE
561, d1tvhA2, 0.7514, 2.13, 0.172, 181, 87, CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2
562, p4f7mA1, 0.7513, 2.23, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PA (649-658)
563, p3uttA1, 0.7513, 2.14, 0.163, 180, 86, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
564, d2gitA2, 0.7513, 2.15, 0.159, 181, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
565, p5c0bF1, 0.7512, 2.17, 0.159, 181, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
566, p3mgtG1, 0.7512, 2.21, 0.170, 180, 88, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
567, p3hpjA1, 0.7512, 2.12, 0.161, 180, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE
568, p5v5lA1, 0.7511, 2.20, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*5801 COMPLEX WITH HIV-1 GAG DERIVED PEPTIDE TW10
569, p5oqgA1, 0.7511, 2.10, 0.161, 180, 87, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB W167A; BETA-2MICROGLOBULIN; AND AND OVALBUMIN-DERIVED PEPTIDE. 
570, d3o3aA1, 0.7511, 2.13, 0.161, 180, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1
571, d2mhaC2, 0.7511, 2.14, 0.161, 180, 87, CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION
572, d2jccA2, 0.7511, 2.24, 0.159, 180, 88, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
573, d1t21A2, 0.7511, 2.26, 0.125, 193, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9 MONOCLINIC CRYSTAL
574, d3o3eA1, 0.7510, 2.21, 0.159, 181, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1
575, d3kpqA1, 0.7510, 2.27, 0.115, 181, 87, CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF A MIMOTOPE
576, p2x4oD1, 0.7510, 2.13, 0.161, 181, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128
577, d1w0vA2, 0.7510, 2.23, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
578, p5wliA1, 0.7509, 2.18, 0.159, 181, 88, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
579, d5eu3A1, 0.7509, 2.20, 0.159, 181, 88, HLA CLASS I ANTIGEN
580, p3v5hA1, 0.7509, 2.19, 0.159, 180, 88, HLA-A2.1 KVAEIVHFL
581, p5wwjA1, 0.7508, 2.22, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 1)
582, p5hhnA1, 0.7508, 2.21, 0.114, 180, 88, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-F5L
583, p5euoA1, 0.7508, 2.19, 0.159, 181, 88, PF6-M1-HLA-A2
584, p3gjfA1, 0.7508, 2.20, 0.159, 180, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
585, d2guoA2, 0.7508, 2.23, 0.170, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE
586, d1uxsA2, 0.7508, 2.20, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS
587, d1hhgA2, 0.7508, 2.18, 0.159, 180, 88, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
588, d1eeyA2, 0.7508, 2.20, 0.159, 180, 88, CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)
589, p3myjA1, 0.7507, 2.18, 0.159, 181, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT.
590, d3b6sA2, 0.7507, 2.21, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
591, d5iueA1, 0.7506, 2.16, 0.161, 181, 87, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
592, p5im7A1, 0.7506, 2.14, 0.161, 181, 87, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
593, p4u6xA1, 0.7506, 2.15, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH ALQDA A 15 MER SELF- PEPTIDE
594, d4l29I1, 0.7506, 2.22, 0.159, 181, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
595, d3kprF1, 0.7506, 2.18, 0.125, 180, 88, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
596, p3dx6A1, 0.7506, 2.23, 0.159, 180, 88, CRYSTAL STRUCTURE OF B*4402 PRESENTING A 10MER EBV EPITOPE
597, d3bgmA2, 0.7506, 2.24, 0.148, 180, 88, CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
598, d2j8uA2, 0.7506, 2.21, 0.161, 181, 87, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
599, d1uxwA2, 0.7506, 2.38, 0.157, 181, 89, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
600, d1rjzD2, 0.7506, 2.23, 0.159, 180, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
601, d1eeyD2, 0.7506, 2.21, 0.159, 181, 88, CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)
602, d1duyA2, 0.7506, 2.13, 0.161, 181, 87, CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX
603, p5e8oD1, 0.7505, 2.22, 0.159, 181, 88, THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P2ABU IN COMPLEX WITH H-2D(B)
604, p3p4nD1, 0.7505, 2.28, 0.125, 181, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM AN 8-MER PEPTIDE FROM PV
605, d1t0nA2, 0.7505, 2.14, 0.161, 181, 87, CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
606, p5ib5A1, 0.7504, 2.20, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*27:09 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND COPPER
607, p2x4sD1, 0.7504, 2.54, 0.111, 178, 90, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN
608, p5nmgF1, 0.7503, 2.29, 0.125, 180, 88, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
609, p3p4oD1, 0.7503, 2.26, 0.125, 181, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE MUTANT NP205-LCMV-V3A EPITOPE YTAKYPNL AN 8-MER MODIFIED PEPTIDE FROM THE LCMV
610, p3am8A1, 0.7503, 2.21, 0.159, 180, 88, CRYSTAL STRUCTURE OF A HUMAN MAJOR HISTOCOMPATIBILTY COMPLEX
611, d2vljA2, 0.7503, 2.17, 0.161, 180, 87, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
612, p5fdwA1, 0.7502, 2.12, 0.163, 180, 86, STRUCTURE OF HLA-A2:01 WITH PEPTIDE Y10L
613, p3bxnA1, 0.7502, 2.29, 0.125, 180, 88, THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 COMPLEXED WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA
614, d2bvpA2, 0.7502, 2.21, 0.161, 180, 87, STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
615, d1hhkA2, 0.7502, 2.14, 0.161, 181, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
616, p5wxcC1, 0.7501, 2.22, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 2)
617, d4l3cW1, 0.7501, 2.23, 0.159, 180, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
618, p4f7pA1, 0.7501, 2.23, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009H1N1 PB1 (496-505)
619, p4f7mD1, 0.7501, 2.20, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PA (649-658)
620, d3o3dA1, 0.7501, 2.26, 0.170, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2
621, p3h7bD1, 0.7501, 2.19, 0.161, 181, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE
622, d1zagB2, 0.7501, 2.23, 0.170, 180, 88, HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
623, d1duzD2, 0.7501, 2.22, 0.170, 180, 88, HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN
624, p4e0rD1, 0.7500, 2.19, 0.159, 181, 88, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401
625, d1jufA2, 0.7500, 2.13, 0.161, 180, 87, STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE H13B COMPLEXED TO H2-DB
626, d1hhjD2, 0.7500, 2.22, 0.092, 179, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
627, p5xovD1, 0.7499, 2.16, 0.161, 181, 87, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
628, p5oqiA1, 0.7499, 2.37, 0.149, 176, 87, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C E63A MUTANT; BETA-2MICROGLOBULIN; AND OVALBUMIN-DERIVED PEPTIDE 
629, d1qqdA2, 0.7499, 2.30, 0.114, 181, 88, CRYSTAL STRUCTURE OF HLA-CW4 A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR
630, d5meqA1, 0.7498, 2.13, 0.161, 181, 87, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHTL
631, p3myjD1, 0.7498, 2.22, 0.170, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT.
632, p3i6gA1, 0.7498, 2.25, 0.125, 193, 88, NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201
633, d3bh8A2, 0.7498, 2.19, 0.182, 180, 88, CRYSTAL STRUCTURE OF RQA_M PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
634, p5w69C1, 0.7497, 2.13, 0.161, 181, 87, HLA-C*06:02 PRESENTING ARFNDLRFV
635, d2gtwA2, 0.7497, 2.14, 0.161, 180, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION
636, d1tvbA2, 0.7497, 2.22, 0.159, 180, 88, CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2
637, p6bxpA1, 0.7496, 2.21, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*57:01 WITH A MODIFIED HIV PEPTIDE RKV-KYN
638, p5w6aA1, 0.7496, 2.29, 0.170, 179, 88, HLA-C*06:02 PRESENTING ARTELYRSL
639, p3mgtA1, 0.7496, 2.16, 0.159, 181, 88, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
640, d3kpoA1, 0.7496, 2.20, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF A MIMOTOPE
641, p3fonC1, 0.7496, 2.23, 0.170, 180, 88, CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI
642, d3bzfA2, 0.7496, 2.25, 0.161, 179, 87, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
643, d2uweA2, 0.7496, 2.15, 0.161, 180, 87, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
644, p5wwiA1, 0.7495, 2.23, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 1)
645, p5c0cF1, 0.7495, 2.25, 0.125, 180, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
646, p5c0bA1, 0.7495, 2.26, 0.148, 180, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
647, p3rewD1, 0.7495, 2.12, 0.161, 181, 87, CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
648, d1a1mA2, 0.7495, 2.17, 0.172, 180, 87, MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2
649, p3dmmA1, 0.7494, 2.12, 0.161, 181, 87, CRYSTAL STRUCTURE OF THE CD8 ALPHA BETA/H-2DD COMPLEX
650, p4uq3C1, 0.7493, 2.14, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE
651, p3l3dA1, 0.7493, 2.21, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
652, d1i1fA2, 0.7493, 2.21, 0.170, 181, 88, CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
653, d1hhjA2, 0.7493, 2.23, 0.125, 179, 88, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
654, d1duzA2, 0.7493, 2.21, 0.159, 180, 88, HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN
655, p5oqiB1, 0.7492, 2.24, 0.159, 180, 88, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C E63A MUTANT; BETA-2MICROGLOBULIN; AND OVALBUMIN-DERIVED PEPTIDE 
656, p5eotA1, 0.7492, 2.12, 0.174, 181, 86, STRUCTURE OF HLA-A2:01 WITH PEPTIDE G13E
657, p4k7fA1, 0.7492, 2.14, 0.161, 181, 87, NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201
658, p2x4sA1, 0.7492, 2.22, 0.159, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN
659, p5c0gA1, 0.7491, 2.23, 0.125, 193, 88, HLA-A02 CARRYING YLGGPDFPTI
660, p4uq3A1, 0.7491, 2.23, 0.159, 179, 88, CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE
661, p4i4wA1, 0.7491, 2.21, 0.159, 179, 88, PEPTIDE LENGTH DETERMINES THE OUTCOME OF T CELL RECEPTOR/PEPTIDE-MHCI ENGAGEMENT
662, d3pwjA1, 0.7491, 2.22, 0.159, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2LI9V) PEPTIDE VARIANT
663, p3i6lD1, 0.7491, 2.21, 0.159, 180, 88, NEWLY IDENTIFIED EPITOPE N1 DERIVED FROM SARS-COV N PROTEIN COMPLEXED WITH HLA-A*2402
664, p3h7bA1, 0.7491, 2.21, 0.159, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE
665, p3ecbA1, 0.7491, 2.20, 0.159, 180, 88, CRYSTAL STRUCTURE OF MOUSE H-2DD IN COMPLEX WITH PEPTIDE P18-I10 DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120
666, d3bzeE2, 0.7491, 2.20, 0.159, 181, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- 2 E
667, p5wwuA1, 0.7490, 2.22, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH 2009 PANDEMIC INFLUENZA A(H1N1) VIRUS AND AVIAN INFLUENZA A(H5N1) VIRUS-DERIVED PEPTIDE H1-25
668, p5v5mA1, 0.7490, 2.21, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B*5701 COMPLEX WITH HIV-1 GAG DERIVED PEPTIDE TW10
669, p5oqfA1, 0.7490, 2.17, 0.126, 179, 87, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC 1 HEAVY CHAIN H2-KB WT; BETA-2MICROGLOBULIN; AND OVALBUMIN DERIVED PEPTIDE 
670, p5gr7A1, 0.7490, 2.40, 0.146, 180, 89, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 37-1
671, d3rgvC1, 0.7490, 2.17, 0.161, 180, 87, A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
672, p3fonA1, 0.7490, 2.23, 0.170, 180, 88, CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI
673, d3cdgC2, 0.7490, 2.26, 0.125, 193, 88, HUMAN CD94/NKG2A IN COMPLEX WITH HLA-E
674, d3cdgA2, 0.7490, 2.27, 0.136, 180, 88, HUMAN CD94/NKG2A IN COMPLEX WITH HLA-E
675, p2x70D1, 0.7490, 2.24, 0.125, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
676, p5euoC1, 0.7489, 2.26, 0.125, 180, 88, PF6-M1-HLA-A2
677, p5defA1, 0.7489, 2.28, 0.159, 180, 88, CRYSTAL STRUCTURE OF B*27:04 COMPLEX BOUND TO THE PVIPR PEPTIDE
678, p4pgcD1, 0.7489, 2.28, 0.159, 180, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(35-DIIODOTYROSINE)PAL
679, p3vxpA1, 0.7489, 2.20, 0.159, 180, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L)
680, p3v5kA1, 0.7489, 2.26, 0.159, 180, 88, HLA2.1 KVAELVWFL
681, d1nanH2, 0.7489, 2.24, 0.159, 180, 88, MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE
682, p5indA1, 0.7488, 2.20, 0.125, 180, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
683, p5c0iA1, 0.7488, 2.17, 0.172, 180, 87, HAL-A02 CARRYING RQFGPDFPTI
684, d2bnqA2, 0.7488, 2.23, 0.159, 180, 88, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
685, d1b0rA2, 0.7488, 2.27, 0.125, 181, 88, CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP
686, p5ivxA1, 0.7487, 2.23, 0.159, 181, 88, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
687, p5wliD1, 0.7486, 2.15, 0.161, 182, 87, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
688, p5hhqA1, 0.7486, 2.20, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-L3W
689, d1t1wA2, 0.7486, 2.21, 0.159, 181, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-3F6I8V
690, d4l3cU1, 0.7485, 2.25, 0.125, 180, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
691, d3kplA1, 0.7485, 2.24, 0.114, 180, 88, CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
692, p3givA1, 0.7485, 2.21, 0.159, 180, 88, ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE
693, p3dxaA1, 0.7485, 2.24, 0.159, 181, 88, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
694, p3dx8A1, 0.7485, 2.22, 0.161, 181, 87, CRYSTAL STRUCTURE OF B*4405 PRESENTING A 10MER EBV EPITOPE
695, d1zagC2, 0.7485, 2.23, 0.159, 181, 88, HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
696, d1qrnA2, 0.7485, 2.21, 0.159, 180, 88, CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
697, p5wwjC1, 0.7484, 2.22, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 1)
698, p5indC1, 0.7484, 2.22, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
699, p3hcvA1, 0.7484, 2.40, 0.091, 178, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
700, p3folA1, 0.7484, 2.10, 0.174, 181, 86, CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFERI
701, p3dxaK1, 0.7484, 2.26, 0.170, 180, 88, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
702, d3bzfC2, 0.7484, 2.24, 0.159, 180, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
703, d1m6oA2, 0.7484, 2.23, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE
704, p5xovA1, 0.7483, 2.18, 0.125, 180, 88, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
705, p5v5mC1, 0.7483, 2.22, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA-B*5701 COMPLEX WITH HIV-1 GAG DERIVED PEPTIDE TW10
706, p3p9lD1, 0.7483, 2.27, 0.148, 180, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE CHICKEN OVALBUMIN EPITOPE OVA
707, d1ce6A2, 0.7483, 2.26, 0.159, 181, 88, MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE
708, p5ib5D1, 0.7482, 2.23, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA-B*27:09 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND COPPER
709, d3kpnA1, 0.7482, 2.25, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
710, d3gsoA1, 0.7482, 2.20, 0.125, 180, 88, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE
711, d1t20A2, 0.7481, 2.24, 0.114, 181, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-6I
712, d1im9A2, 0.7481, 2.24, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4
713, d4l29W1, 0.7480, 2.23, 0.159, 181, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
714, p4e5xA1, 0.7480, 2.16, 0.161, 181, 87, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 2 E3- 19K PROTEIN AND MHC CLASS I MOLECULE HLA-A2/TAX
715, p3to2A1, 0.7480, 2.24, 0.148, 181, 88, STRUCTURE OF HLA-A*0201 COMPLEXED WITH PEPTIDE MD3-C9 DERIVED FROM A CLUSTERING REGION OF RESTRICTED CYTOTOXIC T LYMPHOCYTE EPITOPE FROM SARS-COV M PROTEIN
716, p3l3iA1, 0.7480, 2.21, 0.182, 181, 88, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F7A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
717, d3gsuA1, 0.7480, 2.21, 0.161, 181, 87, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5T PEPTIDE VARIANT
718, p3cchD1, 0.7480, 2.19, 0.161, 180, 87, H-2DB COMPLEX WITH MURINE GP100
719, d2jccH2, 0.7480, 2.14, 0.161, 180, 87, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
720, d1nanL2, 0.7480, 2.25, 0.159, 180, 88, MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE
721, d1kj3I2, 0.7480, 2.17, 0.161, 181, 87, MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE
722, d1k8dA2, 0.7480, 2.27, 0.114, 180, 88, CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE
723, p5oqhA1, 0.7479, 2.16, 0.161, 181, 87, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C K66A MUTANT; BETA-2MICROGLOBULIN; AND OVALBUMIN-DERIVED PEPTIDE 
724, p5jweG1, 0.7479, 2.29, 0.125, 181, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP92-101 PEPTIDE
725, p5c0aF1, 0.7479, 2.31, 0.125, 181, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
726, d1hhkD2, 0.7479, 2.19, 0.126, 181, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
727, d5w1wF1, 0.7478, 2.27, 0.125, 193, 88, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
728, p5oqgB1, 0.7478, 2.24, 0.114, 180, 88, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB W167A; BETA-2MICROGLOBULIN; AND AND OVALBUMIN-DERIVED PEPTIDE. 
729, d1zagA2, 0.7478, 2.15, 0.161, 180, 87, HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
730, p5nq0A1, 0.7477, 2.21, 0.159, 181, 88, PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; PRESENTING DFEREGYSL 
731, p4jfqA1, 0.7477, 2.27, 0.148, 180, 88, A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
732, d3ov6A2, 0.7477, 2.25, 0.125, 193, 88, CD1C IN COMPLEX WITH MPM (MANNOSYL-BETA1-PHOSPHOMYCOKETIDE)
733, p3l3kA1, 0.7477, 2.05, 0.093, 179, 86, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
734, d3gswA1, 0.7477, 2.31, 0.125, 180, 88, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT
735, d3gsrA1, 0.7477, 2.20, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT
736, p3fomA1, 0.7477, 2.19, 0.145, 174, 83, CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE IQQSIERL
737, d1lp9H2, 0.7477, 2.24, 0.159, 180, 88, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
738, d1i7rA2, 0.7477, 2.26, 0.159, 181, 88, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058
739, p5fa3A1, 0.7476, 2.17, 0.161, 181, 87, STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9V
740, p5eu4D1, 0.7476, 2.25, 0.125, 180, 88, HLA CLASS I ANTIGEN
741, p4zfzD1, 0.7476, 2.15, 0.161, 181, 87, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*098 COMPLEXED WITH MYRISTOYLATED 5-MER LIPOPEPTIDE DERIVED FROM SIV NEF PROTEIN
742, p3mrrA1, 0.7476, 2.15, 0.161, 181, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE
743, p3gjfD1, 0.7476, 2.26, 0.148, 179, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
744, p4wj5A1, 0.7475, 2.23, 0.159, 180, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE
745, d1p7qA2, 0.7475, 2.32, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1 A HOST AND VIRAL MHC RECEPTOR
746, p5w67A1, 0.7474, 2.15, 0.161, 180, 87, HLA-C*06:02 PRESENTING VRSRR(ABA)LRL
747, p5w1vK1, 0.7474, 2.24, 0.159, 180, 88, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
748, p3ln5A1, 0.7474, 2.15, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE
749, p3dtxA1, 0.7474, 2.16, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
750, p5jweC1, 0.7473, 2.32, 0.170, 179, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP92-101 PEPTIDE
751, d3pwjD1, 0.7473, 2.29, 0.159, 179, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2LI9V) PEPTIDE VARIANT
752, d1agfA2, 0.7473, 2.23, 0.148, 180, 88, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION)
753, p5w69A1, 0.7472, 2.24, 0.159, 180, 88, HLA-C*06:02 PRESENTING ARFNDLRFV
754, p5c09A1, 0.7472, 2.21, 0.114, 180, 88, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
755, p3l3jA1, 0.7472, 2.21, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
756, p5ib3A1, 0.7471, 2.27, 0.136, 181, 88, CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND COPPER
757, p4jqxA1, 0.7471, 2.29, 0.159, 179, 88, HLA-B*44:03 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 169-180)
758, p3rewA1, 0.7471, 2.19, 0.159, 180, 88, CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
759, p3cchA1, 0.7471, 2.24, 0.159, 180, 88, H-2DB COMPLEX WITH MURINE GP100
760, p5eu6A1, 0.7470, 2.25, 0.159, 180, 88, HLA CLASS I ANTIGEN
761, p4zfzA1, 0.7470, 2.28, 0.159, 180, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*098 COMPLEXED WITH MYRISTOYLATED 5-MER LIPOPEPTIDE DERIVED FROM SIV NEF PROTEIN
762, p3vxsA1, 0.7470, 2.23, 0.159, 180, 88, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
763, p3l3gA1, 0.7470, 2.28, 0.114, 180, 88, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
764, p2xpgA1, 0.7470, 2.17, 0.161, 180, 87, CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX
765, d1kj2I2, 0.7470, 2.32, 0.159, 181, 88, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
766, p5weuA1, 0.7469, 2.27, 0.159, 180, 88, CRYSTAL STRUCTURE OF H2-DD WITH DISULFIDE-LINKED 10MER PEPTIDE
767, p5oqhB1, 0.7469, 2.28, 0.159, 180, 88, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C K66A MUTANT; BETA-2MICROGLOBULIN; AND OVALBUMIN-DERIVED PEPTIDE 
768, p5eu5A1, 0.7469, 2.24, 0.170, 180, 88, HLA CLASS I ANTIGEN
769, p4pgbD1, 0.7469, 2.25, 0.125, 181, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNWPAL
770, p4e5xD1, 0.7469, 2.22, 0.126, 179, 87, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 2 E3- 19K PROTEIN AND MHC CLASS I MOLECULE HLA-A2/TAX
771, p3mgoA1, 0.7469, 2.26, 0.136, 193, 88, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
772, d1s8dA2, 0.7469, 2.20, 0.161, 180, 87, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-3A
773, d4l29O1, 0.7468, 2.29, 0.125, 180, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
774, p4jfoD1, 0.7468, 2.24, 0.159, 180, 88, A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
775, p2x4pD1, 0.7468, 2.16, 0.161, 180, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
776, p5nmhA1, 0.7467, 2.25, 0.159, 181, 88, HLA A02 PRESENTING SLYNTIATL
777, p3pwvD1, 0.7467, 2.24, 0.159, 181, 88, AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801 (BOLA-A11)
778, d3hlaA2, 0.7467, 2.13, 0.163, 180, 86, HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1
779, d3gsxA1, 0.7467, 2.22, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8V PEPTIDE VARIANT
780, p2x4tA1, 0.7467, 2.19, 0.161, 180, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE
781, d1namH2, 0.7467, 2.27, 0.102, 179, 88, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
782, d1ed3D2, 0.7467, 2.23, 0.159, 181, 88, CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.
783, p5c0fA1, 0.7466, 2.17, 0.161, 181, 87, HLA-A02 CARRYING RQWGPDPAAV
784, p4pgcA1, 0.7466, 2.23, 0.159, 180, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(35-DIIODOTYROSINE)PAL
785, p3i6kE1, 0.7466, 2.32, 0.125, 181, 88, NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201
786, d1n2rA2, 0.7466, 2.24, 0.125, 181, 88, A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF PEPTIDE REPORTOIRE AND T CELL RECOGNITION.
787, d1kjmA2, 0.7466, 2.26, 0.159, 182, 88, TAP-A-ASSOCIATED RAT MHC CLASS I MOLECULE
788, d1ed3A2, 0.7466, 2.21, 0.125, 180, 88, CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.
789, p5ts1E1, 0.7465, 2.22, 0.159, 180, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YYQSGLSIV) 
790, p3qq3A1, 0.7465, 2.24, 0.159, 181, 88, CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES
791, p3mgoJ1, 0.7465, 2.24, 0.125, 181, 88, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
792, d1ddhA2, 0.7465, 2.26, 0.125, 181, 88, MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN IMMUNODOMINANT PEPTIDE P18-I10 FROM THE HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120
793, p4zusA1, 0.7464, 2.26, 0.136, 179, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE REV-QW11
794, p3mr9A1, 0.7464, 2.27, 0.136, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE M5A VARIANT
795, p3bvnD1, 0.7464, 2.16, 0.161, 180, 87, HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
796, d1k5nA2, 0.7464, 2.27, 0.125, 181, 88, HLA-B*2709 BOUND TO NONA-PEPTIDE M9
797, d5ddhA1, 0.7463, 2.20, 0.125, 180, 88, STRUCTURE OF HLA-A2:01 WITH THE 12-MER PEPTIDE F12K
798, p3mrgA1, 0.7463, 2.17, 0.161, 180, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE
799, p5eu4A1, 0.7462, 2.23, 0.148, 180, 88, HLA CLASS I ANTIGEN
800, p4l29a1, 0.7462, 2.27, 0.159, 181, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
801, p3mrjA1, 0.7462, 2.16, 0.161, 181, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE V5M VARIANT
802, d1bqhD2, 0.7462, 2.17, 0.161, 180, 87, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
803, d3qdjA1, 0.7461, 2.23, 0.159, 180, 88, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
804, p3i6kA1, 0.7461, 2.19, 0.161, 180, 87, NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201
805, p3d25A1, 0.7461, 2.20, 0.161, 180, 87, CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO HUMAN CLASS I MHC HLA-A2
806, d1s7tD2, 0.7461, 2.26, 0.126, 181, 87, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
807, d1of2A2, 0.7461, 2.20, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
808, d1lp9A2, 0.7461, 2.22, 0.159, 180, 88, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
809, d1biiA2, 0.7461, 2.24, 0.159, 181, 88, THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110
810, p5enwA1, 0.7460, 2.26, 0.125, 181, 88, STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9L
811, p3mrfA1, 0.7460, 2.25, 0.159, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT
812, d3kprA1, 0.7460, 2.16, 0.161, 181, 87, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
813, d1i7rD2, 0.7460, 2.24, 0.125, 181, 88, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058
814, d4z78G1, 0.7459, 2.24, 0.159, 180, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
815, d4l29U1, 0.7459, 2.26, 0.159, 180, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
816, d3qdgA1, 0.7459, 2.30, 0.159, 181, 88, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
817, p3mreA1, 0.7459, 2.17, 0.161, 181, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE
818, p3jtsG1, 0.7459, 2.23, 0.136, 182, 88, GY9-MAMU-A*02-HB2M
819, p2x4tD1, 0.7459, 2.23, 0.161, 181, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE
820, d2uweH2, 0.7459, 2.19, 0.159, 181, 88, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
821, p5oqfB1, 0.7458, 2.26, 0.159, 180, 88, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC 1 HEAVY CHAIN H2-KB WT; BETA-2MICROGLOBULIN; AND OVALBUMIN DERIVED PEPTIDE 
822, p4wuuA1, 0.7458, 2.49, 0.146, 180, 89, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
823, p3dx7A1, 0.7458, 2.25, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B*4403 PRESENTING 10MER EBV ANTIGEN
824, p5f1nD1, 0.7457, 2.14, 0.161, 181, 87, MHC COMPLEXED TO 11MER PEPTIDE
825, p5d2nA1, 0.7457, 2.25, 0.125, 193, 88, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
826, d1i1fD2, 0.7457, 2.16, 0.161, 180, 87, CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
827, p5t6yA1, 0.7456, 2.26, 0.159, 180, 88, HLA-B*57:01 PRESENTING TSTFEDVKILAF
828, d5merD1, 0.7456, 2.34, 0.136, 182, 88, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHEL
829, p5jweE1, 0.7456, 2.26, 0.159, 179, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP92-101 PEPTIDE
830, p4zutA1, 0.7456, 2.19, 0.161, 181, 87, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-GW12
831, p4wj5D1, 0.7456, 2.24, 0.170, 180, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE
832, p4pgbA1, 0.7456, 2.17, 0.161, 181, 87, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNWPAL
833, p4pg2A1, 0.7456, 2.23, 0.114, 177, 88, THE CRYSTAL STRUCTURE OF H-2DB WITH A S-GLUTATHIONYLATED PEPTIDE
834, d1w0wA2, 0.7456, 2.21, 0.125, 180, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
835, d1ogtA2, 0.7456, 2.22, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
836, d1jpfA2, 0.7456, 2.30, 0.125, 180, 88, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP276 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
837, p4pv8A1, 0.7455, 2.25, 0.114, 179, 88, CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX
838, d4l3cO1, 0.7455, 2.26, 0.159, 181, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
839, p3vxmA1, 0.7455, 2.25, 0.159, 181, 88, THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
840, p3skoA1, 0.7455, 2.28, 0.114, 180, 88, CRYSTAL STRUCTURE OF THE HLA-B8-A66-FLR MUTANT A66 OF THE HLA B8
841, d3buyA2, 0.7455, 2.29, 0.125, 180, 88, MHC-I IN COMPLEX WITH PEPTIDE
842, d2bsrA2, 0.7455, 2.27, 0.159, 181, 88, CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
843, d1rjyA2, 0.7455, 2.34, 0.170, 180, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
844, d1hocA2, 0.7455, 2.26, 0.136, 177, 88, THE THREE-DIMENSIONAL STRUCTURE OF H-2DB AT 2.4 ANGSTROMS RESOLUTION: IMPLICATIONS FOR ANTIGEN-DETERMINANT SELECTION
845, p3vxrA1, 0.7454, 2.25, 0.114, 180, 88, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
846, p3tieA1, 0.7454, 2.27, 0.159, 181, 88, CRYSTAL STRUCTURE OF THE VACCINIA DERIVED PEPTIDE A11R IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB
847, p3pabD1, 0.7454, 2.29, 0.125, 181, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1
848, p3lv3A1, 0.7454, 2.25, 0.125, 181, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521)
849, d3b3iA2, 0.7454, 2.28, 0.170, 180, 88, CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES
850, d2bnrA2, 0.7454, 2.31, 0.125, 180, 88, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
851, d1i1yA2, 0.7454, 2.31, 0.125, 180, 88, CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
852, d1hlaA2, 0.7454, 2.24, 0.159, 180, 88, STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-A2
853, d1e27A2, 0.7454, 2.24, 0.161, 181, 87, NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI)
854, p5ib1A1, 0.7453, 2.23, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR MEASURED AT 295 K
855, p4jfoA1, 0.7453, 2.18, 0.161, 181, 87, A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
856, d1rjzA2, 0.7453, 2.17, 0.136, 181, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
857, p5ib4A1, 0.7452, 2.27, 0.170, 181, 88, CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND NICKEL
858, d4l29M1, 0.7452, 2.26, 0.159, 180, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
859, d4hx1A1, 0.7452, 2.21, 0.159, 180, 88, STRUCTURE OF HLA-A68 COMPLEXED WITH A TUMOR ANTIGEN DERIVED PEPTIDE
860, p3mrbA1, 0.7452, 2.23, 0.125, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT
861, d3gsvA1, 0.7452, 2.26, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5Q PEPTIDE VARIANT
862, d3gsqA1, 0.7452, 2.28, 0.159, 181, 88, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT
863, p3givD1, 0.7452, 2.21, 0.161, 181, 87, ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE
864, d2bssA2, 0.7452, 2.18, 0.161, 180, 87, CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
865, d1kj3H2, 0.7452, 2.18, 0.161, 181, 87, MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE
866, d1i1yD2, 0.7452, 2.18, 0.161, 181, 87, CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
867, d4l3cM1, 0.7451, 2.21, 0.159, 180, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
868, d4l3cK1, 0.7451, 2.25, 0.159, 181, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
869, p3ws3A1, 0.7451, 2.24, 0.125, 181, 88, CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE
870, p5fa4A1, 0.7450, 2.17, 0.161, 181, 87, STRUCTURE OF HLA-A2:01 WITH PEPTIDE Y16R
871, p5e8pA1, 0.7450, 2.28, 0.159, 181, 88, THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P5NLE IN COMPLEX WITH H-2D(B)
872, p3p4mD1, 0.7450, 2.29, 0.159, 181, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL AN 8-MER PEPTIDE FROM THE LCMV
873, d3dbxA1, 0.7450, 2.34, 0.114, 176, 88, STRUCTURE OF CHICKEN CD1-2 WITH BOUND FATTY ACID
874, d2bstA2, 0.7450, 2.26, 0.159, 179, 88, CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
875, d1vacA2, 0.7450, 2.32, 0.114, 176, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND CHICKEN OVALBUMIN
876, d1qlfA2, 0.7450, 2.30, 0.125, 180, 88, MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G
877, p5w6aC1, 0.7449, 2.20, 0.047, 181, 86, HLA-C*06:02 PRESENTING ARTELYRSL
878, d5merA1, 0.7449, 2.20, 0.047, 181, 86, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHEL
879, p5jweA1, 0.7449, 2.27, 0.159, 181, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP92-101 PEPTIDE
880, p5c0cA1, 0.7449, 2.26, 0.125, 181, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
881, d4l3cC1, 0.7449, 2.26, 0.114, 181, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
882, d3e6fA1, 0.7449, 2.31, 0.159, 179, 88, MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE PA9 FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
883, d1qo3A2, 0.7449, 2.17, 0.161, 181, 87, COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD
884, p5trzA1, 0.7448, 2.25, 0.114, 180, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YQSGLSIVM) 
885, p4no2A1, 0.7448, 2.18, 0.161, 180, 87, CRYSTAL STRUCTURE OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2
886, p2x4qA1, 0.7448, 2.25, 0.161, 181, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
887, d4l3cA1, 0.7447, 2.21, 0.126, 180, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
888, p3tjhA_, 0.7447, 2.31, 0.125, 180, 88, 42F3-P3A1/H2-LD COMPLEX
889, p3pwuA1, 0.7447, 2.27, 0.136, 179, 88, AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801(BOLA-A11)
890, d3pwpA1, 0.7447, 2.23, 0.159, 180, 88, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
891, d1jpgA2, 0.7447, 2.26, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE NP396 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
892, d1bz9A2, 0.7447, 2.24, 0.161, 181, 87, CRYSTAL STRUCTURE OF MURINE CLASS I MHC H2-DB COMPLEXED WITH A SYNTHETIC PEPTIDE P1027
893, d1a1oA2, 0.7447, 2.30, 0.138, 175, 87, MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM
894, p5npzA1, 0.7446, 2.30, 0.102, 179, 88, PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; PRESENTING EFEDLTFLA 
895, p5ib2A1, 0.7446, 2.22, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR
896, p5c07A1, 0.7446, 2.32, 0.114, 180, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
897, p4g8iA1, 0.7446, 2.32, 0.114, 180, 88, CRYSTAL STRUCTURE OF HLA B2705-KK10-L6M
898, p3tieD1, 0.7446, 2.27, 0.170, 181, 88, CRYSTAL STRUCTURE OF THE VACCINIA DERIVED PEPTIDE A11R IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB
899, d2ciiA2, 0.7446, 2.30, 0.126, 181, 87, THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY- INTERMEDIATE
900, d1syvA2, 0.7446, 2.26, 0.159, 180, 88, HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF
901, d1jf1A2, 0.7446, 2.16, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A
902, d1a9dA1, 0.7446, 2.26, 0.159, 180, 88,  
903, p5wshA1, 0.7445, 2.30, 0.125, 180, 88, STRUCTURE OF HLA-A2 P130
904, d3pwnD1, 0.7445, 2.26, 0.114, 178, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT
905, p5c0eA1, 0.7444, 2.26, 0.159, 181, 88, HLA-A02 CARRYING YLGGPDFPTI
906, p5c0dA1, 0.7444, 2.21, 0.159, 181, 88, HLA-A02 CARRYING AQWGPDPAAA
907, p5t6zA1, 0.7443, 2.31, 0.114, 180, 88, KIR3DL1 IN COMPLEX WITH HLA-B*57:01-TW10
908, p5c08A1, 0.7443, 2.17, 0.163, 180, 86, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
909, p4zuwA1, 0.7443, 2.24, 0.159, 181, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00601) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-GW12
910, p4l3ca1, 0.7443, 2.22, 0.149, 181, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
911, d4l29E1, 0.7443, 2.14, 0.174, 180, 86, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
912, p3ox8D1, 0.7443, 2.29, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27
913, p2x4uA1, 0.7443, 2.18, 0.161, 180, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476
914, d2clzH2, 0.7443, 2.21, 0.125, 181, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE
915, d1tvhD2, 0.7443, 2.21, 0.161, 180, 87, CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2
916, d1mwaH2, 0.7443, 2.24, 0.161, 181, 87, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
917, p5eo0A1, 0.7442, 2.24, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B0702-RFL9
918, p4jfqD1, 0.7442, 2.24, 0.159, 180, 88, A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
919, d3o3aD1, 0.7442, 2.33, 0.125, 178, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1
920, p3mrlA1, 0.7442, 2.24, 0.159, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT
921, p5iehA1, 0.7441, 2.35, 0.125, 181, 88, STRUCTURE OF HLA-B*40:02 IN COMPLEX WITH THE PHOSPHORYLATED ENDOGENOUS PEPTIDE REF(P)SKEPEL
922, p5d2nH1, 0.7441, 2.29, 0.148, 180, 88, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
923, d4onoA2, 0.7441, 2.24, 0.159, 180, 88, CD1C IN COMPLEX WITH PM (PHOSPHOMYCOKETIDE)
924, d4l29K1, 0.7441, 2.26, 0.159, 181, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
925, p3rooC1, 0.7441, 2.23, 0.159, 180, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH IMMUNODOMINANT LCMV-DERIVED GP34-41 PEPTIDE
926, p5wmoA1, 0.7440, 2.28, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B7 IN COMPLEX WITH RPP; AN EBV PEPTIDE 
927, p5e6iC1, 0.7440, 2.19, 0.161, 179, 87, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
928, p5c09F1, 0.7440, 2.23, 0.145, 172, 83, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
929, p3utqA1, 0.7440, 2.27, 0.159, 181, 88, HUMAN HLA-A*0201-ALWGPDPAAA
930, p3pqyF1, 0.7440, 2.27, 0.136, 180, 88, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
931, d2fwoA2, 0.7440, 2.28, 0.148, 180, 88, MHC CLASS I H-2KD HEAVY CHAIN IN COMPLEX WITH BETA- 2MICROGLOBULIN AND PEPTIDE DERIVED FROM INFLUENZA NUCLEOPROTEIN
932, d2bckD2, 0.7440, 2.27, 0.149, 179, 87, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE
933, p5ts1C1, 0.7439, 2.22, 0.159, 180, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YYQSGLSIV) 
934, d5t7gA1, 0.7439, 2.21, 0.172, 180, 87, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PT9) OF HIV GP120 MN ISOLATE (IGPGRAFYT)
935, p5nqkH1, 0.7439, 2.15, 0.115, 178, 87, HUMAN 199.16 TCR IN COMPLEX WITH MELAN-A/MART-1 (26-35) PEPTIDE AND HLA-A2 
936, p5incC1, 0.7439, 2.28, 0.136, 181, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
937, p4g9dA1, 0.7439, 2.20, 0.172, 181, 87, CRYSTAL STRUCTURE OF HLA B2705-KK10
938, d1akjA2, 0.7439, 2.28, 0.136, 179, 88, COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8
939, p3utsA1, 0.7438, 2.29, 0.125, 180, 88, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
940, p3ox8A1, 0.7438, 2.17, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27
941, p5w1vP1, 0.7437, 2.24, 0.170, 180, 88, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
942, p4e0rA1, 0.7437, 2.26, 0.159, 180, 88, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401
943, d1de4G2, 0.7437, 2.22, 0.159, 181, 88, HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR
944, d1de4D2, 0.7437, 2.25, 0.159, 180, 88, HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR
945, d1de4A2, 0.7437, 2.24, 0.159, 180, 88, HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR
946, p6bxqB1, 0.7436, 2.33, 0.148, 179, 88, CRYSTAL STRUCTURE OF HLA-B*57:01 WITH AN HIV PEPTIDE RKV
947, p5e8nA1, 0.7436, 2.40, 0.149, 176, 87, THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)
948, d2ol3H2, 0.7436, 2.36, 0.161, 178, 87, CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE
949, d1n3nG2, 0.7436, 2.36, 0.161, 178, 87, CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
950, p5n1yA1, 0.7435, 2.36, 0.161, 178, 87, HLA-A02 CARRYING MVWGPDPLYV
951, p5c0aA1, 0.7435, 2.27, 0.170, 180, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
952, p3vj6A1, 0.7435, 2.25, 0.115, 176, 87, STRUCTURE OF THE MHC CLASS IB MOLECULE QA-1B
953, p3utsF1, 0.7435, 2.35, 0.125, 178, 88, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
954, p3p9mD1, 0.7435, 2.40, 0.124, 181, 89, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4
955, d2guoD2, 0.7435, 2.23, 0.159, 182, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE
956, p5t6wA1, 0.7434, 2.18, 0.161, 181, 87, HLA-B*57:01 PRESENTING SSTRGISQLW
957, d4l29S1, 0.7434, 2.22, 0.126, 180, 87, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
958, p4g42A1, 0.7434, 2.23, 0.161, 180, 87, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO PEPITDE P8D
959, p4qrpA1, 0.7433, 2.31, 0.125, 180, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
960, p3ws6B1, 0.7433, 2.23, 0.159, 181, 88, CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH A MIMOTOPIC PEPTIDE
961, p2x4uD1, 0.7433, 2.26, 0.170, 180, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476
962, p5jwdA1, 0.7432, 2.27, 0.161, 181, 87, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP392-401 PEPTIDE
963, d5d9sA1, 0.7432, 2.39, 0.149, 176, 87, STRUCTURE OF HLA-A2:01 WITH THE 11-MER PEPTIDE F11V
964, p4qokA1, 0.7432, 2.26, 0.148, 180, 88, STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES
965, p4no0A1, 0.7432, 2.29, 0.114, 176, 88, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1
966, d3o3eD1, 0.7432, 2.24, 0.159, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1
967, d2hjkA2, 0.7432, 2.40, 0.114, 180, 88, CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE
968, p6at5A1, 0.7431, 2.24, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH AN NY-ESO-1 PEPTIDE
969, p5vz5A1, 0.7431, 2.16, 0.161, 180, 87, CRYSTAL STRUCTURE OF AN ANAPLASTIC LYMPHOMA KINASE-DERIVED NEUROBLASTOMA TUMOR ANTIGEN BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501
970, p5f1iS1, 0.7431, 2.24, 0.159, 180, 88, MHC WITH 9-MER PEPTIDE
971, p3mrcA1, 0.7431, 2.25, 0.159, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6C VARIANT
972, d1fo0H2, 0.7431, 2.28, 0.170, 181, 88, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
973, d1bd2A2, 0.7431, 2.30, 0.148, 180, 88, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7 VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
974, d1ao7A2, 0.7431, 2.16, 0.140, 180, 86, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR VIRAL PEPTIDE (TAX) AND HLA-A 0201
975, p5ts1A1, 0.7430, 2.31, 0.136, 181, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YYQSGLSIV) 
976, p5f7dA1, 0.7430, 2.29, 0.159, 180, 88, STRUCTURE OF HLA-A2:01 WITH PEPTIDE G11N
977, p4o2cA1, 0.7430, 2.30, 0.125, 182, 88, AN NT-ACETYLATED PEPTIDE COMPLEXED WITH HLA-B*3901
978, d3qdmA1, 0.7430, 2.21, 0.161, 181, 87, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
979, d3e6hA1, 0.7430, 2.14, 0.174, 181, 86, MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE PI10 FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
980, d2rfxA2, 0.7430, 2.29, 0.136, 179, 88, CRYSTAL STRUCTURE OF HLA-B*5701 PRESENTING THE SELF PEPTIDE LSSPVTKSF
981, d1yn7A2, 0.7430, 2.23, 0.161, 179, 87, CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN H2-DB IN COMPLEX WITH A MUTATED PEPTIDE (R7A) OF THE INFLUENZA A ACID POLYMERASE
982, p2x4rD1, 0.7429, 2.29, 0.148, 180, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE
983, d1agcA2, 0.7429, 2.24, 0.159, 181, 88, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION)
984, p5ts1G1, 0.7428, 2.29, 0.125, 180, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YYQSGLSIV) 
985, d4l29G1, 0.7428, 2.27, 0.159, 181, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
986, p3ft2A1, 0.7428, 2.31, 0.114, 178, 88, CRYSTAL STRUCTURE OF A CITRULLINE PEPTIDE VARIANT OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1 IN COMPLEX WITH HLA- A2
987, d2zokG2, 0.7428, 2.27, 0.159, 180, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
988, p2x4nA1, 0.7428, 2.29, 0.148, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT
989, d1tvbD2, 0.7428, 2.29, 0.136, 179, 88, CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2
990, p5incA1, 0.7427, 2.29, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
991, p5d2lC1, 0.7427, 2.24, 0.161, 180, 87, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
992, p3mrpA1, 0.7427, 2.30, 0.114, 178, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT
993, d3kppA1, 0.7427, 2.26, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
994, d2bvoA2, 0.7427, 2.25, 0.159, 181, 88, STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
995, p4zuvD1, 0.7426, 2.26, 0.170, 180, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12
996, d4l3cE1, 0.7426, 2.24, 0.159, 179, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
997, d1zt7A2, 0.7426, 2.24, 0.159, 180, 88, CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE
998, d1w72A2, 0.7426, 2.27, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3
999, p5nhtH1, 0.7425, 2.29, 0.159, 181, 88, HUMAN 199.54-16 TCR IN COMPLEX WITH MELAN-A/MART-1 (26-35) PEPTIDE AND HLA-A2 
1000, p4u1jA1, 0.7425, 2.24, 0.136, 180, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1001, d4qrrA1, 0.7425, 2.29, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA B*3501-IPS IN COMPLEX WITH A DELTA-BETA TCR CLONE 12 TCR
1002, p3pqyK1, 0.7425, 2.18, 0.138, 176, 87, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
1003, p3mrmA1, 0.7425, 2.25, 0.159, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE
1004, d1s7rA2, 0.7425, 2.19, 0.161, 180, 87, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1005, d1qr1A2, 0.7425, 2.30, 0.148, 181, 88, POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE
1006, d1qewA2, 0.7425, 2.21, 0.148, 181, 88, HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279)
1007, d1agdA2, 0.7425, 2.17, 0.115, 179, 87, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE)
1008, p5t70A1, 0.7424, 2.19, 0.161, 180, 87, KIR3DL1 IN COMPLEX WITH HLA-B*57:01 PRESENTING TSNLQEQIGW
1009, p5t6xA1, 0.7424, 2.28, 0.136, 181, 88, HLA-B*57:01 PRESENTING TSTTSVASSW
1010, d4l3cI1, 0.7424, 2.19, 0.161, 181, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1011, d4l29A1, 0.7424, 2.25, 0.136, 181, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
1012, p4g9fA1, 0.7424, 2.29, 0.148, 181, 88, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
1013, p3p4nA1, 0.7424, 2.29, 0.159, 180, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM AN 8-MER PEPTIDE FROM PV
1014, p2zsvC1, 0.7424, 2.27, 0.170, 180, 88, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598
1015, d1zt7C2, 0.7424, 2.30, 0.159, 181, 88, CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE
1016, d1wbxA2, 0.7424, 2.32, 0.159, 181, 88, CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1017, d1n3nE2, 0.7424, 2.30, 0.159, 180, 88, CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1018, d4l3cG1, 0.7423, 2.32, 0.125, 181, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1019, p3mrdA1, 0.7423, 2.29, 0.126, 179, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT
1020, d1t22A2, 0.7423, 2.18, 0.138, 176, 87, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9 ORTHORHOMBIC CRYSTAL
1021, d1qr1D2, 0.7423, 2.31, 0.114, 178, 88, POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE
1022, p5swqA1, 0.7422, 2.44, 0.112, 181, 89, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH NA231 AN INFLUENZA EPITOPE
1023, p4zuvA1, 0.7422, 2.29, 0.159, 181, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12
1024, p3oxrA1, 0.7422, 2.25, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA A*02:06 BOUND TO HBV CORE 18-27
1025, d2zokA2, 0.7422, 2.27, 0.159, 181, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
1026, p2yplA1, 0.7422, 2.19, 0.161, 181, 87, STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS
1027, d2p5eA2, 0.7422, 2.29, 0.159, 180, 88, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
1028, d1s7rD2, 0.7422, 2.24, 0.125, 180, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1029, d1rk1A2, 0.7422, 2.27, 0.159, 180, 88, MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
1030, d1kpvA2, 0.7422, 2.27, 0.114, 178, 88, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/SEV9
1031, p5trzC1, 0.7421, 2.28, 0.148, 180, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YQSGLSIVM) 
1032, p5n6bD1, 0.7421, 2.18, 0.163, 181, 86, HUMAN LEUKOCYTE ANTIGEN CLASS I A02 CARRYING LLWNPGMAV
1033, p4l3eA1, 0.7420, 2.28, 0.136, 181, 88, THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26YBETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
1034, p3cchG1, 0.7420, 2.29, 0.136, 181, 88, H-2DB COMPLEX WITH MURINE GP100
1035, p2x70A1, 0.7420, 2.26, 0.136, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
1036, d2hjlA2, 0.7420, 2.28, 0.136, 179, 88, CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE
1037, d1t0mA2, 0.7420, 2.18, 0.161, 180, 87, CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1038, p3bvnA1, 0.7419, 2.21, 0.159, 180, 88, HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
1039, d1t0nD2, 0.7419, 2.19, 0.115, 176, 87, CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1040, d1n5aJ2, 0.7419, 2.24, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1041, p5nmgA1, 0.7418, 2.30, 0.170, 181, 88, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
1042, d5kd4A1, 0.7418, 2.30, 0.125, 181, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PVI10) OF HIV GP120 MN ISOLATE (IGPGRAFYVI)
1043, p5c0jA1, 0.7418, 2.25, 0.159, 180, 88, HLA-A02 CARRYING RQFGPDWIVA
1044, d3w39D1, 0.7418, 2.23, 0.125, 181, 88, CRYSTAL STRUCTURE OF HLA-B*5201 IN COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE (TAFTIPSI)
1045, p3ft4A1, 0.7418, 2.41, 0.124, 180, 89, CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1ARG IN COMPLEX WITH HLA-A2
1046, p3cchJ1, 0.7418, 2.17, 0.163, 180, 86, H-2DB COMPLEX WITH MURINE GP100
1047, p2x4rA1, 0.7418, 2.26, 0.125, 180, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE
1048, d1fg2J2, 0.7418, 2.28, 0.148, 182, 88, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1049, p4zfzG1, 0.7417, 2.27, 0.170, 181, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*098 COMPLEXED WITH MYRISTOYLATED 5-MER LIPOPEPTIDE DERIVED FROM SIV NEF PROTEIN
1050, p4prbA1, 0.7417, 2.29, 0.148, 180, 88, CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-A4
1051, p4hkjM1, 0.7417, 2.19, 0.115, 176, 87, STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)
1052, p4hkjI1, 0.7417, 2.26, 0.159, 180, 88, STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)
1053, p4hkjE1, 0.7417, 2.42, 0.124, 180, 89, STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)
1054, p4hkjA1, 0.7417, 2.33, 0.159, 181, 88, STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)
1055, p3tbsA1, 0.7417, 2.25, 0.182, 180, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3PY4A)
1056, d3o3dD1, 0.7417, 2.35, 0.125, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2
1057, d3o3bD1, 0.7417, 2.35, 0.125, 180, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1
1058, p3hg1A1, 0.7417, 2.35, 0.125, 180, 88, GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR
1059, d1yn6A2, 0.7417, 2.35, 0.125, 180, 88, CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN H2-DB IN COMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE
1060, d1n5aG2, 0.7417, 2.43, 0.112, 179, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1061, p4ihoA1, 0.7416, 2.26, 0.159, 181, 88, CRYSTAL STRUCTURE OF H-2DB Y159F IN COMPLEX WITH CHIMERIC GP100
1062, d3uprC1, 0.7416, 2.27, 0.159, 181, 88, HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR
1063, p5c08F1, 0.7415, 2.23, 0.159, 180, 88, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
1064, d2zokE2, 0.7415, 2.32, 0.114, 178, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
1065, d1wbyA2, 0.7415, 2.42, 0.124, 180, 89, CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1066, d1q94D2, 0.7415, 2.55, 0.112, 179, 89, STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1067, d5mepA1, 0.7414, 2.30, 0.170, 180, 88, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILGKFLHWL
1068, p3ft3A1, 0.7414, 2.21, 0.161, 180, 87, CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1HIS IN COMPLEX WITH HLA-A2
1069, p2x4qD1, 0.7414, 2.28, 0.114, 178, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
1070, d1sysA2, 0.7414, 2.31, 0.114, 178, 88, CRYSTAL STRUCTURE OF HLA B*4403 AND PEPTIDE EEPTVIKKY
1071, d5t7gC1, 0.7413, 2.25, 0.159, 181, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PT9) OF HIV GP120 MN ISOLATE (IGPGRAFYT)
1072, p5f1iJ1, 0.7413, 2.20, 0.161, 181, 87, MHC WITH 9-MER PEPTIDE
1073, p5eo1A1, 0.7413, 2.29, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA-B0702-RL9
1074, p4zuuA1, 0.7413, 2.25, 0.159, 180, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-CF9
1075, p4lcyA1, 0.7413, 2.26, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION
1076, d4l29C1, 0.7413, 2.30, 0.125, 180, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
1077, p4jfpA1, 0.7413, 2.34, 0.136, 181, 88, A2 HLA COMPLEX WITH G4A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
1078, d3bwaA2, 0.7413, 2.30, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8- MER PEPTIDE FROM THE PP65 PROTEIN
1079, d2hlaA2, 0.7413, 2.23, 0.125, 180, 88, SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68
1080, d1mheA2, 0.7413, 2.32, 0.170, 180, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1081, d1ageA2, 0.7413, 2.32, 0.159, 181, 88, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION)
1082, p3tbsD1, 0.7412, 2.17, 0.161, 180, 87, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3PY4A)
1083, p3rolA1, 0.7412, 2.28, 0.182, 181, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH POST-TRANSLATIONALLY MODIFIED LCMV-DERIVED GP34-41 PEPTIDE COMPRISING A NITROTYROSINE AT POSITION 3
1084, p3fqtA1, 0.7412, 2.29, 0.159, 181, 88, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1085, p2x4nD1, 0.7412, 2.30, 0.148, 180, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT
1086, d1rk0A2, 0.7412, 2.31, 0.148, 181, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
1087, d1qsfA2, 0.7412, 2.42, 0.124, 179, 89, STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
1088, d1jgeA2, 0.7412, 2.27, 0.136, 180, 88, HLA-B*2705 BOUND TO NONA-PEPTIDE M9
1089, d1fg2D2, 0.7412, 2.24, 0.161, 180, 87, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1090, d5kd7A1, 0.7411, 2.25, 0.159, 180, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PV9) OF HIV GP120 MN ISOLATE (IGPGRAFYV)
1091, p4zfzJ1, 0.7411, 2.29, 0.136, 181, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*098 COMPLEXED WITH MYRISTOYLATED 5-MER LIPOPEPTIDE DERIVED FROM SIV NEF PROTEIN
1092, p4prdA1, 0.7411, 2.16, 0.174, 181, 86, CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-D5
1093, p4lcyF1, 0.7411, 2.27, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION
1094, p4g43A1, 0.7411, 2.42, 0.124, 180, 89, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO P5E
1095, p3tpuE_, 0.7411, 2.32, 0.125, 180, 88, 42F3 P5E8/H2-LD COMPLEX
1096, p3spvA1, 0.7411, 2.33, 0.170, 181, 88, CRYSTAL STRUCTURE OF A PEPTIDE-HLA COMPLEX
1097, p3rwfA1, 0.7411, 2.26, 0.182, 179, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-QW9
1098, d4l29Q1, 0.7410, 2.28, 0.170, 180, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
1099, p3rolC1, 0.7410, 2.57, 0.149, 176, 87, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH POST-TRANSLATIONALLY MODIFIED LCMV-DERIVED GP34-41 PEPTIDE COMPRISING A NITROTYROSINE AT POSITION 3
1100, p3ln4A1, 0.7410, 2.35, 0.138, 175, 87, CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2
1101, d2zolA2, 0.7410, 2.27, 0.148, 180, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510
1102, d1fg2G2, 0.7410, 2.31, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1103, d1fg2A2, 0.7410, 2.28, 0.159, 181, 88, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1104, p5d2lM1, 0.7409, 2.27, 0.136, 180, 88, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1105, p3vh8A1, 0.7409, 2.28, 0.148, 180, 88, KIR3DL1 IN COMPLEX WITH HLA-B*5701
1106, d2zolC2, 0.7409, 2.30, 0.114, 176, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510
1107, d1zhbG2, 0.7409, 2.43, 0.124, 180, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE
1108, p4ihoD1, 0.7408, 2.43, 0.124, 180, 89, CRYSTAL STRUCTURE OF H-2DB Y159F IN COMPLEX WITH CHIMERIC GP100
1109, d3jvgB1, 0.7408, 2.25, 0.161, 179, 87, CRYSTAL STRUCTURE OF CHICKEN CD1-1
1110, p5v5lC1, 0.7407, 2.30, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B*5801 COMPLEX WITH HIV-1 GAG DERIVED PEPTIDE TW10
1111, p4f7tD1, 0.7407, 2.31, 0.114, 176, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505)
1112, p3p4mA1, 0.7407, 2.41, 0.112, 178, 89, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL AN 8-MER PEPTIDE FROM THE LCMV
1113, d3jvgA1, 0.7407, 2.59, 0.112, 178, 89, CRYSTAL STRUCTURE OF CHICKEN CD1-1
1114, d1agbA2, 0.7407, 2.30, 0.174, 174, 86, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION)
1115, p5iekA1, 0.7406, 2.35, 0.159, 181, 88, STRUCTURE OF HLA-B*40:02 IN COMPLEX WITH THE ENDOGENOUS PEPTIDE REFSKEPEL
1116, p3mroA1, 0.7406, 2.30, 0.172, 180, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT
1117, d1zhbJ2, 0.7406, 2.33, 0.125, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE
1118, d1hsaA2, 0.7406, 2.32, 0.174, 174, 86, THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC
1119, p5txsA1, 0.7405, 2.32, 0.174, 174, 86, CRYSTAL STRUCTURE OF AN ANAPLASTIC LYMPHOMA KINASE-DERIVED NEUROBLASTOMA TUMOR ANTIGEN BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501
1120, p3d3vA1, 0.7405, 2.31, 0.148, 181, 88, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(34-DIFLUOROPHENYLALANINE)) PEPTIDE
1121, d1zhbD2, 0.7405, 2.31, 0.148, 180, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE
1122, d1qseA2, 0.7405, 2.25, 0.159, 180, 88, STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
1123, d1n5aD2, 0.7405, 2.41, 0.112, 178, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1124, p4qrqA1, 0.7404, 2.34, 0.148, 181, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL
1125, d3qfjA1, 0.7404, 2.28, 0.170, 180, 88, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
1126, p5wmnA1, 0.7402, 2.26, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B7 IN COMPLEX WITH SPI; AN INFLUENZA PEPTIDE 
1127, p5f1iV1, 0.7402, 2.41, 0.124, 178, 89, MHC WITH 9-MER PEPTIDE
1128, p5c07F1, 0.7402, 2.22, 0.161, 181, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
1129, d2p5wA2, 0.7402, 2.27, 0.125, 181, 88, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
1130, d2gtzD2, 0.7402, 2.28, 0.148, 173, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION
1131, d2c7uD2, 0.7402, 2.22, 0.161, 181, 87, CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.
1132, d1xr8A2, 0.7402, 2.31, 0.148, 180, 88, CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1133, d1e28A2, 0.7402, 2.34, 0.136, 181, 88, NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI)
1134, p5e00A1, 0.7401, 2.23, 0.149, 181, 87, STRUCTURE OF HLA-A2 P130
1135, p4u1kA1, 0.7401, 2.20, 0.163, 181, 86, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1136, d1lk2A2, 0.7401, 2.28, 0.159, 181, 88, 1.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE
1137, p5f9jA1, 0.7400, 2.28, 0.159, 181, 88, STRUCTURE OF HLA-A2:01 WITH PEPTIDE Y9L
1138, p5e8nD1, 0.7400, 2.29, 0.170, 181, 88, THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)
1139, p4u1kD1, 0.7400, 2.28, 0.172, 181, 87, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1140, d4l3cQ1, 0.7400, 2.21, 0.161, 180, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1141, p3pqyA1, 0.7400, 2.32, 0.148, 181, 88, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
1142, p3fquA1, 0.7400, 2.29, 0.136, 181, 88, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1143, d1n5aA2, 0.7400, 2.26, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1144, d2ckbI2, 0.7399, 2.15, 0.115, 176, 87, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1145, d2ckbH2, 0.7399, 2.31, 0.148, 181, 88, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1146, d1ffoA2, 0.7399, 2.29, 0.159, 181, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A)
1147, d5m00A1, 0.7398, 2.16, 0.115, 179, 87, CRYSTAL STRUCTURE OF MURINE P14 TCR COMPLEX WITH H-2DB AND Y4A MODIFIED GP33 PEPTIDE FROM LCMV
1148, p4u1nA1, 0.7398, 2.25, 0.161, 180, 87, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1149, d3qfdD1, 0.7398, 2.28, 0.125, 181, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE
1150, p3p9mA1, 0.7398, 2.27, 0.126, 181, 87, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4
1151, d3kpsA1, 0.7398, 2.27, 0.126, 181, 87, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
1152, p2e7lF_, 0.7398, 2.30, 0.114, 180, 88, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1153, d1s7tA2, 0.7398, 2.37, 0.114, 181, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1154, d4l29Y1, 0.7397, 2.31, 0.136, 181, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
1155, p3cplC1, 0.7397, 2.28, 0.159, 181, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH A VARIANT M6A OF THE NP366 PEPTIDE FROM INFLUENZA A VIRUS
1156, p4u1mA1, 0.7396, 2.33, 0.125, 180, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1157, p4nskA1, 0.7396, 2.25, 0.149, 181, 87, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND V3P
1158, p4nqxG1, 0.7396, 2.15, 0.140, 175, 86, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1159, p4jfeA1, 0.7396, 2.28, 0.136, 181, 88, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
1160, p3tidA1, 0.7396, 2.31, 0.159, 181, 88, CRYSTAL STRUCTURE OF THE LCMV DERIVED PEPTIDE GP34 IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB
1161, d3pwlD1, 0.7396, 2.33, 0.114, 179, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE
1162, d2ve6G2, 0.7396, 2.31, 0.148, 180, 88, CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
1163, d2mhaA2, 0.7396, 2.36, 0.114, 180, 88, CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION
1164, d1t0mD2, 0.7396, 2.28, 0.159, 181, 88, CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1165, d1n3nA2, 0.7396, 2.21, 0.161, 180, 87, CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1166, d1ffoD2, 0.7396, 2.35, 0.125, 180, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A)
1167, p5wesA1, 0.7395, 2.28, 0.159, 181, 88, CRYSTAL STRUCTURE H2-DD WITH DISULFIDE-LINKED 5MER PEPTIDE
1168, p4gksA1, 0.7395, 2.32, 0.125, 178, 88, A2-MHC COMPLEX CARRYING FLTGIGIITV
1169, d3ch1A1, 0.7395, 2.31, 0.125, 181, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
1170, d1wbzC2, 0.7395, 2.25, 0.125, 181, 88, CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1171, d1p4lA2, 0.7395, 2.29, 0.114, 181, 88, CRYSTAL STRUCTURE OF NK RECEPTOR LY49C MUTANT WITH ITS MHC CLASS I LIGAND H-2KB
1172, p5wetA1, 0.7394, 2.30, 0.114, 180, 88, CRYSTAL STRUCTURE OF H2-DD WITH DISULFIDE-LINKED 6MER PEPTIDE
1173, d2clvA2, 0.7394, 2.33, 0.125, 179, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE
1174, p5b38A1, 0.7393, 2.19, 0.161, 180, 87, KIR3DL1*005 IN COMPLEX WITH HLA-B*57:01
1175, p4preA1, 0.7393, 2.32, 0.114, 179, 88, CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-Q5
1176, p3tbwA1, 0.7393, 2.33, 0.125, 178, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G V3P Y4S)
1177, p3p9lA1, 0.7393, 2.31, 0.125, 180, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE CHICKEN OVALBUMIN EPITOPE OVA
1178, p5nmfF1, 0.7392, 2.33, 0.125, 179, 88, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
1179, p4pg9A1, 0.7392, 2.31, 0.125, 178, 88, MHC CLASS I IN COMPLEX WITH SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAL
1180, p3x12A1, 0.7392, 2.27, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA-B*57:01.I80N
1181, p3cplA1, 0.7392, 2.27, 0.182, 179, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH A VARIANT M6A OF THE NP366 PEPTIDE FROM INFLUENZA A VIRUS
1182, p3vh8D1, 0.7391, 2.41, 0.124, 180, 89, KIR3DL1 IN COMPLEX WITH HLA-B*5701
1183, p3vclA1, 0.7391, 2.26, 0.125, 180, 88, CRYSTAL STRUCTURE OF HLA-B7 WITH THE HCMV PP65 PEPTIDE RPHERNGFTVL
1184, d3uprA1, 0.7391, 2.18, 0.163, 180, 86, HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR
1185, p3tpuK_, 0.7391, 2.28, 0.136, 180, 88, 42F3 P5E8/H2-LD COMPLEX
1186, p3tf7E_, 0.7391, 2.32, 0.159, 179, 88, 42F3 QL9/H2-LD COMPLEX
1187, p3mriA1, 0.7391, 2.33, 0.114, 180, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT
1188, d2vlrF2, 0.7391, 2.32, 0.159, 180, 88, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
1189, d1mheC2, 0.7391, 2.34, 0.148, 180, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1190, p5n6bA1, 0.7390, 2.34, 0.170, 180, 88, HUMAN LEUKOCYTE ANTIGEN CLASS I A02 CARRYING LLWNPGMAV
1191, p5e8oA1, 0.7390, 2.17, 0.140, 175, 86, THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P2ABU IN COMPLEX WITH H-2D(B)
1192, d2f54F2, 0.7390, 2.43, 0.136, 175, 88, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
1193, d1s7xD2, 0.7390, 2.27, 0.161, 180, 87, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1194, d1oszA2, 0.7390, 2.22, 0.161, 181, 87, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1195, p5wmpA1, 0.7389, 2.30, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA-B7 IN COMPLEX WITH TPR; A CMV PEPTIDE 
1196, p3rooA1, 0.7389, 2.21, 0.161, 180, 87, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH IMMUNODOMINANT LCMV-DERIVED GP34-41 PEPTIDE
1197, p3d39A1, 0.7389, 2.13, 0.115, 176, 87, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
1198, d1kbgH2, 0.7389, 2.27, 0.159, 181, 88, MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2
1199, p6enyF1, 0.7388, 2.26, 0.125, 181, 88, STRUCTURE OF THE HUMAN PLC EDITING MODULE
1200, p4nqvA1, 0.7388, 2.29, 0.136, 181, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1201, p3ws3C1, 0.7388, 2.32, 0.148, 180, 88, CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE
1202, d2c7uA2, 0.7388, 2.29, 0.125, 180, 88, CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.
1203, p5vgdA1, 0.7387, 2.24, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA-C*0501 IN COMPLEX WITH SAE
1204, p5e9dF1, 0.7387, 2.30, 0.136, 181, 88, RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2
1205, p4nqvI1, 0.7387, 2.29, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1206, p4nqvG1, 0.7387, 2.28, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1207, p4jqvA1, 0.7387, 2.25, 0.114, 177, 88, HLA-B*18:01 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 173-180)
1208, d2xfxA1, 0.7387, 2.28, 0.159, 181, 88, CATTLE MHC CLASS I N01301 PRESENTING AN 11MER FROM THEILERIA PARVA
1209, d2pyeA2, 0.7387, 2.36, 0.170, 179, 88, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
1210, d1q94A2, 0.7387, 2.19, 0.161, 180, 87, STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1211, p4qrpF1, 0.7386, 2.28, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
1212, p4jffA1, 0.7386, 2.26, 0.159, 181, 88, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
1213, d4huxA1, 0.7386, 2.31, 0.170, 180, 88, CRYSTAL STRUCTURE OF H2DB-H155A-NP
1214, d3bw9A2, 0.7386, 2.32, 0.115, 181, 87, CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12- MER PEPTIDE FROM THE PP65 PROTEIN
1215, d2gt9D2, 0.7386, 2.23, 0.161, 181, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE
1216, d1s7uD2, 0.7386, 2.22, 0.161, 181, 87, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1217, d1ffpA2, 0.7386, 2.26, 0.136, 180, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)
1218, p5wmnC1, 0.7385, 2.26, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-B7 IN COMPLEX WITH SPI; AN INFLUENZA PEPTIDE 
1219, p5vclA1, 0.7385, 2.42, 0.114, 181, 88, STRUCTURE OF THE QDM PEPTIDE BOUND TO QA-1A
1220, p5m01A1, 0.7385, 2.29, 0.182, 181, 88, CRYSTAL STRUCTURE OF MURINE P14 TCR/ H-2DB COMPLEX WITH PA MODIFIED GP33 PEPTIDE FROM LCMV
1221, p5e6iM1, 0.7385, 2.28, 0.159, 181, 88, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
1222, p4nqvK1, 0.7385, 2.27, 0.125, 181, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1223, p4jfdA1, 0.7385, 2.31, 0.114, 180, 88, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
1224, d4huuA1, 0.7385, 2.32, 0.148, 180, 88, CRYSTAL STRUCTURE OF H2DB-NPM6I
1225, d2ve6A2, 0.7385, 2.18, 0.126, 180, 87, CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
1226, d2fz3A2, 0.7385, 2.40, 0.114, 180, 88, THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION
1227, p4u1hA1, 0.7384, 2.26, 0.159, 179, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1228, d4l3cS1, 0.7384, 2.28, 0.159, 180, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1229, d2bvqA2, 0.7384, 2.23, 0.161, 180, 87, STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
1230, d1xh3A2, 0.7384, 2.32, 0.114, 181, 88, CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501
1231, d1ffpD2, 0.7384, 2.35, 0.114, 178, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)
1232, p4zezD1, 0.7383, 2.28, 0.182, 181, 88, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
1233, p4nqxA1, 0.7383, 2.33, 0.148, 181, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1234, p2ypkA1, 0.7383, 2.29, 0.161, 181, 87, STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS
1235, d2nw3A2, 0.7383, 2.32, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1236, p5h94A1, 0.7382, 2.28, 0.170, 181, 88, CRYSTAL STRUCTURE OF SWINE MHC CLASSI FOR 1.48 ANGSTROMS
1237, d4huwA1, 0.7382, 2.31, 0.114, 180, 88, CRYSTAL STRUCTURE OF H2DB-NPM6T
1238, d4huuD1, 0.7382, 2.26, 0.159, 180, 88, CRYSTAL STRUCTURE OF H2DB-NPM6I
1239, p3jtsD1, 0.7382, 2.27, 0.159, 180, 88, GY9-MAMU-A*02-HB2M
1240, d5kd7F1, 0.7381, 2.31, 0.170, 180, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PV9) OF HIV GP120 MN ISOLATE (IGPGRAFYV)
1241, p5b39A1, 0.7381, 2.28, 0.182, 181, 88, KIR3DL1*015 IN COMPLEX WITH HLA-B*57:01
1242, p3x14A1, 0.7381, 2.38, 0.125, 180, 88, CRYSTAL STRUCTURE OF HLA-B*0801.N80I.R82L.G83R
1243, p3tbwC1, 0.7380, 2.29, 0.114, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G V3P Y4S)
1244, d2ak4Q2, 0.7380, 2.32, 0.114, 180, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
1245, p5nmfA1, 0.7379, 2.41, 0.148, 180, 88, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
1246, p5nmeF1, 0.7379, 2.33, 0.125, 180, 88, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1247, d2f74D2, 0.7379, 2.27, 0.161, 180, 87, MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33
1248, d1zhbA2, 0.7379, 2.30, 0.148, 180, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE
1249, d1g7qA2, 0.7379, 2.45, 0.112, 180, 89, CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA
1250, p5y91A1, 0.7378, 2.27, 0.182, 181, 88, THE STRUCTURE OF THE MHC CLASS I MOLECULE OF BONY FISHES PROVIDES INSIGHTS INTO THE CONSERVED NATURE OF THE ANTIGEN-PRESENTING SYSTEM
1251, p5xosA1, 0.7378, 2.18, 0.163, 180, 86, CRYSTAL STRUCTURE OF HLA-B35 IN COMPLEX WITH A PEPETIDE ANTIGEN
1252, p5swzA1, 0.7378, 2.23, 0.161, 180, 87, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1253, d3qeqA1, 0.7378, 2.37, 0.125, 178, 88, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
1254, p3l3hA1, 0.7378, 2.45, 0.124, 178, 89, X-RAY CRYSTAL STRUCTURE OF THE F6A MUTANT OF INFLUENZA A ACID POLYMERASE EPITOPE PA224 BOUND TO MURINE H2-DB MHC
1255, d3c8kA2, 0.7378, 2.31, 0.136, 181, 88, THE CRYSTAL STRUCTURE OF LY49C BOUND TO H-2KB
1256, d2hn7A2, 0.7378, 2.32, 0.149, 176, 87, HLA-A*1101 IN COMPLEX WITH HBV PEPTIDE HOMOLOGUE
1257, d1s7xA2, 0.7378, 2.28, 0.170, 180, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1258, p6at9A1, 0.7377, 2.36, 0.114, 180, 88, CRYSTAL STRUCTURE OF AN ANAPLASTIC LYMPHOMA KINASE-DERIVED NEUROBLASTOMA TUMOR ANTIGEN BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-A*0101
1259, p4qruA1, 0.7377, 2.22, 0.161, 181, 87, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELR_MYM ELRRKMMYM
1260, p4prnA1, 0.7377, 2.33, 0.114, 179, 88, CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-A4
1261, p3wuwA1, 0.7377, 2.36, 0.125, 178, 88, KIR3DL1 IN COMPLEX WITH HLA-B*57:01.I80T
1262, d1s7xG2, 0.7377, 2.27, 0.149, 181, 87, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1263, p4pr5A1, 0.7376, 2.29, 0.125, 181, 88, CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-D5
1264, d4huwC1, 0.7376, 2.31, 0.159, 180, 88, CRYSTAL STRUCTURE OF H2DB-NPM6T
1265, d1s9xA2, 0.7376, 2.29, 0.148, 179, 88, CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE SLLMWITQA IN COMPLEX WITH HLA-A2
1266, d1s7uJ2, 0.7376, 2.28, 0.170, 180, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1267, d1mhcA2, 0.7376, 2.32, 0.159, 180, 88, MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION
1268, p4nnxA1, 0.7375, 2.43, 0.112, 181, 89, CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2
1269, p3x11A1, 0.7375, 2.28, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA-B*57:01.I80N.L82R.R83G
1270, d2axgA2, 0.7375, 2.32, 0.114, 181, 88, THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION
1271, d1wbzA2, 0.7375, 2.28, 0.161, 181, 87, CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1272, p5swzP1, 0.7374, 2.43, 0.112, 180, 89, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1273, d4huwG1, 0.7374, 2.24, 0.115, 181, 87, CRYSTAL STRUCTURE OF H2DB-NPM6T
1274, p3vfrA1, 0.7374, 2.24, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA B*3508LPEP-P4ALA PEPTIDE MUTANT P4-ALA
1275, d1s7wG2, 0.7374, 2.29, 0.170, 180, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1276, d1n59A2, 0.7373, 2.29, 0.170, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1277, p5wmrA1, 0.7372, 2.35, 0.125, 178, 88, CRYSTAL STRUCTURE OF HLA-B8 IN COMPLEX WITH QIK; A CMV PEPTIDE 
1278, d3c9nA2, 0.7372, 2.34, 0.114, 180, 88, CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501
1279, p4nqxI1, 0.7371, 2.32, 0.114, 181, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1280, p3fqrA1, 0.7371, 2.28, 0.182, 180, 88, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1281, p2zswC1, 0.7371, 2.40, 0.124, 181, 89, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
1282, p2x4pA1, 0.7371, 2.32, 0.125, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
1283, d1s7xJ2, 0.7371, 2.28, 0.148, 171, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1284, d1ld9D2, 0.7371, 2.30, 0.148, 181, 88, THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE
1285, d1ld9A2, 0.7371, 2.29, 0.159, 181, 88, THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE
1286, p3e3qY_, 0.7370, 2.29, 0.159, 179, 88, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1287, p2zswE1, 0.7370, 2.38, 0.125, 180, 88, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
1288, p2zswA1, 0.7370, 2.29, 0.159, 180, 88, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
1289, p6ei2A1, 0.7369, 2.47, 0.112, 181, 89, CRYSTAL STRUCTURE OF HLA-A68 PRESENTING A C-TERMINALLY EXTENDED PEPTIDE
1290, p5wkhA1, 0.7369, 2.28, 0.138, 181, 87, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
1291, p5hyjF1, 0.7369, 2.28, 0.138, 181, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
1292, p5h5zA1, 0.7369, 2.31, 0.149, 175, 87, CRYSTAL STRUCTURE OF BONY FISH MHC CLASS I PEPTIDE AND B2M II
1293, p5cnzA1, 0.7369, 2.37, 0.125, 180, 88, CRYSTAL STRUCTURE OF BONY FISH MHC CLASS I PEPTIDE AND B2M II
1294, p4pgdA1, 0.7369, 2.37, 0.125, 180, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAF
1295, p3oxsA1, 0.7369, 2.27, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27
1296, d2fo4A2, 0.7369, 2.29, 0.159, 180, 88, ENHANCED MHC CLASS I BINDING AND IMMUNE RESPONSES THROUGH ANCHOR MODIFICATION OF THE NON-CANONICAL TUMOR ASSOCIATED MUC1-8 PEPTIDE
1297, d2f74A2, 0.7369, 2.15, 0.163, 180, 86, MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33
1298, d4nqvE1, 0.7368, 2.29, 0.138, 176, 87, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1299, p4lnrA1, 0.7368, 2.29, 0.138, 176, 87, THE STRUCTURE OF HLA-B*35:01 IN COMPLEX WITH THE PEPTIDE (RPQVPLRPMTY)
1300, d4huwE1, 0.7368, 2.29, 0.138, 176, 87, CRYSTAL STRUCTURE OF H2DB-NPM6T
1301, p3e3qP_, 0.7368, 2.31, 0.136, 180, 88, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1302, d2ak4K2, 0.7368, 2.24, 0.161, 180, 87, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
1303, d1s7wD2, 0.7368, 2.32, 0.136, 178, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1304, d1s7uA2, 0.7368, 2.40, 0.114, 178, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1305, p5wjlA1, 0.7367, 2.28, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-A*11:01 WITH GTS1 PEPTIDE
1306, d1s9yA2, 0.7367, 2.29, 0.170, 180, 88, CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE SLLMWITQS IN COMPLEX WITH HLA-A2
1307, d1n59C2, 0.7367, 2.30, 0.114, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1308, p3mrnA1, 0.7366, 2.32, 0.149, 175, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS4B-1807-1816 DECAPEPTIDE
1309, p3e3qc_, 0.7366, 2.28, 0.182, 181, 88, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1310, d2bckA2, 0.7366, 2.28, 0.125, 181, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE
1311, p5hyjA1, 0.7365, 2.31, 0.114, 181, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
1312, p5e6iR1, 0.7365, 2.31, 0.159, 180, 88, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
1313, p5e6iI1, 0.7365, 2.28, 0.161, 181, 87, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
1314, p3mrqA1, 0.7365, 2.32, 0.125, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT
1315, p5bs0A1, 0.7364, 2.26, 0.159, 180, 88, MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1
1316, d2clvH2, 0.7364, 2.32, 0.149, 175, 87, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE
1317, d1g6rH2, 0.7364, 2.31, 0.170, 181, 88, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1318, p3e3qH_, 0.7363, 2.26, 0.159, 180, 88, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1319, d3ch1J1, 0.7363, 2.25, 0.161, 178, 87, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
1320, d1s7sA2, 0.7363, 2.24, 0.161, 180, 87, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1321, p5f1iD1, 0.7362, 2.29, 0.159, 180, 88, MHC WITH 9-MER PEPTIDE
1322, p3fqwA1, 0.7362, 2.26, 0.161, 180, 87, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1323, p3e3qB_, 0.7362, 2.35, 0.125, 178, 88, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1324, p2zswG1, 0.7362, 2.33, 0.126, 181, 87, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
1325, d2gtwD2, 0.7362, 2.32, 0.149, 175, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION
1326, d1g6rI2, 0.7362, 2.50, 0.114, 177, 88, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1327, d5kd4C1, 0.7361, 2.31, 0.136, 181, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PVI10) OF HIV GP120 MN ISOLATE (IGPGRAFYVI)
1328, d1s7qA2, 0.7361, 2.43, 0.136, 181, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1329, p4pgeA1, 0.7360, 2.29, 0.159, 180, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAW
1330, p3qq3D1, 0.7360, 2.33, 0.149, 175, 87, CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES
1331, d2f53A2, 0.7360, 2.38, 0.125, 180, 88, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
1332, d1ffnD2, 0.7360, 2.30, 0.159, 181, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M)
1333, p5wmqA1, 0.7359, 2.33, 0.126, 181, 87, CRYSTAL STRUCTURE OF HLA-B8 IN COMPLEX WITH ELR; AN INFLUENZA A VIRUS PEPTIDE 
1334, p4xxcA1, 0.7359, 2.23, 0.126, 180, 87, HLA-B*1801 IN COMPLEX WITH A SELF-PEPTIDE DELEIKAY
1335, d4hv8C1, 0.7359, 2.30, 0.136, 181, 88, CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I
1336, p3e3qL_, 0.7359, 2.25, 0.138, 180, 87, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1337, d1s7uG2, 0.7359, 2.39, 0.136, 180, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1338, d1ffnA2, 0.7359, 2.28, 0.159, 181, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M)
1339, p5u98D1, 0.7358, 2.32, 0.114, 180, 88, THE CRYSTAL STRUCTURE OF A SELF-PEPTIDE COMPLEXED TO ABACAVIR AND HLA- B*57:01
1340, p5swsA1, 0.7358, 2.26, 0.136, 180, 88, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
1341, p5e8pD1, 0.7358, 2.31, 0.170, 180, 88, THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P5NLE IN COMPLEX WITH H-2D(B)
1342, d4hv8A1, 0.7358, 2.34, 0.114, 181, 88, CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I
1343, p3rl1A1, 0.7358, 2.32, 0.149, 175, 87, HIV RT DERIVED PEPTIDE COMPLEXED TO HLA-A*0301
1344, d3ftgA1, 0.7358, 2.45, 0.112, 181, 89, CRYSTAL STRUCTURE OF H2DB IN COMPLEX WITH NP366-N3A VARIANT PEPTIDE FROM INFLUENZA
1345, p3tpuI_, 0.7357, 2.32, 0.114, 180, 88, 42F3 P5E8/H2-LD COMPLEX
1346, d3gsnH1, 0.7357, 2.33, 0.170, 179, 88, CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
1347, p3fqnA1, 0.7357, 2.37, 0.114, 180, 88, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1348, d1a1nA2, 0.7357, 2.45, 0.114, 175, 88, MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1
1349, p3tbvE1, 0.7356, 2.33, 0.114, 180, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2GV3PY4A)
1350, p5knmA1, 0.7355, 2.31, 0.170, 180, 88, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
1351, p5f1iP1, 0.7355, 2.30, 0.114, 181, 88, MHC WITH 9-MER PEPTIDE
1352, p3e3qA_, 0.7355, 2.22, 0.140, 173, 86, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1353, d2gj6A2, 0.7355, 2.26, 0.149, 181, 87, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
1354, d1mhcD2, 0.7355, 2.30, 0.159, 180, 88, MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION
1355, p2e7lE_, 0.7354, 2.30, 0.170, 181, 88, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1356, d1hhhA2, 0.7354, 2.46, 0.124, 180, 89, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1357, p5wjnG1, 0.7353, 2.17, 0.103, 180, 87, CRYSTAL STRUCTURE OF HLA-A*11:01-GTS3
1358, p5m02A1, 0.7352, 2.35, 0.148, 181, 88, CRYSTAL STRUCTURE OF MURINE P14 TCR / H-2DB WITH PF MODIFIED GP33 PEPTIDE FROM LCMV
1359, d5kd7C1, 0.7352, 2.33, 0.149, 175, 87, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PV9) OF HIV GP120 MN ISOLATE (IGPGRAFYV)
1360, p4u1sA1, 0.7352, 2.24, 0.161, 181, 87, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1361, p3vfmA1, 0.7352, 2.29, 0.115, 181, 87, CRYSTAL STRUCTURE OF HLA B*3508 LPEP155A HLA MUTANT ALA155
1362, d1s9wA2, 0.7352, 2.18, 0.140, 175, 86, CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE SLLMWITQC IN COMPLEX WITH HLA-A2
1363, p5u98A1, 0.7351, 2.24, 0.161, 181, 87, THE CRYSTAL STRUCTURE OF A SELF-PEPTIDE COMPLEXED TO ABACAVIR AND HLA- B*57:01
1364, p4prpA1, 0.7350, 2.32, 0.159, 180, 88, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX
1365, p4gksD1, 0.7350, 2.41, 0.114, 180, 88, A2-MHC COMPLEX CARRYING FLTGIGIITV
1366, p3vfuA1, 0.7350, 2.36, 0.125, 180, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P7ALA PEPTIDE MUTANT P7-ALA
1367, d2ve6J2, 0.7350, 2.34, 0.125, 181, 88, CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
1368, d1kpuA2, 0.7350, 2.29, 0.170, 180, 88, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/VSV8
1369, p3ws6A1, 0.7349, 2.33, 0.159, 181, 88, CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH A MIMOTOPIC PEPTIDE
1370, d1s7wJ2, 0.7349, 2.34, 0.170, 179, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1371, p6avgG1, 0.7348, 2.23, 0.172, 180, 87, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1372, p5wjnD1, 0.7348, 2.40, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-A*11:01-GTS3
1373, p5e8nG1, 0.7348, 2.30, 0.182, 180, 88, THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)
1374, p3tbvA1, 0.7348, 2.39, 0.114, 178, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2GV3PY4A)
1375, d1w72D2, 0.7348, 2.31, 0.136, 181, 88, CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3
1376, d1hsaD2, 0.7348, 2.35, 0.114, 179, 88, THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC
1377, p5vgeA1, 0.7347, 2.46, 0.112, 181, 89, CRYSTAL STRUCTURE OF HLA-C*07:02 IN COMPLEX WITH RYR PEPTIDE
1378, p3vftA1, 0.7347, 2.38, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA B*3508LPEP-P6ALA PEPTIDE MUTANT P6-ALA
1379, d3lkrA1, 0.7347, 2.32, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN
1380, p2oi9A_, 0.7347, 2.16, 0.116, 175, 86, STRUCTURE OF THE 2C/LD/QL9 ALLOGENEIC COMPLEX
1381, d2axfA2, 0.7347, 2.47, 0.124, 180, 89, THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION
1382, p3tbvC1, 0.7346, 2.31, 0.159, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2GV3PY4A)
1383, p3kxfK1, 0.7346, 2.38, 0.148, 181, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
1384, p5e8nJ1, 0.7344, 2.32, 0.149, 179, 87, THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)
1385, p4eupA1, 0.7344, 2.30, 0.182, 180, 88, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
1386, p3kxfI1, 0.7344, 2.29, 0.148, 181, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
1387, p3jttD1, 0.7344, 2.39, 0.138, 175, 87, CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02
1388, d1hsbA2, 0.7344, 2.31, 0.182, 181, 88, DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE
1389, p5h94D1, 0.7343, 2.31, 0.125, 180, 88, CRYSTAL STRUCTURE OF SWINE MHC CLASSI FOR 1.48 ANGSTROMS
1390, p3fqxA1, 0.7343, 2.30, 0.170, 180, 88, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1391, d1n3nC2, 0.7343, 2.14, 0.116, 175, 86, CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1392, p5jziF1, 0.7342, 2.25, 0.161, 180, 87, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
1393, d4pv9A1, 0.7342, 2.31, 0.170, 180, 88, CRYSTAL STRUCTURE OF H2KB-Q600V COMPLEX
1394, p4o2eD1, 0.7342, 2.30, 0.149, 180, 87, A PEPTIDE COMPLEXED WITH HLA-B*3901
1395, p3vrjA1, 0.7342, 2.33, 0.148, 181, 88, HLA-B*57:01-LTTKLTNTNI IN COMPLEX WITH ABACAVIR
1396, p3tbwE1, 0.7342, 2.39, 0.136, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G V3P Y4S)
1397, p5wjlD1, 0.7341, 2.30, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-A*11:01 WITH GTS1 PEPTIDE
1398, p5nq2A1, 0.7341, 2.32, 0.114, 181, 88,  PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; PRESENTING IAYERMCNI 
1399, p3skmA1, 0.7341, 2.32, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE HLA-B8FLRGRAYVL MUTANT G8V OF THE FLR PEPTIDE
1400, p3mv7A1, 0.7341, 2.24, 0.126, 180, 87, CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG
1401, d3lkoA1, 0.7341, 2.35, 0.136, 180, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN
1402, d1k8iB2, 0.7341, 2.34, 0.159, 180, 88, CRYSTAL STRUCTURE OF MOUSE H2-DM
1403, p4hwzA1, 0.7340, 2.60, 0.112, 178, 89, STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV DERIVED PEPTIDE
1404, d1i4fA2, 0.7340, 2.29, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX
1405, d5kd7I1, 0.7339, 2.43, 0.148, 181, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PV9) OF HIV GP120 MN ISOLATE (IGPGRAFYV)
1406, p5e9dA1, 0.7339, 2.32, 0.148, 174, 88, RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2
1407, p3vfnA1, 0.7339, 2.42, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA B*3508LPEP151A HLA MUTANT ALA151
1408, p3tbvG1, 0.7339, 2.30, 0.170, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2GV3PY4A)
1409, p3kxfA1, 0.7339, 2.18, 0.140, 94, 86, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
1410, d1s7wA2, 0.7339, 2.18, 0.140, 94, 86, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1411, p4u1lD1, 0.7338, 2.33, 0.159, 180, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1412, d4l8dC1, 0.7338, 2.33, 0.159, 181, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5D PEPTIDE
1413, p3x13A1, 0.7338, 2.32, 0.126, 179, 87, CRYSTAL STRUCTURE OF HLA-B*0801.N80I
1414, p3qulA1, 0.7338, 2.28, 0.159, 180, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)
1415, d1zsdA2, 0.7338, 2.31, 0.182, 180, 88, CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY
1416, d1zhlA2, 0.7338, 2.47, 0.124, 180, 89, CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1417, d5wlgF1, 0.7336, 2.38, 0.159, 180, 88, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
1418, p3vfvA1, 0.7336, 2.31, 0.125, 181, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P9ALA PEPTIDE MUTANT P9-ALA
1419, d1x7qA2, 0.7336, 2.36, 0.125, 181, 88, CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE
1420, p5wjnA1, 0.7335, 2.31, 0.114, 181, 88, CRYSTAL STRUCTURE OF HLA-A*11:01-GTS3
1421, p5grgA1, 0.7335, 2.32, 0.148, 180, 88, CRYSTAL STRUCTURE OF DUAL PEPTIDE FROM EBV IN COMPLEX WITH HLA-A*11:01
1422, p4praA1, 0.7333, 2.33, 0.114, 177, 88, CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-Q5
1423, p3vfsA1, 0.7333, 2.31, 0.170, 181, 88, CRYSTAL STRUCTURE OF HLA B*3508LPEP-P5ALA  PEPTIDE MUTANT P5-ALA
1424, p3e2hA_, 0.7333, 2.31, 0.182, 181, 88, STRUCTURE OF THE M67 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1425, p3pqyP1, 0.7332, 2.44, 0.114, 181, 88, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
1426, d3ch1G1, 0.7332, 2.31, 0.182, 179, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
1427, p3bo8A1, 0.7332, 2.28, 0.161, 181, 87, THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-A1 COMPLEXED WITH THE MAGE-A1 PEPTIDE
1428, d2vaaA2, 0.7332, 2.33, 0.159, 180, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1429, p4ftvA1, 0.7331, 2.32, 0.159, 180, 88, THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE
1430, p3kwwA1, 0.7331, 2.30, 0.170, 180, 88, CRYSTAL STRUCTURE OF THE  RESTRICTION TRIAD  MUTANT OF HLA B*3508 BETA-2-MICROGLOBULIN AND EBV PEPTIDE
1431, p3jtsA1, 0.7330, 2.31, 0.182, 180, 88, GY9-MAMU-A*02-HB2M
1432, d1xr9A2, 0.7330, 2.35, 0.140, 175, 86, CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1433, p4qrsA1, 0.7329, 2.36, 0.114, 179, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELK_IYM ELKRKMIYM
1434, p4hs3A1, 0.7329, 2.22, 0.115, 176, 87, CRYSTAL STRUCTURE OF H-2KB WITH A DISULFIDE STABILIZED F POCKET IN COMPLEX WITH THE LCMV DERIVED PEPTIDE GP34
1435, p5f1iG1, 0.7328, 2.32, 0.159, 180, 88, MHC WITH 9-MER PEPTIDE
1436, p4o2eA1, 0.7328, 2.33, 0.136, 181, 88, A PEPTIDE COMPLEXED WITH HLA-B*3901
1437, d1qvoA2, 0.7328, 2.31, 0.159, 180, 88, STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1438, d1m05C2, 0.7327, 2.32, 0.170, 180, 88, HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT
1439, p6avgF1, 0.7326, 2.36, 0.148, 180, 88, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1440, p3rwcA1, 0.7326, 2.33, 0.170, 181, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW9
1441, p3jttA1, 0.7326, 2.32, 0.148, 180, 88, CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02
1442, p4nqvC1, 0.7325, 2.31, 0.136, 180, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1443, p3qulJ1, 0.7325, 2.42, 0.136, 181, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)
1444, d3ch1D1, 0.7325, 2.36, 0.136, 180, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
1445, d1vadA2, 0.7325, 2.34, 0.159, 181, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1446, p4u1lA1, 0.7324, 2.33, 0.148, 173, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1447, d4huvD1, 0.7324, 2.38, 0.148, 180, 88, CRYSTAL STRUCTURE OF H2DB-NPM6W
1448, p3vriA1, 0.7324, 2.40, 0.159, 180, 88, HLA-B*57:01-RVAQLENVYI IN COMPLEX WITH ABACAVIR
1449, p3tbyA1, 0.7324, 2.36, 0.148, 180, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4F)
1450, d1t80A2, 0.7324, 2.35, 0.159, 180, 88, ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 200
1451, d4l3cY1, 0.7323, 2.21, 0.115, 176, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1452, p4u1iA1, 0.7322, 2.42, 0.114, 178, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1453, p4pv8C1, 0.7322, 2.35, 0.125, 181, 88, CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX
1454, p3p4oA1, 0.7322, 2.38, 0.125, 181, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE MUTANT NP205-LCMV-V3A EPITOPE YTAKYPNL AN 8-MER MODIFIED PEPTIDE FROM THE LCMV
1455, p3mrkA1, 0.7321, 2.34, 0.114, 181, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE
1456, p3eryA_, 0.7321, 2.35, 0.159, 179, 88, DIFFERENT THERMODYNAMIC BINDING MECHANISMS AND PEPTIDE FINE SPECIFICITIES ASSOCIATED WITH A PANEL OF STRUCTURALLY SIMILAR HIGH-AFFINITY T CELL RECEPTORS
1457, d2fyyA2, 0.7321, 2.51, 0.124, 180, 89, THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION
1458, p4nqxK1, 0.7320, 2.40, 0.080, 179, 87, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1459, p3vfwA1, 0.7319, 2.30, 0.161, 181, 87, CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P10ALA PEPTIDE MUTANT P10-ALA
1460, p3vfoA1, 0.7319, 2.35, 0.125, 181, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP157A HLA MUTANT ALA157
1461, p5wkfA1, 0.7318, 2.26, 0.126, 179, 87, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
1462, p5gsdA1, 0.7318, 2.39, 0.125, 181, 88, CRYSTAL STRUCTURE OF LMP2 PEPTIDE FROM EBV IN COMPLEX WITH HLA-A*11:01
1463, p5f1iM1, 0.7318, 2.35, 0.159, 180, 88, MHC WITH 9-MER PEPTIDE
1464, p3mv9A1, 0.7318, 2.10, 0.153, 174, 85, CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG
1465, d1t7yA2, 0.7318, 2.32, 0.170, 181, 88, ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG PEG 200 NO GLYCEROL
1466, d1fzoA2, 0.7318, 2.34, 0.159, 180, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1467, d1g7pA2, 0.7317, 2.31, 0.182, 180, 88, CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1468, d4l8bA1, 0.7316, 2.32, 0.170, 180, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5H PEPTIDE
1469, p3qukA1, 0.7316, 2.32, 0.159, 180, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4A)
1470, d5xmmA1, 0.7315, 2.34, 0.159, 180, 88, FLA-E*01801-167W/S
1471, p3tbyD1, 0.7315, 2.41, 0.148, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4F)
1472, p4nnyA1, 0.7314, 2.46, 0.159, 180, 88, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2
1473, d4huvA1, 0.7314, 2.47, 0.091, 179, 88, CRYSTAL STRUCTURE OF H2DB-NPM6W
1474, p3mv8A1, 0.7314, 2.26, 0.138, 180, 87, CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG
1475, p3jttG1, 0.7314, 2.34, 0.136, 181, 88, CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02
1476, p5f1iA1, 0.7313, 2.41, 0.114, 181, 88, MHC WITH 9-MER PEPTIDE
1477, d1t7wA2, 0.7313, 2.21, 0.115, 176, 87, ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 400
1478, p5tilD1, 0.7312, 2.30, 0.126, 181, 87, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1479, p5d2lA1, 0.7312, 2.49, 0.124, 180, 89, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1480, p4uq2C1, 0.7312, 2.28, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE
1481, p4nqxC1, 0.7312, 2.35, 0.125, 181, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1482, d4l8dA1, 0.7312, 2.29, 0.172, 180, 87, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5D PEPTIDE
1483, d4l8cE1, 0.7312, 2.36, 0.148, 180, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
1484, p3vfpA1, 0.7312, 2.44, 0.148, 181, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP158G HLA MUTANT GLY158
1485, p3rweA1, 0.7312, 2.41, 0.080, 179, 87, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-FW9
1486, p3cc5D1, 0.7312, 2.42, 0.114, 179, 88, H-2DB COMPLEX WITH HUMAN GP100
1487, d1t7vA2, 0.7312, 2.29, 0.159, 179, 88, ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG PEG 200
1488, d2zokC2, 0.7311, 2.33, 0.148, 180, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
1489, p4uq2A1, 0.7310, 2.36, 0.159, 180, 88, CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE
1490, p3cc5A1, 0.7310, 2.34, 0.114, 181, 88, H-2DB COMPLEX WITH HUMAN GP100
1491, d2vabA2, 0.7310, 2.33, 0.114, 181, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1492, p4mj6A1, 0.7309, 2.33, 0.170, 180, 88, CRYSTAL STRUCTURE OF HLA-A*1101 IN COMPLEX WITH H7-22 AN INFLUENZA A(H7N9) VIRUS EPITOPE
1493, p2zsvA1, 0.7309, 2.40, 0.159, 180, 88, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598
1494, p5grdA1, 0.7308, 2.39, 0.114, 180, 88, CRYSTAL STRUCTURE OF 10-MER PEPTIDE FROM EBV IN COMPLEX WITH HLA- A1101.
1495, p4eupD1, 0.7307, 2.40, 0.080, 179, 87, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
1496, p3tbwG1, 0.7307, 2.18, 0.116, 173, 86, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G V3P Y4S)
1497, p5nmeA1, 0.7306, 2.35, 0.148, 180, 88, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1498, p4prhA1, 0.7304, 2.40, 0.125, 180, 88, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG-D5 COMPLEX
1499, p5tilA1, 0.7303, 2.35, 0.136, 181, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1500, p5brzA1, 0.7303, 2.34, 0.159, 180, 88, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
1501, p4mj5A1, 0.7303, 2.22, 0.128, 175, 86, CRYSTAL STRUCTURE OF HLA-A*1101 IN COMPLEX WITH H1-22 AN INFLUENZA A(H1N1) VIRUS EPITOPE
1502, d1efxA2, 0.7303, 2.32, 0.159, 180, 88, STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3
1503, p4i48A1, 0.7302, 2.27, 0.161, 180, 87, STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV ENV DERIVED PEPTIDE
1504, p4gknD1, 0.7302, 2.17, 0.115, 177, 87, A2-MHC COMPLEX CARRYING FATGIGIITV
1505, d2ak4A2, 0.7302, 2.28, 0.172, 180, 87, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
1506, d1mi5A2, 0.7302, 2.27, 0.184, 179, 87, THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX
1507, p3rwcD1, 0.7301, 2.44, 0.114, 179, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW9
1508, p3rl2A1, 0.7301, 2.30, 0.161, 180, 87, HIV NEF DERIVED PEPTIDE NEF73 COMPLEXED TO HLA-A*0301
1509, p3rwhA1, 0.7300, 2.35, 0.159, 180, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MF8
1510, d2h6pA2, 0.7300, 2.39, 0.159, 181, 88, CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450 DERIVED PEPTIDE KPIVVLHGY
1511, d1m05A2, 0.7300, 2.32, 0.159, 180, 88, HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT
1512, p5wkfF1, 0.7299, 2.24, 0.161, 180, 87, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
1513, d3lkqA1, 0.7299, 2.39, 0.170, 181, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN
1514, d3cvhA2, 0.7297, 2.36, 0.148, 181, 88, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
1515, p3rwjA1, 0.7295, 2.43, 0.159, 180, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-HW8
1516, d4pv9C1, 0.7294, 2.49, 0.148, 179, 88, CRYSTAL STRUCTURE OF H2KB-Q600V COMPLEX
1517, p3rwgA1, 0.7294, 2.43, 0.159, 180, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MW9
1518, d3lksA1, 0.7293, 2.29, 0.149, 181, 87, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN
1519, p3es6A1, 0.7293, 2.37, 0.136, 173, 88, CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC 2- GLYCOPROTEIN (ZAG) AND PROLACTIN INDUCIBLE PROTEIN (PIP) FROM HUMAN SEMINAL PLASMA
1520, d2cikA2, 0.7293, 2.32, 0.159, 180, 88, INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450.
1521, p3tf7A_, 0.7291, 2.32, 0.170, 181, 88, 42F3 QL9/H2-LD COMPLEX
1522, d1t7zA2, 0.7291, 2.30, 0.128, 181, 86, ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG NO PEG NO GLYCEROL
1523, p4qrtA1, 0.7290, 2.41, 0.161, 180, 87, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELN_YYM ELNRKMIYM
1524, d2ak4F2, 0.7290, 2.27, 0.126, 180, 87, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
1525, p5mzmD1, 0.7289, 2.47, 0.148, 180, 88, STRUCTURE OF H-2DB IN COMPLEX WITH TEIPP APL TRH4 P3P
1526, d2vlrA2, 0.7288, 2.32, 0.170, 181, 88, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
1527, p5mzmA1, 0.7287, 2.36, 0.103, 181, 87, STRUCTURE OF H-2DB IN COMPLEX WITH TEIPP APL TRH4 P3P
1528, d4l8cA1, 0.7285, 2.36, 0.103, 181, 87, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
1529, d3lkpA1, 0.7285, 2.29, 0.172, 181, 87, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN
1530, d5xmfA1, 0.7284, 2.42, 0.138, 175, 87, CRYSTAL STRUCTURE OF FELINE MHC CLASS I FOR 21 ANGSTROM
1531, p4o2fA1, 0.7284, 2.49, 0.091, 179, 88, A PEPTIDE COMPLEXED WITH HLA-B*3901
1532, p4jfpD1, 0.7283, 2.29, 0.149, 179, 87, A2 HLA COMPLEX WITH G4A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
1533, p3tbyG1, 0.7283, 2.41, 0.170, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4F)
1534, d1cg9A2, 0.7283, 2.44, 0.114, 176, 88, COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6
1535, p5wkhF1, 0.7281, 2.30, 0.161, 181, 87, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
1536, d1zt1A2, 0.7281, 2.12, 0.116, 175, 86, CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH AN OCTAPEPTIDE
1537, p5d2lG1, 0.7280, 2.32, 0.114, 181, 88, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1538, d3lknA1, 0.7280, 2.33, 0.170, 181, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN
1539, d4l8cC1, 0.7279, 2.33, 0.126, 181, 87, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
1540, p3qulG1, 0.7279, 2.43, 0.136, 180, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)
1541, d1legA2, 0.7279, 2.42, 0.138, 179, 87, CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE
1542, p5j6gC1, 0.7278, 2.52, 0.112, 177, 89, RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C
1543, p5j6gA1, 0.7278, 2.39, 0.170, 181, 88, RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C
1544, p4gknA1, 0.7277, 2.33, 0.159, 180, 88, A2-MHC COMPLEX CARRYING FATGIGIITV
1545, p5wjlG1, 0.7275, 2.38, 0.140, 176, 86, CRYSTAL STRUCTURE OF HLA-A*11:01 WITH GTS1 PEPTIDE
1546, d1ldpH2, 0.7275, 2.32, 0.159, 178, 88, CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES
1547, p3ffcA1, 0.7274, 2.33, 0.170, 181, 88, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
1548, p3ffcF1, 0.7272, 2.36, 0.114, 181, 88, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
1549, p5swzK1, 0.7268, 2.33, 0.115, 175, 87, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1550, d1kprC2, 0.7267, 2.31, 0.138, 180, 87, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1551, p6avfH1, 0.7264, 2.32, 0.138, 179, 87, CRYSTAL STRUCTURE OF THE KFJ5 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1552, d5wlgA1, 0.7263, 2.30, 0.138, 180, 87, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
1553, d1ktlC2, 0.7263, 2.26, 0.161, 180, 87, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1554, d4l8cG1, 0.7262, 2.36, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
1555, p3tbtJ1, 0.7262, 2.39, 0.136, 181, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4S)
1556, p3rwdA1, 0.7262, 2.38, 0.148, 180, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW11
1557, d1zhkA2, 0.7262, 2.38, 0.148, 180, 88, CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1558, d1qvoD2, 0.7261, 2.44, 0.114, 180, 88, STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1559, d1ktlA2, 0.7259, 2.34, 0.149, 181, 87, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1560, d1a9eA2, 0.7259, 2.31, 0.153, 98, 85, DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1561, p3rwhD1, 0.7257, 2.39, 0.114, 181, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MF8
1562, d3bzeC2, 0.7257, 2.38, 0.159, 181, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- 2 E
1563, p3rwiA1, 0.7256, 2.33, 0.114, 181, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-GW10
1564, d1t7xA2, 0.7256, 2.26, 0.115, 176, 87, ZN-ALPHA-2-GLYCOPROTEIN; REFOLDED CHO-ZAG PEG 400
1565, d3cvhM2, 0.7254, 2.42, 0.159, 180, 88, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
1566, d2bc4B1, 0.7254, 2.37, 0.170, 181, 88, CRYSTAL STRUCTURE OF HLA-DM
1567, p3uttF1, 0.7250, 2.41, 0.159, 181, 88, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
1568, p5j6hA1, 0.7249, 2.39, 0.159, 181, 88, RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C
1569, p3tbyJ1, 0.7249, 2.38, 0.161, 181, 87, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4F)
1570, p5iroQ1, 0.7248, 2.44, 0.161, 180, 87, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1571, p4mvbA_, 0.7248, 2.28, 0.138, 180, 87, 42F3 PCPB7/H-2LD COMPLEX
1572, p3qukD1, 0.7247, 2.47, 0.159, 180, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4A)
1573, p5iroM1, 0.7246, 2.42, 0.080, 179, 87, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1574, p3tbtA1, 0.7245, 2.39, 0.126, 181, 87, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4S)
1575, p3rwdD1, 0.7245, 2.23, 0.106, 91, 85, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW11
1576, d2nx5K2, 0.7245, 2.30, 0.163, 180, 86, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1577, d2nx5A2, 0.7245, 2.38, 0.115, 180, 87, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1578, p5tjeA1, 0.7244, 2.38, 0.115, 176, 87, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
1579, d2nx5F2, 0.7244, 2.41, 0.136, 180, 88, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1580, d1kjvA2, 0.7242, 2.34, 0.140, 174, 86, TAP-B-ASSOCIATED RAT MHC CLASS I MOLECULE
1581, p5tjeC1, 0.7240, 2.36, 0.115, 175, 87, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
1582, p4nhuE_, 0.7240, 2.43, 0.136, 180, 88, THE M33 TCR P3M33L/H-2 LD COMPLEX
1583, d1lekA2, 0.7240, 2.27, 0.115, 176, 87, CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8
1584, p3sjvK1, 0.7236, 2.47, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1585, p4i0pF1, 0.7233, 2.31, 0.172, 181, 87, HLA-DO IN COMPLEX WITH HLA-DM
1586, p3qulD1, 0.7233, 2.25, 0.138, 181, 87, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)
1587, p3tbtG1, 0.7232, 2.52, 0.114, 178, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4S)
1588, d1kprA2, 0.7229, 2.34, 0.148, 181, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1589, p4mjiF1, 0.7228, 2.32, 0.103, 181, 87, T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01
1590, d2bc4D1, 0.7228, 2.52, 0.114, 177, 88, CRYSTAL STRUCTURE OF HLA-DM
1591, p4i0pB1, 0.7226, 2.18, 0.141, 186, 85, HLA-DO IN COMPLEX WITH HLA-DM
1592, p6bj8A1, 0.7222, 2.18, 0.141, 186, 85, TCR55 IN COMPLEX WITH PEP20/HLA-B35 
1593, p3w39A1, 0.7220, 2.35, 0.138, 180, 87, CRYSTAL STRUCTURE OF HLA-B*5201 IN COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE (TAFTIPSI)
1594, p5iroA1, 0.7218, 2.41, 0.148, 180, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1595, p6bj2A1, 0.7217, 2.23, 0.106, 90, 85, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
1596, p4jrxA1, 0.7217, 2.15, 0.118, 174, 85, CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX
1597, p3tfkA_, 0.7216, 2.37, 0.115, 175, 87, 42F3-P4B10/H2-LD
1598, d1fzjA2, 0.7215, 2.41, 0.159, 181, 88, MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1599, p6bj3A1, 0.7212, 2.52, 0.148, 180, 88, TCR55 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
1600, p4mjiA1, 0.7210, 2.25, 0.106, 91, 85, T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01
1601, d2nx5Q2, 0.7210, 2.23, 0.106, 90, 85, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1602, p5w69G1, 0.7208, 2.50, 0.159, 178, 88, HLA-C*06:02 PRESENTING ARFNDLRFV
1603, d1fzmA2, 0.7208, 2.08, 0.179, 98, 84, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1604, d1a9bD2, 0.7206, 2.40, 0.136, 180, 88, DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1605, d1a9bA2, 0.7206, 2.43, 0.170, 181, 88, DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1606, p4jryA1, 0.7204, 2.45, 0.170, 180, 88, CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX
1607, p4nhuG_, 0.7203, 2.34, 0.140, 174, 86, THE M33 TCR P3M33L/H-2 LD COMPLEX
1608, d3hujC1, 0.7200, 2.35, 0.138, 180, 87, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1609, p5iroI1, 0.7196, 2.49, 0.159, 179, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1610, p3qq4A1, 0.7194, 2.37, 0.149, 180, 87, CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES
1611, p3kxfC1, 0.7193, 2.39, 0.170, 181, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
1612, p3sjvA1, 0.7192, 2.14, 0.181, 175, 83, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1613, d4fqxD1, 0.7191, 2.34, 0.138, 180, 87, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
1614, d4x6cA1, 0.7187, 2.46, 0.170, 181, 88, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
1615, d5c9jA1, 0.7184, 2.46, 0.170, 181, 88, HUMAN CD1C WITH LIGANDS IN A  AND F  CHANNEL
1616, p3tbtD1, 0.7181, 2.50, 0.182, 180, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4S)
1617, d4ms8A1, 0.7180, 2.25, 0.141, 185, 85, 42F3 TCR PCPB9/H-2LD COMPLEX
1618, p3sjvP1, 0.7176, 2.23, 0.108, 179, 83, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1619, d1fzkA2, 0.7176, 2.46, 0.136, 176, 88, MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1620, p3tpuQ1, 0.7175, 2.54, 0.136, 180, 88, 42F3 P5E8/H2-LD COMPLEX
1621, d1lqvB_, 0.7174, 2.45, 0.159, 180, 88, CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR WITH PHOSPHOLIPID IN THE GROOVE IN COMPLEX WITH GLA DOMAIN OF PROTEIN C.
1622, p4n8vA1, 0.7172, 2.37, 0.149, 180, 87, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A
1623, p4n8vD1, 0.7170, 2.24, 0.106, 91, 85, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A
1624, d1tmcA_, 0.7170, 2.28, 0.145, 168, 83, THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN
1625, p3sjvF1, 0.7165, 2.31, 0.157, 179, 83, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1626, d1kcgC_, 0.7165, 2.19, 0.118, 174, 85, NKG2D IN COMPLEX WITH ULBP3
1627, p4gbxD1, 0.7164, 2.09, 0.145, 161, 83, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5
1628, p6c09A1, 0.7155, 2.44, 0.148, 180, 88, TERNARY CRYSTAL STRUCTURE OF THE 3C8 TCR-CD1C-MONOACYLGLYCEROL COMPLEX
1629, d1zt4C2, 0.7155, 2.37, 0.138, 180, 87, THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- GALACTOSYLCERAMIDE
1630, p4nt6A1, 0.7154, 2.28, 0.143, 94, 84, HLA-C*0801 CRYSTAL STRUCTURE
1631, d3jtcB_, 0.7146, 2.27, 0.155, 173, 84, IMPORTANCE OF MG2+ IN THE CA2+-DEPENDENT FOLDING OF THE GAMMA- CARBOXYGLUTAMIC ACID DOMAINS OF VITAMIN K-DEPENDENT CLOTTING AND ANTICLOTTING PROTEINS
1632, p4n0cE_, 0.7141, 2.27, 0.155, 173, 84, 42F3 TCR PCPE3/H-2LD COMPLEX
1633, d1hdmB2, 0.7129, 2.41, 0.159, 180, 88, HISTOCOMPATIBILITY ANTIGEN HLA-DM
1634, d3u0pA1, 0.7124, 2.42, 0.159, 180, 88, CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE
1635, d4lhuA1, 0.7120, 2.26, 0.140, 175, 86, CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D
1636, p3eryB_, 0.7120, 2.47, 0.136, 180, 88, DIFFERENT THERMODYNAMIC BINDING MECHANISMS AND PEPTIDE FINE SPECIFICITIES ASSOCIATED WITH A PANEL OF STRUCTURALLY SIMILAR HIGH-AFFINITY T CELL RECEPTORS
1637, d1nezA2, 0.7117, 2.53, 0.143, 170, 84, THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION CO-RECEPTOR PREFERENCE AND AFFINITY
1638, p3e3qU1, 0.7103, 2.25, 0.106, 90, 85, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1639, d3hujA1, 0.7096, 2.38, 0.145, 176, 83, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1640, d3gmnA1, 0.7095, 2.28, 0.120, 180, 83, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH
1641, d3gmoA1, 0.7094, 2.51, 0.159, 180, 88, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF
1642, d4x6cC1, 0.7088, 2.33, 0.129, 173, 85, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
1643, p5iroE1, 0.7087, 2.32, 0.141, 174, 85, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1644, p4n0cA_, 0.7081, 2.17, 0.108, 85, 83, 42F3 TCR PCPE3/H-2LD COMPLEX
1645, d3gmlA1, 0.7081, 2.21, 0.120, 178, 83, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH
1646, d3gmqA1, 0.7079, 2.27, 0.108, 178, 83, STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS NO LIGAND ADDED
1647, p3pabA1, 0.7078, 1.95, 0.162, 149, 80, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1
1648, d3gmpA1, 0.7076, 2.71, 0.138, 181, 87, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25
1649, d3u0pC1, 0.7066, 2.25, 0.145, 93, 83, CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE
1650, d1zt4A2, 0.7065, 2.29, 0.108, 178, 83, THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- GALACTOSYLCERAMIDE
1651, d2akrC2, 0.7064, 2.37, 0.143, 179, 84, STRUCTURAL BASIS OF SULFATIDE PRESENTATION BY MOUSE CD1D
1652, d3gmmA1, 0.7058, 2.38, 0.143, 179, 84, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH
1653, d4wwkC1, 0.7056, 2.35, 0.133, 177, 83, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV12-3 BETA CHAIN-TRBV6- 5 ANTIGEN-PRESENTING MOLECULE CD1D AND BETA-2-MICROGLOBULIN
1654, d4wo4A1, 0.7050, 2.54, 0.136, 180, 88, THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION.
1655, d2po6A2, 0.7050, 2.40, 0.140, 173, 86, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1656, d2gazA2, 0.7050, 2.21, 0.145, 179, 83, MYCOBACTERIAL LIPOGLYCAN PRESENTATION BY CD1D
1657, d1onqA2, 0.7049, 2.36, 0.143, 179, 84, CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE
1658, d4ww2C1, 0.7045, 2.26, 0.131, 98, 84, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 BETA CHAIN- TRBV7-8 ANTIGEN-PRESENTING GLYCOPROTEIN CD1D AND BETA-2- MICROGLOBULIN
1659, d2po6E2, 0.7045, 2.39, 0.143, 179, 84, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1660, d1mwaI2, 0.7043, 2.31, 0.108, 178, 83, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1661, d3au1A1, 0.7042, 2.28, 0.120, 178, 83, CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3
1662, d1onqC2, 0.7041, 2.40, 0.143, 179, 84, CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE
1663, d4mngC1, 0.7039, 2.40, 0.143, 179, 84, STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
1664, d4x6dC1, 0.7037, 2.26, 0.108, 176, 83, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
1665, d3t8xC1, 0.7034, 2.35, 0.108, 177, 83, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER
1666, d4x6dA1, 0.7032, 2.34, 0.108, 178, 83, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
1667, d3tzvC1, 0.7031, 2.38, 0.143, 175, 84, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
1668, d4f7eA1, 0.7030, 2.38, 0.143, 177, 84, CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C16:0-ALPHA-GALACTOSYL CERAMIDE
1669, d2akrA2, 0.7026, 2.38, 0.143, 177, 84, STRUCTURAL BASIS OF SULFATIDE PRESENTATION BY MOUSE CD1D
1670, d4mngA1, 0.7024, 2.37, 0.096, 181, 83, STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
1671, d3sdxA1, 0.7020, 2.37, 0.096, 181, 83, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1672, d3sdxC1, 0.7019, 2.31, 0.108, 178, 83, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1673, d3ma7A1, 0.7012, 2.54, 0.125, 181, 88, CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D
1674, d4v3eB_, 0.7011, 2.41, 0.143, 179, 84, THE CIDRA DOMAIN FROM IT4VAR07 PFEMP1 BOUND TO ENDOTHELIAL PROTEIN C RECEPTOR
1675, d1cd1C2, 0.7009, 2.40, 0.143, 177, 84, CD1(MOUSE) ANTIGEN PRESENTING MOLECULE
1676, d1zhnA2, 0.7004, 2.31, 0.108, 178, 83, CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE
1677, d4s0uC_, 0.6998, 2.54, 0.141, 177, 85, CRYSTAL STRUCTURE OF NKG2D IN COMPLEX WITH ULBP6
1678, d4y4fA1, 0.6997, 2.43, 0.119, 178, 84, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
1679, p5l2kA1, 0.6996, 2.42, 0.143, 172, 84, CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX
1680, p5fkpA1, 0.6996, 2.39, 0.096, 176, 83, CRYSTAL STRUCTURE OF THE MOUSE CD1D IN COMPLEX WITH THE P99 PEPTIDE
1681, d2fikA2, 0.6995, 2.38, 0.071, 176, 84, STRUCTURE OF A MICROBIAL GLYCOSPHINGOLIPID BOUND TO MOUSE CD1D
1682, d4y2dE1, 0.6994, 2.36, 0.133, 179, 83, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
1683, d2q7yC2, 0.6991, 2.32, 0.108, 178, 83, STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D
1684, d3gmrA1, 0.6990, 2.36, 0.108, 178, 83, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH DIFFERENT SPACE GROUP
1685, d3quzA1, 0.6986, 2.36, 0.108, 178, 83, STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
1686, d5tw5A1, 0.6985, 2.42, 0.143, 179, 84, STRUCTURE OF MOUSE CD1D WITH BOUND GLYCOSPHINGOLIPID JJ112
1687, d4zakA1, 0.6985, 2.23, 0.159, 167, 82, CRYSTAL STRUCTURE OF THE MCD1D/DB06-1/INKTCR TERNARY COMPLEX
1688, d4mx7A1, 0.6985, 2.34, 0.145, 179, 83, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH DIOLEOYL-PHOSPHATIDIC ACID
1689, d1gzqA2, 0.6983, 2.34, 0.145, 176, 83, CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL
1690, d3quxA1, 0.6980, 2.64, 0.140, 175, 86, STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
1691, d4v3dB_, 0.6979, 2.64, 0.140, 175, 86, THE CIDRA DOMAIN FROM HB3VAR03 PFEMP1 BOUND TO ENDOTHELIAL PROTEIN C RECEPTOR
1692, d1cd1A2, 0.6978, 2.30, 0.145, 179, 83, CD1(MOUSE) ANTIGEN PRESENTING MOLECULE
1693, d4y16A1, 0.6974, 2.47, 0.131, 179, 84, CRYSTAL STRUCTURE OF THE MCD1D/NC-AGC/INKTCR TERNARY COMPLEX
1694, d4y2dA1, 0.6972, 2.30, 0.134, 172, 82, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
1695, d3ta3A1, 0.6968, 2.42, 0.143, 171, 84, STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
1696, d3quyA1, 0.6966, 2.30, 0.145, 180, 83, STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1 -INKT TCR COMPLEX
1697, d1gzpA2, 0.6963, 2.29, 0.145, 179, 83, CD1B IN COMPLEX WITH GM2 GANGLIOSIDE
1698, d1lqvA_, 0.6961, 2.47, 0.143, 179, 84, CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR WITH PHOSPHOLIPID IN THE GROOVE IN COMPLEX WITH GLA DOMAIN OF PROTEIN C.
1699, d3jtcA_, 0.6958, 2.30, 0.145, 179, 83, IMPORTANCE OF MG2+ IN THE CA2+-DEPENDENT FOLDING OF THE GAMMA- CARBOXYGLUTAMIC ACID DOMAINS OF VITAMIN K-DEPENDENT CLOTTING AND ANTICLOTTING PROTEINS
1700, d3rugC1, 0.6955, 2.27, 0.145, 179, 83, CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D- ALPHAGLUCOSYLCERAMIDE (C20:2)
1701, d3rzcA1, 0.6949, 2.31, 0.145, 179, 83, STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
1702, d3ubxA1, 0.6947, 2.44, 0.143, 179, 84, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
1703, d4irjA1, 0.6945, 2.45, 0.119, 181, 84, STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
1704, d1p1zA2, 0.6945, 2.45, 0.119, 181, 84, X-RAY CRYSTAL STRUCTURE OF THE LECTIN-LIKE NATURAL KILLER CELL RECEPTOR LY-49C BOUND TO ITS MHC CLASS I LIGAND H-2KB
1705, d3ubxD1, 0.6942, 2.31, 0.145, 179, 83, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
1706, d4irsA1, 0.6939, 2.19, 0.136, 169, 81, STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
1707, d3rugA1, 0.6939, 2.34, 0.145, 179, 83, CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D- ALPHAGLUCOSYLCERAMIDE (C20:2)
1708, d2h26A2, 0.6939, 2.32, 0.145, 180, 83, HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINE AND SPACER
1709, d4y4hE1, 0.6930, 2.28, 0.145, 180, 83, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
1710, d4y4hA1, 0.6926, 2.31, 0.145, 179, 83, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
1711, d3rtqA1, 0.6925, 2.31, 0.145, 180, 83, STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
1712, d2q7yA2, 0.6925, 2.46, 0.119, 180, 84, STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D
1713, d1xz0C2, 0.6925, 2.27, 0.146, 172, 82, CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE
1714, d4ei5E1, 0.6924, 2.27, 0.159, 172, 82, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1715, p3d2uA1, 0.6924, 2.47, 0.143, 178, 84, STRUCTURE OF UL18 A PEPTIDE-BINDING VIRAL MHC MIMIC BOUND TO A HOST INHIBITORY RECEPTOR
1716, d5wkeA1, 0.6923, 2.32, 0.145, 180, 83, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PS
1717, p5vcjA1, 0.6921, 2.29, 0.145, 180, 83, STRUCTURE OF ALPHA-GALACTOSYLPHYTOSPHINGOSINE BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR
1718, d4y4kA1, 0.6920, 2.33, 0.145, 179, 83, CRYSTAL STRUCTURE OF THE MCD1D/EF77/INKTCR TERNARY COMPLEX
1719, d3sddA1, 0.6920, 2.18, 0.136, 162, 81, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
1720, d4y4fE1, 0.6917, 2.29, 0.145, 180, 83, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
1721, d4en3C1, 0.6916, 2.33, 0.145, 180, 83, CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
1722, p5efiA1, 0.6913, 2.31, 0.145, 178, 83, CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH THE P99P LIPOPEPTIDE
1723, p6bmhC1, 0.6912, 2.22, 0.122, 180, 82, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1724, d3o8xA1, 0.6912, 2.35, 0.145, 179, 83, RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
1725, d3sdaA1, 0.6909, 2.35, 0.145, 179, 83, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1726, d5l2jA1, 0.6906, 2.34, 0.145, 179, 83, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH C36-GMM
1727, d5wkgA1, 0.6903, 2.38, 0.145, 179, 83, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PA
1728, d1i1aA2, 0.6903, 2.47, 0.133, 176, 83, CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC
1729, d5tw2A1, 0.6899, 2.49, 0.143, 179, 84, STRUCTURE OF MOUSE CD1D WITH BOUND ALPHA-GALACTOSYLSPHINGAMIDE JG168
1730, d1uqsA2, 0.6897, 2.37, 0.094, 186, 85, THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID
1731, d1xz0A2, 0.6896, 2.37, 0.094, 186, 85, CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE
1732, p3d2uE2, 0.6895, 2.21, 0.122, 180, 82, STRUCTURE OF UL18 A PEPTIDE-BINDING VIRAL MHC MIMIC BOUND TO A HOST INHIBITORY RECEPTOR
1733, p6bnlE1, 0.6894, 2.45, 0.145, 177, 83, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
1734, d3o9wA1, 0.6892, 2.36, 0.145, 180, 83, RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
1735, d3tvmA1, 0.6889, 2.35, 0.145, 180, 83, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
1736, d3ilqC1, 0.6889, 2.33, 0.145, 179, 83, STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2C FROM BORRELIA BURGDORFERI
1737, p6bmhG1, 0.6885, 2.30, 0.099, 174, 81, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1738, p6bnlA1, 0.6882, 2.41, 0.136, 171, 81, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
1739, p6bnkE1, 0.6881, 2.43, 0.133, 177, 83, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
1740, p4ei5A1, 0.6880, 2.35, 0.145, 179, 83, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1741, d3ilpA1, 0.6877, 2.34, 0.145, 180, 83, STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2F FROM BORRELIA BURGDORFERI
1742, d1hyrC2, 0.6876, 2.44, 0.120, 180, 83, CRYSTAL STRUCTURE OF HUMAN MICA IN COMPLEX WITH NATURAL KILLER CELL RECEPTOR NKG2D
1743, d3scmA1, 0.6875, 2.31, 0.120, 180, 83, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
1744, d3l9rG1, 0.6874, 2.51, 0.143, 174, 84, CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
1745, d3arbA1, 0.6873, 2.41, 0.134, 177, 82, TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
1746, p6bnkA1, 0.6871, 2.33, 0.120, 181, 83, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
1747, p4gupC1, 0.6870, 2.51, 0.143, 177, 84, STRUCTURE OF MHC-CLASS I RELATED MOLECULE MR1
1748, p4n0uA1, 0.6868, 2.33, 0.095, 103, 84, TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR SERUM ALBUMIN AND FC
1749, d3ma7C1, 0.6866, 2.47, 0.145, 177, 83, CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D
1750, d3sdcA1, 0.6865, 2.37, 0.145, 180, 83, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
1751, d4n0fH1, 0.6863, 2.39, 0.145, 180, 83, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
1752, d4n0fA1, 0.6860, 2.16, 0.137, 176, 80, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
1753, d4v3dD_, 0.6858, 2.46, 0.133, 177, 83, THE CIDRA DOMAIN FROM HB3VAR03 PFEMP1 BOUND TO ENDOTHELIAL PROTEIN C RECEPTOR
1754, d4n0fE1, 0.6858, 2.47, 0.145, 178, 83, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
1755, d3t8xA1, 0.6856, 2.47, 0.145, 176, 83, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER
1756, d4n0fK1, 0.6855, 2.47, 0.145, 177, 83, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
1757, p4elmC1, 0.6854, 2.34, 0.136, 173, 81, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1758, d4k71B1, 0.6846, 2.84, 0.103, 181, 87, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
1759, d3qi9A1, 0.6846, 2.84, 0.103, 181, 87, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
1760, d1z5lA2, 0.6846, 2.38, 0.145, 179, 83, STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D
1761, p6c97A1, 0.6838, 2.48, 0.108, 180, 83, CRYSTAL STRUCTURE OF FCRN AT PH3 
1762, p6bmhE1, 0.6835, 2.39, 0.145, 178, 83, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1763, d5wl1A1, 0.6835, 2.48, 0.145, 176, 83, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PG
1764, d4k71E1, 0.6832, 2.63, 0.129, 173, 85, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
1765, d4apqA1, 0.6828, 2.52, 0.143, 172, 84, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
1766, d4f7cA1, 0.6823, 2.41, 0.146, 173, 82, CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE
1767, p6c97C1, 0.6822, 2.39, 0.145, 179, 83, CRYSTAL STRUCTURE OF FCRN AT PH3 
1768, d3m1bA1, 0.6821, 2.61, 0.143, 173, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
1769, p6c15A1, 0.6820, 2.60, 0.143, 173, 84, CD1C IN COMPLEX WITH PHOSPHATIDYLCHOLINE
1770, p6bmhA1, 0.6816, 2.21, 0.137, 168, 80, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1771, p4elmA1, 0.6810, 2.61, 0.143, 173, 84, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1772, p3m17A1, 0.6809, 2.50, 0.120, 180, 83, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
1773, p6bmkC1, 0.6807, 2.61, 0.143, 173, 84, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1774, d3g08A1, 0.6807, 2.44, 0.134, 177, 82, CRYSTAL STRUCTURE OF THE ALPHA-GALACTOSYLCERAMIDE ANALOG OCH IN COMPLEX WITH MOUSE CD1D
1775, p5bjtG1, 0.6806, 2.42, 0.145, 172, 83, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A PEPTIDE INHIBITOR AT MULTIPLE SITES
1776, p6c99A1, 0.6805, 2.41, 0.145, 180, 83, CRYSTAL STRUCTURE OF FCRN BOUND TO UCB-303 
1777, d3he6A1, 0.6801, 2.36, 0.136, 175, 81, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
1778, p3m17G1, 0.6796, 2.51, 0.143, 172, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
1779, d3arfA1, 0.6795, 2.48, 0.133, 177, 83, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
1780, p5bjtC1, 0.6794, 2.57, 0.119, 180, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A PEPTIDE INHIBITOR AT MULTIPLE SITES
1781, p6bmkA1, 0.6793, 2.61, 0.143, 172, 84, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1782, d3t1fA1, 0.6788, 2.39, 0.145, 180, 83, CRYSTAL STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2 COMPLEX
1783, d3l9rE1, 0.6788, 2.29, 0.075, 173, 80, CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
1784, d3l9rA1, 0.6783, 2.40, 0.145, 172, 83, CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
1785, d5bxfA1, 0.6782, 2.74, 0.141, 172, 85, APO FCRN STRUCTURE AT PH 4.5
1786, d3m1bG1, 0.6782, 2.16, 0.141, 172, 78, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
1787, p3tn0A1, 0.6780, 2.51, 0.133, 177, 83, STRUCTURE OF MOUSE VA14VB8.2NKT TCR-MOUSE CD1D-A-C-GALACTOSYLCERAMIDE COMPLEX
1788, d3l9rC1, 0.6777, 2.56, 0.134, 175, 82, CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
1789, d3areA1, 0.6776, 2.56, 0.143, 171, 84, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE
1790, d1z5lC2, 0.6776, 2.50, 0.133, 176, 83, STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D
1791, d5bxfC1, 0.6775, 2.40, 0.136, 173, 81, APO FCRN STRUCTURE AT PH 4.5
1792, d3u0pE1, 0.6766, 2.67, 0.143, 170, 84, CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE
1793, d3m1bE1, 0.6753, 2.45, 0.145, 172, 83, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
1794, p6c98A1, 0.6751, 2.39, 0.146, 173, 82, CRYSTAL STRUCTURE OF FCRN BOUND TO UCB-84 
1795, d1l8jA_, 0.6749, 2.47, 0.145, 170, 83, CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR AND BOUND PHOSPHOLIPID MOLECULE
1796, p6c98C1, 0.6747, 2.42, 0.134, 178, 82, CRYSTAL STRUCTURE OF FCRN BOUND TO UCB-84 
1797, p5bjtE1, 0.6736, 2.63, 0.143, 170, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A PEPTIDE INHIBITOR AT MULTIPLE SITES
1798, d1je6A2, 0.6735, 2.53, 0.107, 176, 84, STRUCTURE OF THE MHC CLASS I HOMOLOG MICB
1799, p4mxqA1, 0.6732, 2.38, 0.137, 171, 80, 42F3 TCR PCPC5/H-2LD COMPLEX
1800, p4n5eA1, 0.6721, 2.54, 0.120, 180, 83, 42F3 TCR PCPA12/H-2LD COMPLEX
1801, p5bjtA1, 0.6718, 2.53, 0.120, 180, 83, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A PEPTIDE INHIBITOR AT MULTIPLE SITES
1802, p3m17C1, 0.6717, 2.57, 0.131, 172, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
1803, p3ardA1, 0.6717, 2.44, 0.145, 172, 83, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3 DEOXY-ALPHA- GALACTOSYLCERAMIDE
1804, p3m17E1, 0.6699, 2.35, 0.146, 177, 82, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
1805, d3m1bC1, 0.6684, 2.58, 0.108, 180, 83, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
1806, d3fruA2, 0.6680, 2.43, 0.134, 177, 82, NEONATAL FC RECEPTOR PH 6.5
1807, d3fruE2, 0.6670, 2.38, 0.137, 175, 80, NEONATAL FC RECEPTOR PH 6.5
1808, d3to4A1, 0.6668, 2.64, 0.143, 172, 84, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
1809, p4zezA1, 0.6664, 2.24, 0.101, 172, 79, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
1810, d3tvmE1, 0.6658, 2.81, 0.141, 172, 85, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
1811, d3fruC2, 0.6657, 2.67, 0.143, 169, 84, NEONATAL FC RECEPTOR PH 6.5
1812, d3he7A1, 0.6653, 2.45, 0.136, 170, 81, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
1813, d4mq7A1, 0.6641, 2.67, 0.143, 169, 84, STRUCTURE OF HUMAN CD1D-SULFATIDE
1814, p3argA1, 0.6637, 2.55, 0.143, 171, 84, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2)
1815, p4n5eA2, 0.6635, 2.81, 0.141, 181, 85, 42F3 TCR PCPA12/H-2LD COMPLEX
1816, d4x6fA1, 0.6633, 2.71, 0.155, 96, 84, CD1A BINARY COMPLEX WITH SPHINGOMYELIN
1817, p5jziA1, 0.6629, 2.72, 0.155, 96, 84, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
1818, d1frtA2, 0.6611, 2.51, 0.145, 170, 83, CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC
1819, d5j1aA1, 0.6607, 2.50, 0.157, 170, 83, ANTIGEN PRESENTING MOLECULE
1820, p4mxqA2, 0.6591, 2.36, 0.136, 177, 81, 42F3 TCR PCPC5/H-2LD COMPLEX
1821, d4x6eA1, 0.6581, 2.60, 0.143, 171, 84, CD1A BINARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE
1822, d5wkiA1, 0.6575, 2.83, 0.141, 172, 85, CRYSTAL STRUCTURE OF PG90 TCR-CD1B-PG COMPLEX
1823, d1zs8I2, 0.6575, 2.50, 0.145, 178, 83, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1824, d1zs8G2, 0.6575, 2.51, 0.145, 178, 83, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1825, d1zs8E2, 0.6575, 2.35, 0.137, 175, 80, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1826, d1zs8C2, 0.6575, 2.90, 0.153, 139, 85, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1827, d1zs8A2, 0.6575, 2.37, 0.139, 175, 79, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1828, p3dxaF1, 0.6573, 2.45, 0.146, 178, 82, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
1829, d2wy3A_, 0.6568, 2.37, 0.137, 168, 80, STRUCTURE OF THE HCMV UL16-MICB COMPLEX ELUCIDATES SELECT BINDING OF A VIRAL IMMUNOEVASIN TO DIVERSE NKG2D LIGANDS
1830, p5swzF1, 0.6543, 2.33, 0.103, 173, 78, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1831, d2wy3C_, 0.6532, 2.35, 0.137, 174, 80, STRUCTURE OF THE HCMV UL16-MICB COMPLEX ELUCIDATES SELECT BINDING OF A VIRAL IMMUNOEVASIN TO DIVERSE NKG2D LIGANDS
1832, p4o2fD1, 0.6513, 2.02, 0.143, 78, 77, A PEPTIDE COMPLEXED WITH HLA-B*3901
1833, d1exuA2, 0.6509, 2.18, 0.145, 164, 76, CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR
1834, p5w69E1, 0.6497, 2.93, 0.153, 151, 85, HLA-C*06:02 PRESENTING ARFNDLRFV
1835, p5xotA1, 0.6488, 2.54, 0.145, 178, 83, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
1836, p5iroU2, 0.6479, 2.54, 0.145, 178, 83, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1837, p6c99C1, 0.6457, 2.20, 0.145, 169, 76, CRYSTAL STRUCTURE OF FCRN BOUND TO UCB-303 
1838, p5w1vA1, 0.6457, 2.07, 0.143, 78, 77, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
1839, d4fqxA1, 0.6431, 2.22, 0.145, 165, 76, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
1840, p4priA1, 0.6414, 2.42, 0.111, 176, 81, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX
1841, p4nqxE1, 0.6390, 2.77, 0.110, 171, 82, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1842, d1i3rC2, 0.6311, 2.77, 0.110, 171, 82, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
1843, d1i3rE2, 0.6303, 2.77, 0.110, 171, 82, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
1844, d1i3rA2, 0.6302, 2.77, 0.110, 171, 82, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
1845, d1i3rG2, 0.6295, 2.77, 0.110, 171, 82, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
1846, p3pdoA1, 0.6290, 2.77, 0.110, 171, 82, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP102-120
1847, d1bx2A2, 0.6258, 2.18, 0.158, 86, 76, CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN
1848, d2wbjA1, 0.6256, 2.71, 0.145, 173, 83, TCR COMPLEX
1849, p3s4sD1, 0.6251, 2.82, 0.131, 111, 84, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
1850, d5ksbA1, 0.6238, 2.52, 0.146, 167, 82, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
1851, d1hqrA2, 0.6228, 2.17, 0.147, 86, 75, CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH- AFFINITY ZINC-DEPENDENT SITE ON MHC CLASS II
1852, p4ov5G1, 0.6226, 2.71, 0.145, 165, 83, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
1853, d4aenA1, 0.6219, 2.85, 0.131, 121, 84, HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION
1854, d1bx2D2, 0.6217, 2.17, 0.173, 86, 75, CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN
1855, d5ksbC1, 0.6213, 2.27, 0.139, 83, 79, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
1856, d2wbjE1, 0.6213, 2.48, 0.152, 167, 79, TCR COMPLEX
1857, d3o6fE1, 0.6212, 2.96, 0.119, 110, 84, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
1858, p5iroU1, 0.6211, 2.62, 0.103, 80, 78, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1859, d1iebC2, 0.6211, 1.99, 0.189, 86, 74, HISTOCOMPATIBILITY ANTIGEN
1860, d5laxA1, 0.6207, 2.23, 0.158, 118, 76, CRYSTAL STRUCTURE OF HLA_DRB1*04:01 IN COMPLEX WITH ALPHA-ENOLASE PEPTIDE 26-40
1861, d1r5wC2, 0.6206, 2.64, 0.103, 81, 78, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
1862, p4ov5M1, 0.6205, 2.63, 0.103, 81, 78, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
1863, d1r5wA2, 0.6205, 2.65, 0.103, 81, 78, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
1864, d1hxyA2, 0.6203, 2.81, 0.104, 81, 77, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II
1865, p3qxdD1, 0.6200, 2.57, 0.077, 81, 78, F54C HLA-DR1 BOUND WITH CLIP PEPTIDE
1866, d3c5jA1, 0.6198, 2.62, 0.078, 80, 77, CRYSTAL STRUCTURE OF HLA DR52C
1867, d1fneC2, 0.6198, 2.57, 0.079, 79, 76, HISTOCOMPATIBILITY ANTIGEN
1868, d1r5vC2, 0.6197, 2.72, 0.077, 81, 78, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
1869, p6cpnA1, 0.6195, 2.56, 0.079, 82, 76, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1870, d1r5vA2, 0.6195, 2.61, 0.079, 79, 76, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
1871, d1aqdJ2, 0.6188, 2.46, 0.079, 78, 76, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
1872, d1aqdD2, 0.6188, 2.49, 0.079, 81, 76, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
1873, d5laxC1, 0.6187, 2.67, 0.078, 80, 77, CRYSTAL STRUCTURE OF HLA_DRB1*04:01 IN COMPLEX WITH ALPHA-ENOLASE PEPTIDE 26-40
1874, d3qibA1, 0.6187, 2.58, 0.079, 82, 76, CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
1875, d5ksuD1, 0.6186, 2.45, 0.080, 78, 75, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP1 AT 2.73 RESOLUTION
1876, d1s9vD2, 0.6186, 2.56, 0.078, 80, 77, CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
1877, d4ozgC1, 0.6185, 2.83, 0.150, 93, 80, D2 PROTEIN COMPLEX
1878, d4i5bD1, 0.6184, 2.74, 0.104, 81, 77, STRUCTURE OF HUMAN MHC CLASS II PROTEIN HLA-DR1 CARRYING AN INFLUENZA HEMAGGLUTININ PEPTIDE PARTIALLY FILLING THE BINDING GROOVE
1879, d1iebA2, 0.6184, 2.70, 0.078, 80, 77, HISTOCOMPATIBILITY ANTIGEN
1880, d1fytA2, 0.6184, 2.61, 0.105, 79, 76, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR1
1881, d4ozhC1, 0.6183, 2.41, 0.080, 78, 75, S16 PROTEIN COMPLEX
1882, d1ktdC2, 0.6183, 2.61, 0.105, 79, 76, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
1883, p4ov5J1, 0.6178, 2.55, 0.079, 79, 76, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
1884, d1kt2C2, 0.6178, 2.42, 0.080, 78, 75, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
1885, d1ieaA2, 0.6178, 2.59, 0.079, 79, 76, HISTOCOMPATIBILITY ANTIGEN
1886, d1aqdA2, 0.6177, 2.83, 0.103, 81, 78, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
1887, d1aqdG2, 0.6175, 2.58, 0.105, 79, 76, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
1888, d4h26D1, 0.6174, 2.76, 0.077, 81, 78, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
1889, p3s5lD1, 0.6174, 2.58, 0.105, 79, 76, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
1890, d4i5bA1, 0.6173, 2.56, 0.079, 79, 76, STRUCTURE OF HUMAN MHC CLASS II PROTEIN HLA-DR1 CARRYING AN INFLUENZA HEMAGGLUTININ PEPTIDE PARTIALLY FILLING THE BINDING GROOVE
1891, p4ov5D1, 0.6171, 2.58, 0.079, 79, 76, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
1892, d1fngC2, 0.6171, 2.72, 0.078, 80, 77, HISTOCOMPATIBILITY ANTIGEN
1893, d1h15A2, 0.6169, 2.79, 0.103, 81, 78, X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE
1894, p3s4sA1, 0.6168, 2.57, 0.079, 82, 76, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
1895, d5ksuA1, 0.6167, 2.58, 0.079, 83, 76, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP1 AT 2.73 RESOLUTION
1896, d1s9vA2, 0.6165, 2.56, 0.079, 81, 76, CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
1897, p3l6fA1, 0.6163, 2.72, 0.078, 80, 77, STRUCTURE OF MHC CLASS II MOLECULE HLA-DR1 COMPLEXED WITH PHOSPHOPEPTIDE MART-1
1898, d1kg0A2, 0.6161, 2.65, 0.104, 81, 77, STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TO THE MHC CLASS II RECEPTOR HLA-DR1
1899, d1ieaC2, 0.6161, 2.68, 0.078, 80, 77, HISTOCOMPATIBILITY ANTIGEN
1900, d5ksvA1, 0.6158, 2.59, 0.079, 81, 76, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP2
1901, d5whkA1, 0.6155, 2.80, 0.103, 81, 78, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY DX-2507 BOUND TO FCRN- B2M
1902, d3o6fA1, 0.6155, 2.42, 0.080, 77, 75, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
1903, d1kt2A2, 0.6152, 2.92, 0.103, 81, 78, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
1904, d1fneA2, 0.6151, 2.67, 0.104, 81, 77, HISTOCOMPATIBILITY ANTIGEN
1905, d1dlhA2, 0.6151, 2.57, 0.079, 79, 76, CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
1906, d1jfmB_, 0.6150, 2.57, 0.079, 79, 76, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
1907, d1fv1A2, 0.6149, 2.61, 0.079, 79, 76, STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES
1908, d1j8hA2, 0.6147, 2.64, 0.079, 78, 76, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
1909, d1h15D2, 0.6146, 2.71, 0.078, 80, 77, X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE
1910, d1sebE2, 0.6145, 2.57, 0.079, 78, 76, COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
1911, d1sebA2, 0.6145, 2.66, 0.104, 81, 77, COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
1912, d1fngA2, 0.6145, 2.58, 0.079, 79, 76, HISTOCOMPATIBILITY ANTIGEN
1913, d1dlhD2, 0.6145, 2.55, 0.080, 79, 75, CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
1914, p2xn9D1, 0.6142, 2.58, 0.079, 82, 76, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL RECEPTOR STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
1915, p6cqnA1, 0.6140, 2.59, 0.079, 83, 76, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1916, p6cqjG1, 0.6140, 2.61, 0.079, 79, 76, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1917, d4ozhA1, 0.6140, 2.54, 0.080, 79, 75, S16 PROTEIN COMPLEX
1918, p3s5lA1, 0.6140, 2.68, 0.104, 81, 77, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
1919, d3qiuA1, 0.6136, 2.62, 0.079, 81, 76, CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK
1920, p6cqjA1, 0.6135, 2.75, 0.150, 160, 80, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1921, d5ksaA1, 0.6134, 2.43, 0.080, 78, 75, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
1922, d4ozfA1, 0.6134, 2.84, 0.103, 81, 78, JR5.1 PROTEIN COMPLEX
1923, d3pl6A1, 0.6133, 2.70, 0.104, 81, 77, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
1924, d4ozgA1, 0.6132, 2.70, 0.104, 81, 77, D2 PROTEIN COMPLEX
1925, d2ianK2, 0.6128, 2.62, 0.079, 79, 76, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
1926, d1fv1D2, 0.6128, 2.87, 0.062, 174, 81, STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES
1927, p6cqrF1, 0.6127, 2.58, 0.079, 79, 76, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1928, d1jwmA2, 0.6127, 2.71, 0.078, 80, 77, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1(HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3
1929, d2ianP2, 0.6125, 2.63, 0.079, 79, 76, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
1930, d1t5wD2, 0.6125, 2.84, 0.077, 81, 78, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
1931, p6cqrA1, 0.6124, 2.84, 0.077, 81, 78, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1932, d4grlA1, 0.6118, 2.70, 0.104, 81, 77, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
1933, d1t5wA2, 0.6117, 2.62, 0.079, 79, 76, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
1934, d4z7vA1, 0.6116, 2.49, 0.080, 78, 75, L3-12 COMPLEX
1935, p4y19A1, 0.6116, 2.60, 0.081, 77, 74, IMMUNE COMPLEX
1936, d1jwsA2, 0.6116, 2.63, 0.079, 79, 76, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B1
1937, p6atiD1, 0.6114, 2.61, 0.079, 81, 76, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN-64CIT59-71
1938, d1ktdA2, 0.6114, 2.62, 0.079, 79, 76, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
1939, p6atiA1, 0.6113, 2.58, 0.105, 79, 76, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN-64CIT59-71
1940, d4z7vC1, 0.6113, 2.62, 0.079, 79, 76, L3-12 COMPLEX
1941, d5v4mJ1, 0.6112, 2.62, 0.079, 82, 76, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
1942, d4h26A1, 0.6109, 2.58, 0.079, 81, 76, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
1943, d5v4mA1, 0.6107, 2.63, 0.079, 83, 76, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
1944, p4p2oA1, 0.6107, 2.57, 0.079, 81, 76, CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH 2A/I-EK
1945, d2sebA2, 0.6107, 2.68, 0.080, 79, 75, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II
1946, p6cpoA1, 0.6105, 2.45, 0.080, 78, 75, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1947, d1jwuA2, 0.6104, 2.59, 0.079, 79, 76, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B2
1948, d4mayA1, 0.6099, 2.61, 0.079, 79, 76, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
1949, p6cpoD1, 0.6098, 2.73, 0.079, 79, 76, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1950, d4pp8C_, 0.6097, 2.48, 0.080, 78, 75, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA IN COMPLEX WITH NKG2D
1951, d4ah2A1, 0.6096, 2.58, 0.079, 79, 76, HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN CANONICAL ORIENTATION
1952, d4h25D1, 0.6094, 2.58, 0.093, 83, 75, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
1953, d5v4mG1, 0.6093, 2.48, 0.080, 78, 75, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
1954, d2ianF2, 0.6093, 2.63, 0.092, 81, 76, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
1955, d1uvqA2, 0.6093, 2.55, 0.079, 79, 76, CRYSTAL STRUCTURE OF HLA-DQ0602 IN COMPLEX WITH A HYPOCRETIN PEPTIDE
1956, d1jfmA_, 0.6093, 2.64, 0.079, 79, 76, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
1957, p5ni9A1, 0.6088, 2.70, 0.079, 78, 76, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 WITH THE ALPHA-ENOLASE PEPTIDE 326-340 
1958, p4mdjA1, 0.6088, 2.72, 0.104, 81, 77, IMMUNE RECEPTOR
1959, p2q6wD1, 0.6087, 2.70, 0.079, 78, 76, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
1960, d5v4mD1, 0.6086, 2.63, 0.092, 81, 76, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
1961, d1iaoA2, 0.6084, 2.48, 0.080, 78, 75, CLASS II MHC I-AD IN COMPLEX WITH OVALBUMIN PEPTIDE 323-339
1962, d4z7wC1, 0.6082, 2.66, 0.079, 79, 76, T316 COMPLEX
1963, d1pywA2, 0.6078, 2.48, 0.080, 78, 75, HUMAN CLASS II MHC PROTEIN HLA-DR1 BOUND TO A DESIGNED PEPTIDE RELATED TO INFLUENZA VIRUS HEMAGGLUTININ FVKQNA(MAA)AL IN COMPLEX WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1964, d4e41A1, 0.6077, 2.68, 0.105, 77, 76, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
1965, d2iamA2, 0.6076, 2.86, 0.077, 81, 78, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
1966, d1sjeA2, 0.6076, 2.51, 0.080, 77, 75, HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDE BOUND IN A HAIRPIN CONFORMATION
1967, p5w1vA2, 0.6074, 2.58, 0.080, 79, 75, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
1968, d4z7wA1, 0.6073, 2.78, 0.078, 82, 77, T316 COMPLEX
1969, d3c6lG2, 0.6072, 2.58, 0.079, 79, 76, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20
1970, d4e41F1, 0.6070, 2.98, 0.089, 146, 79, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
1971, d1jk8A2, 0.6069, 2.51, 0.080, 80, 75, CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX
1972, d4pp8D_, 0.6068, 2.58, 0.079, 79, 76, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA IN COMPLEX WITH NKG2D
1973, d1jfmE_, 0.6068, 2.50, 0.080, 78, 75, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
1974, d3c6lC2, 0.6066, 2.64, 0.079, 79, 76, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20
1975, d4z7uC1, 0.6064, 2.54, 0.093, 83, 75, S13 COMPLEX
1976, d1t5xA2, 0.6064, 3.03, 0.061, 174, 82, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR) AND THE SUPERANTIGEN SEC3-3B2
1977, d1sjhA2, 0.6064, 3.03, 0.061, 174, 82, HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE
1978, d2fseA2, 0.6063, 2.74, 0.078, 80, 77, CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE HLA-DR1 (DRB1*0101) COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
1979, d1lo5A2, 0.6062, 2.65, 0.079, 79, 76, CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN A IN COMPLEX WITH HUMAN MHC CLASS II
1980, p6cqqA1, 0.6060, 2.64, 0.079, 79, 76, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1981, p6cqqF1, 0.6058, 2.51, 0.080, 78, 75, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1982, d3c5zG2, 0.6055, 2.88, 0.078, 82, 77, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
1983, d3c5zC2, 0.6054, 2.65, 0.092, 82, 76, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
1984, d1d5xA2, 0.6054, 2.46, 0.081, 78, 74, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB
1985, d4z7uA1, 0.6052, 2.67, 0.079, 79, 76, S13 COMPLEX
1986, d2ianA2, 0.6051, 2.74, 0.079, 79, 76, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
1987, p3pgdD1, 0.6039, 2.53, 0.080, 78, 75, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 CANONICAL PEPTIDE ORIENTATION
1988, d5ujtA1, 0.6038, 1.93, 0.174, 70, 69, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
1989, d5ks9C1, 0.6031, 2.65, 0.092, 82, 76, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
1990, d2fseC2, 0.6028, 2.93, 0.104, 82, 77, CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE HLA-DR1 (DRB1*0101) COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
1991, d1kluA2, 0.6027, 2.65, 0.079, 79, 76, CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1992, d5ks9A1, 0.6021, 2.84, 0.091, 84, 77, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
1993, d1d9kC2, 0.6020, 3.14, 0.061, 150, 82, CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
1994, d5ujtD1, 0.6019, 2.87, 0.090, 174, 78, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
1995, p2q6wA1, 0.6019, 2.89, 0.104, 82, 77, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
1996, d1d5mA2, 0.6019, 2.67, 0.092, 83, 76, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB
1997, d3cupA1, 0.6016, 2.53, 0.080, 78, 75, CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE I-AG7 IN COMPLEX WITH THE PEPTIDE GAD221-235
1998, d5ujtG1, 0.6013, 2.54, 0.080, 78, 75, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
1999, d1b3jA2, 0.6009, 2.47, 0.081, 78, 74, STRUCTURE OF THE MHC CLASS I HOMOLOG MIC-A A GAMMADELTA T CELL LIGAND
2000, d3wexE1, 0.6007, 2.52, 0.080, 78, 75, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
2001, d4p57C1, 0.6005, 2.70, 0.080, 78, 75, MHC TCR PEPTIDE COMPLEX
2002, d4h25A1, 0.6004, 2.69, 0.080, 77, 75, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
2003, d5dmkG1, 0.5998, 2.79, 0.107, 83, 75, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
2004, d2z31C2, 0.5994, 2.79, 0.107, 83, 75, CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
2005, d3wexA1, 0.5992, 2.51, 0.080, 79, 75, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
2006, d1d6eA2, 0.5990, 2.68, 0.092, 83, 76, CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB
2007, d1c16E2, 0.5990, 2.51, 0.080, 78, 75, CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
2008, d2p24A2, 0.5989, 2.62, 0.079, 78, 76, I-AU/MBP125-135
2009, d4p5mC1, 0.5988, 2.71, 0.092, 83, 76, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
2010, d4p5mA1, 0.5988, 2.69, 0.092, 83, 76, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
2011, p4p23C1, 0.5987, 2.58, 0.080, 78, 75, J809.B5 TCR BOUND TO IAB/3K
2012, d1iakA2, 0.5985, 2.55, 0.080, 78, 75, HISTOCOMPATIBILITY ANTIGEN I-AK
2013, d4p57A1, 0.5984, 2.68, 0.092, 83, 76, MHC TCR PEPTIDE COMPLEX
2014, d1es0A2, 0.5984, 2.73, 0.079, 82, 76, CRYSTAL STRUCTURE OF THE MURINE CLASS II ALLELE I-A(G7) COMPLEXED WITH THE GLUTAMIC ACID DECARBOXYLASE (GAD65) PEPTIDE 207-220
2015, d1klgA2, 0.5981, 2.72, 0.092, 84, 76, CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37 THR28-->ILE MUTANT) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
2016, d1d5zA2, 0.5981, 2.69, 0.079, 78, 76, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB
2017, d1u3hG2, 0.5975, 2.51, 0.080, 78, 75, CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
2018, p3it8J1, 0.5973, 2.82, 0.080, 84, 75, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
2019, d1lnuE2, 0.5973, 2.70, 0.092, 85, 76, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
2020, d1lnuA2, 0.5973, 3.09, 0.104, 170, 77, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
2021, p3it8E1, 0.5972, 2.93, 0.107, 82, 75, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
2022, d1lnuC2, 0.5972, 2.93, 0.107, 82, 75, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
2023, p3it8K1, 0.5971, 2.74, 0.079, 79, 76, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
2024, p3it8F1, 0.5971, 2.84, 0.080, 84, 75, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
2025, p3it8D1, 0.5971, 2.66, 0.108, 79, 74, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
2026, d1k2dA2, 0.5971, 2.94, 0.107, 82, 75, CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A
2027, p3it8L1, 0.5970, 2.57, 0.080, 78, 75, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
2028, d1lnuG2, 0.5970, 3.70, 0.120, 158, 83, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
2029, d6blqA1, 0.5968, 2.66, 0.108, 79, 74, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8E9E
2030, d5dmkE1, 0.5968, 3.11, 0.105, 83, 76, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
2031, d3c60C2, 0.5967, 2.90, 0.107, 83, 75, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
2032, d4p46C1, 0.5966, 2.84, 0.107, 82, 75, J809.B5 Y31A TCR BOUND TO IAB3K
2033, d5dmkC1, 0.5965, 2.82, 0.080, 82, 75, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
2034, d3wexC1, 0.5965, 2.87, 0.105, 82, 76, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
2035, d5dmkA1, 0.5962, 2.86, 0.080, 84, 75, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
2036, d2iadA2, 0.5961, 2.57, 0.080, 78, 75, CLASS II MHC I-AD IN COMPLEX WITH AN INFLUENZA HEMAGGLUTININ PEPTIDE 126-138
2037, d4p4rC1, 0.5959, 2.74, 0.079, 79, 76, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
2038, d2pxyC2, 0.5959, 2.67, 0.108, 79, 74, CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
2039, d4g59B_, 0.5957, 2.97, 0.053, 191, 76, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M152 WITH LIGAND RAE-1 GAMMA
2040, d3wexG1, 0.5955, 2.78, 0.105, 83, 76, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
2041, p3rdtC1, 0.5955, 2.78, 0.105, 83, 76, CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
2042, d4p5mG1, 0.5954, 2.97, 0.053, 191, 76, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
2043, d4p4kE1, 0.5950, 2.78, 0.105, 83, 76, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
2044, d1ypzC2, 0.5950, 2.97, 0.053, 191, 76, IMMUNE RECEPTOR
2045, d1a6aA2, 0.5949, 2.97, 0.053, 191, 76, THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3
2046, d4p4rA1, 0.5945, 2.97, 0.053, 191, 76, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
2047, d4p5mE1, 0.5939, 2.97, 0.053, 191, 76, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
2048, d4p5kD1, 0.5939, 2.65, 0.108, 79, 74, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGY AND AUTOIMMUNITY
2049, d1r3hE2, 0.5938, 2.97, 0.053, 191, 76, CRYSTAL STRUCTURE OF T10
2050, d6blxA1, 0.5936, 2.78, 0.105, 83, 76, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8G9E
2051, d1r5iE2, 0.5935, 2.88, 0.080, 86, 75, CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX
2052, d1r5iA2, 0.5935, 2.88, 0.080, 86, 75, CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX
2053, d4p4kA1, 0.5932, 2.91, 0.079, 84, 76, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
2054, d1u3hC2, 0.5930, 2.86, 0.107, 82, 75, CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
2055, d4p5kA1, 0.5925, 2.86, 0.107, 82, 75, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGY AND AUTOIMMUNITY
2056, d1pqzA2, 0.5913, 2.86, 0.080, 84, 75, MURINE CYTOMEGALOVIRUS IMMUNOMODULATORY PROTEIN M144
2057, d1c16A2, 0.5909, 2.96, 0.107, 82, 75, CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
2058, p5swzF2, 0.5908, 2.87, 0.080, 83, 75, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2059, d1r3hG2, 0.5905, 2.86, 0.080, 83, 75, CRYSTAL STRUCTURE OF T10
2060, d1f3jD2, 0.5905, 2.95, 0.107, 82, 75, HISTOCOMPATIBILITY ANTIGEN I-AG7
2061, d3c60G2, 0.5904, 2.69, 0.108, 79, 74, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
2062, d1c16C2, 0.5902, 3.19, 0.100, 163, 80, CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
2063, d1f3jA2, 0.5899, 2.97, 0.107, 82, 75, HISTOCOMPATIBILITY ANTIGEN I-AG7
2064, d1d9kG2, 0.5898, 2.87, 0.107, 82, 75, CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
2065, d1mujA2, 0.5894, 2.89, 0.105, 83, 76, CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE
2066, d1c16G2, 0.5888, 2.95, 0.107, 83, 75, CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
2067, p3d2uE1, 0.5875, 3.11, 0.101, 164, 79, STRUCTURE OF UL18 A PEPTIDE-BINDING VIRAL MHC MIMIC BOUND TO A HOST INHIBITORY RECEPTOR
2068, d3vwjA1, 0.5868, 2.51, 0.081, 77, 74, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
2069, d4g59A_, 0.5867, 3.00, 0.105, 82, 76, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M152 WITH LIGAND RAE-1 GAMMA
2070, d6blrA1, 0.5866, 2.92, 0.105, 83, 76, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8E9E6SS
2071, d3s6cA2, 0.5861, 2.99, 0.107, 83, 75, STRUCTURE OF HUMAN CD1E
2072, p4priA2, 0.5858, 3.49, 0.086, 154, 81, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX
2073, d1jl4A2, 0.5844, 2.91, 0.080, 84, 75, CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
2074, d1r3hC2, 0.5843, 2.89, 0.079, 78, 76, CRYSTAL STRUCTURE OF T10
2075, d1jfmD_, 0.5842, 2.89, 0.079, 78, 76, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
2076, d1ypzA2, 0.5823, 2.97, 0.107, 82, 75, IMMUNE RECEPTOR
2077, d3vwkA1, 0.5808, 2.69, 0.108, 79, 74, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX
2078, d4f7cC1, 0.5803, 2.92, 0.107, 83, 75, CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE
2079, d1jfmC_, 0.5788, 3.31, 0.051, 139, 79, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
2080, d2bc4C1, 0.5778, 3.31, 0.051, 139, 79, CRYSTAL STRUCTURE OF HLA-DM
2081, d2bc4A1, 0.5759, 3.49, 0.111, 164, 81, CRYSTAL STRUCTURE OF HLA-DM
2082, p4o2fD2, 0.5754, 3.49, 0.111, 164, 81, A PEPTIDE COMPLEXED WITH HLA-B*3901
2083, p3e3qU2, 0.5742, 2.03, 0.130, 69, 69, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
2084, d1r3hA2, 0.5740, 3.51, 0.125, 151, 80, CRYSTAL STRUCTURE OF T10
2085, d1k8iA2, 0.5736, 2.91, 0.080, 83, 75, CRYSTAL STRUCTURE OF MOUSE H2-DM
2086, p4pdcE_, 0.5719, 2.85, 0.105, 82, 76, CRYSTAL STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP) BOUND TO HUMAN NKG2D
2087, p4pdcF_, 0.5711, 3.52, 0.111, 164, 81, CRYSTAL STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP) BOUND TO HUMAN NKG2D
2088, p3w39A2, 0.5705, 2.96, 0.079, 83, 76, CRYSTAL STRUCTURE OF HLA-B*5201 IN COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE (TAFTIPSI)
2089, p6avfH2, 0.5704, 2.89, 0.080, 82, 75, CRYSTAL STRUCTURE OF THE KFJ5 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
2090, p3dxaF2, 0.5699, 2.93, 0.107, 85, 75, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2091, d1u58A2, 0.5697, 3.68, 0.110, 164, 82, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M144
2092, d1hdmA2, 0.5682, 2.58, 0.068, 81, 73, HISTOCOMPATIBILITY ANTIGEN HLA-DM
2093, p5xotA2, 0.5678, 2.94, 0.111, 171, 81, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
2094, p4ffeZ_, 0.5667, 3.34, 0.086, 162, 81, THE STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP)
2095, p3pabA3, 0.5586, 2.95, 0.080, 84, 75, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1
2096, p3tpuQ2, 0.5580, 2.96, 0.073, 170, 82, 42F3 P5E8/H2-LD COMPLEX
2097, p4ffeX_, 0.5557, 2.73, 0.135, 95, 74, THE STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP)
2098, d4fqxC1, 0.5553, 2.61, 0.082, 78, 73, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
2099, p4ffeY_, 0.5539, 3.64, 0.122, 154, 82, THE STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP)
2100, d1ymmA2, 0.5406, 3.06, 0.076, 174, 79, TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
2101, p4gbxA1, 0.5376, 3.75, 0.120, 164, 83, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5
2102, p3qiwA1, 0.5327, 3.07, 0.098, 172, 82, CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC-P5E/I-EK
2103, p2o5nA2, 0.5318, 3.20, 0.122, 172, 82, CRYSTAL STRUCTURE OF A VIRAL GLYCOPROTEIN
2104, p4p2qP1, 0.5292, 3.10, 0.076, 174, 79, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
2105, p4p2qA1, 0.5288, 3.07, 0.092, 85, 76, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
2106, p4p2rP1, 0.5283, 3.07, 0.092, 85, 76, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
2107, d1zglJ2, 0.5282, 3.08, 0.092, 84, 76, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2108, p4p2rA1, 0.5280, 2.96, 0.122, 95, 74, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
2109, d1zglG2, 0.5279, 2.90, 0.176, 82, 74, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2110, d1zglD2, 0.5278, 3.70, 0.111, 154, 81, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2111, d2g9hA2, 0.5271, 3.00, 0.107, 82, 75, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN I (SEI) IN COMPLEX WITH A HUMAN MHC CLASS II MOLECULE
2112, d1zglA2, 0.5269, 3.11, 0.070, 150, 71, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2113, p4p2qK1, 0.5266, 3.35, 0.055, 150, 73, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
2114, p4p2qF1, 0.5264, 3.07, 0.133, 83, 75, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
2115, p4p2rK1, 0.5249, 2.88, 0.149, 82, 74, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
2116, p2o5nB2, 0.5249, 3.02, 0.149, 95, 74, CRYSTAL STRUCTURE OF A VIRAL GLYCOPROTEIN
2117, p4p2rF1, 0.5242, 3.32, 0.051, 124, 78, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
2118, p4g59D2, 0.5240, 2.88, 0.081, 81, 74, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M152 WITH LIGAND RAE-1 GAMMA
2119, p6cqjD1, 0.5225, 2.97, 0.122, 95, 74, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2120, d2ipkA2, 0.5221, 3.33, 0.082, 150, 73, CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DR1 IN COMPLEX WITH THE FLUOROGENIC PEPTIDE ACPKXVKQNTLKLAT (X=3- [5-(DIMETHYLAMINO)-13-DIOXO-13-DIHYDRO-2H-ISOINDOL-2-YL]- L-ALANINE) AND THE SUPERANTIGEN SEC3 VARIANT 3B2
2121, p6bgaA1, 0.5217, 3.01, 0.176, 83, 74, 2B4 I-EK TCR-MHC COMPLEX WITH AFFINITY-ENHANCING VELCRO PEPTIDE 
2122, p4i0pA1, 0.5217, 2.79, 0.178, 82, 73, HLA-DO IN COMPLEX WITH HLA-DM
2123, p4g59C2, 0.5215, 3.31, 0.080, 150, 75, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M152 WITH LIGAND RAE-1 GAMMA
2124, p4oziA1, 0.5206, 3.31, 0.080, 150, 75, S2 PROTEIN COMPLEX
2125, p5jlzA1, 0.5204, 2.88, 0.097, 82, 72, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 IN COMPLEX WITH MODIFIED ALPHA- ENOLASE PEPTIDE 26-40 WITH CITRULLINE AT THE POSITION 32
2126, p3pgcD1, 0.5203, 3.32, 0.080, 150, 75, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 FLIPPED PEPTIDE ORIENTATION
2127, p4x5wA1, 0.5191, 2.47, 0.091, 69, 66, HLA-DR1 WITH CLIP102-120(M107W)
2128, p5jlzC1, 0.5176, 2.61, 0.092, 65, 65, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 IN COMPLEX WITH MODIFIED ALPHA- ENOLASE PEPTIDE 26-40 WITH CITRULLINE AT THE POSITION 32
2129, p4i0pE1, 0.5174, 2.52, 0.106, 67, 66, HLA-DO IN COMPLEX WITH HLA-DM
2130, p4i0pG1, 0.5165, 3.03, 0.101, 159, 69, HLA-DO IN COMPLEX WITH HLA-DM
2131, p4ov5P1, 0.5164, 3.03, 0.101, 159, 69, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
2132, p3t0eA1, 0.5159, 2.47, 0.092, 66, 65, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
2133, p2nykA1, 0.5159, 2.62, 0.091, 67, 66, CRYSTAL STRUCTURE OF M157 FROM MOUSE CYTOMEGALOVIRUS
2134, p4ov5A1, 0.5158, 2.49, 0.092, 66, 65, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
2135, p4c56J1, 0.5153, 2.55, 0.091, 69, 66, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
2136, p4i0pC1, 0.5147, 2.64, 0.091, 67, 66, HLA-DO IN COMPLEX WITH HLA-DM
2137, p3pgcA1, 0.5147, 2.55, 0.091, 69, 66, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 FLIPPED PEPTIDE ORIENTATION
2138, p4is6A1, 0.5139, 2.55, 0.091, 69, 66, CRYSTAL STRUCTURE OF HLA-DR4 BOUND TO GP100 PEPTIDE
2139, p6atzC1, 0.5131, 2.59, 0.091, 69, 66, HLA-DRB1*1402 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
2140, p4oziC1, 0.5131, 2.55, 0.091, 69, 66, S2 PROTEIN COMPLEX
2141, p6cplA1, 0.5126, 2.65, 0.091, 67, 66, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2142, p6atfA1, 0.5120, 2.66, 0.091, 67, 66, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN59-71
2143, p4h1lD1, 0.5118, 2.68, 0.091, 67, 66, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
2144, p4h1lA1, 0.5118, 3.10, 0.101, 159, 69, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
2145, p6atfD1, 0.5113, 2.67, 0.091, 67, 66, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN59-71
2146, p6atzA1, 0.5112, 2.98, 0.103, 157, 68, HLA-DRB1*1402 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
2147, p4md4A1, 0.5112, 2.81, 0.077, 67, 65, IMMUNE RECEPTOR
2148, p4y1aA1, 0.5111, 2.59, 0.091, 69, 66, IMMUNE COMPLEX
2149, p6birA1, 0.5107, 2.54, 0.092, 67, 65, HLA-DRB1 IN COMPLEX WITH CITRULLINATED VIMENTIN PEPTIDE
2150, p6cqlA1, 0.5103, 3.10, 0.103, 71, 68, CRYSTAL STRUCTURE OF A TCR 
2151, p5nigA1, 0.5097, 2.98, 0.103, 157, 68, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 WITH MODIFIED ALPHA-ENOLASE PEPTIDE 326-340 (ARGININE 327 TO CITRULLINE) 
2152, p4md0A1, 0.5097, 2.98, 0.103, 157, 68, IMMUNE RECEPTOR
2153, p3qxaD1, 0.5097, 2.53, 0.062, 67, 64, HLA-DR1 BOUND WITH CLIP PEPTIDE
2154, p4mczA1, 0.5096, 2.73, 0.077, 66, 65, IMMUNE RECEPTOR
2155, p4md5A1, 0.5095, 2.36, 0.079, 64, 63, IMMUNE RECEPTOR
2156, p4mcyA1, 0.5090, 2.64, 0.076, 68, 66, IMMUNE RECEPTOR
2157, p3qxdA1, 0.5089, 2.74, 0.077, 66, 65, F54C HLA-DR1 BOUND WITH CLIP PEPTIDE
2158, p4mdiA1, 0.5087, 3.10, 0.103, 71, 68, IMMUNE RECEPTOR
2159, p6binA1, 0.5084, 3.13, 0.078, 67, 64, HLA-DRB1 IN COMPLEX WITH TYPE II COLLAGEN PEPTIDE
2160, p6bijA1, 0.5082, 2.41, 0.079, 64, 63, HLA-DRB1 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
2161, p6bixA1, 0.5078, 2.37, 0.079, 64, 63, HLA-DRB1 IN COMPLEX WITH CITRULLINATED LL37 PEPTIDE
2162, p6bizA1, 0.5074, 3.35, 0.074, 146, 68, HLA-DRB1 IN COMPLEX WITH CITRULLINATED HISTONE 2B PEPTIDE
2163, p4c56D1, 0.5072, 2.61, 0.078, 65, 64, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
2164, p2nnaA1, 0.5072, 2.65, 0.078, 65, 64, STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DQ8 BOUND WITH A DEAMIDATED GLUTEN PEPTIDE
2165, p6bilA1, 0.5071, 2.97, 0.063, 67, 63, HLA-DRB1 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
2166, p5v4nA1, 0.5065, 2.44, 0.079, 64, 63, STRUCTURE OF HLA-DR1 WITH BOUND ALPHA3(135-145) PEPTIDE
2167, p6bivB1, 0.5061, 2.53, 0.078, 65, 64, HLA-DRB1 IN COMPLEX WITH CITRULLINATED LL37 PEPTIDE
2168, p3qxaA1, 0.5061, 2.63, 0.079, 64, 63, HLA-DR1 BOUND WITH CLIP PEPTIDE
2169, p6biyA1, 0.5055, 2.59, 0.062, 67, 64, HLA-DRB1 IN COMPLEX WITH HISTONE 2B PEPTIDE
2170, p4x5xA1, 0.5054, 2.75, 0.077, 66, 65, HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W)
2171, p4x5xC1, 0.5035, 2.69, 0.078, 65, 64, HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W)
2172, p5v4nD1, 0.5034, 2.68, 0.078, 65, 64, STRUCTURE OF HLA-DR1 WITH BOUND ALPHA3(135-145) PEPTIDE
2173, p4gg6C1, 0.5021, 2.67, 0.078, 65, 64, PROTEIN COMPLEX
2174, p4gg6A1, 0.5021, 2.70, 0.078, 65, 64, PROTEIN COMPLEX
2175, d2icwD2, 0.5014, 2.49, 0.079, 64, 63, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
2176, d2icwA2, 0.5014, 2.68, 0.078, 65, 64, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
2177, d2ojeE2, 0.5007, 2.59, 0.079, 64, 63, MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA
2178, d2ojeA2, 0.5007, 2.45, 0.079, 64, 63, MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA
